incivo works by blocking the virus that causes hepatitis c infection . inciVO is used to treat chronic hepatis  c disease in adults who are at least 1865 years of age at least two years of old . it can be used alone or together with peginterferon alfa - 2b , ribavirin and telaprevir . these belong to a group of medicines called ns3 - 4a protease inhibitors . the nns 3 - 5a proteace inhibitor is designed to stop the heptis cr virus from multiplying . when used with peggedinterferone alf - 3b or rib avirine , the combination of inciva is used for the treatment of chronic hpatiti c infections in adults . to treat adult patients with chronic
do not take incivo - if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). - when taking peginterferon alfa and ribavirin , please be aware of their constraints ( e . g . pregnancy precautions ). warnings and precautions talk to your doctor or pharmacist before taking inciVO . taking peggedinterferone alf - 2b or rib avirIN with inciva , some patients may be more likely to be fatally affected by the following medicines , which may cause severe side effects 56 of the medicine alfuzosin . symptoms of an enlarged prostate may occur more frequently in women who are already taking alpha - 1 - adrenal antagonists ( i . ex ., amiodarone , bepridil 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . if necessary , your doctor will prescribe the appropriate dose regimen . the recommended dose regimen is : 3 to 6 capsules daily , with or without food , at 2 to 8 days per week . this is a total of 6 capsule / day . for patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , the recommended dosage regimen is 3 to 8 capsules per day , depending on the body surface area of the patient . your doctor may increase your dose if incivo is taken with food or drinks . you should swallow the capsules whole with water . it is recommended that you take the capsule with food . maximum recommended doses of inciVO are 60 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . rash : - if you develop an itchy skin rash the rash may get worse over time . your doctor will tell you what to do if the rashes get worse or get other symptoms of the ring . these may be signs of a severe skin reaction , and you should report it immediately . when you develop a skin r , tell your doctor , pharmacist or nurse immediately , as incivo may need to be stopped and you may need medical attention . other symptoms that may occur after a rash include fever , tiredness , swelling of the face , or swelling of lymph glands . very common : is a wide - spread rash with peeling skin . fever ; flu - like symptoms , painful skin skin , rash and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . incivo tablets should be stored in the original bottle and keep the bottle tightly closed in order to protect from moisture . keep the blister in the bottle and do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of inciVO contains 375 mg of tel aprevic . - other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrously , sodium lauryl sulphate , croscarmellose sodium , and sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , the active ingredient in inci Vo is talc , titanium dioxide ( e171 ), iron oxide yellow ( 233 ). what if you notice that the pack film  is yellow caplet - shaped tablets , imprinted with " tmc " on one side . the tablet is 20 
what zinbryta is zinberytta contains the active substance daclizumab beta , a monoclonal antibody . what zbrytar is used for zin Bryte is used to treat multiple sclerosis in adults , when therapy is not available or has failed to work adequately . it is used in combination with two ms treatment cycles or with other treatments to reduce inflammation and reduce the protective sheath around the nerves ( central nervous system ) that surrounds the brain and spinal cord . this loss of myelin ( also called demyelinate ) can lead to relapsing m , with repeated attacks ( relapses ). it is believed that these attacks ( and not everyone gets them ) are due to nerves not working properly . these attacks may be severe and involve a lack of protective mye
do not take zinbryta - if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine listed in section 6 . - have liver problems . warnings and precautions talk to your doctor or pharmacist before taking zinberyt : - you have any other autoimmune disorders . do not use any other medicines , herbal supplements or any medicines or supplements you take at the same time ( for example , coffee grounds ). this is because some people take these medicines and some people do not have any symptoms at all . you may get liver side effects when taking these medicines . your doctor may need to change your dose . talk to you doctor or pharmacy before taking the medicine if : you have ever had depression in the past you have or have had , or you have a severe infection such as pneumonia or tuberculosis
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much zinbryta to inject the recommended dose of zinberyt , which is 150 mg , depends on a blood test results showing how well your liver is working . your doctor will decide how much medicine you should receive . the recommended starting dose of one injection of zbrytar is 40 mg . based on the results of this blood test your doctor may decide to give you a test to see if zinblita is working for you , your doctor , or your pharmacist will decide whether you should inject yourself zin brryte under the skin ( subcutaneously ) into your thigh , stomach , back or upper arm . when injecting zinbrita , you should wait at least 7 minutes before injecting
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor , pharmacist or nurse . your doctor will discuss the side effects with you and will explain the risks and benefits of your treatment . serious side effects tell your doctor or pharmacist immediately if any of the following happen : liver problems ( very common : may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) or vomiting ( being sick ), stomach pain increased tiredness loss of appetite ( anorexia ) your skin or the whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon : might affect up to 1 in 100 people severe inflammation of the liver that may lead to death . tell your physician immediately , if your liver is not working properly . you may also experience muscle pain , weakness or joint
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled ssyre in original package in order to protect from light . you should use a new slyringe / pen in the original package . put the pen back into the refrigerator immediately after you have used it . zindryte s / pens must be kept at room temperature ( not above 30 ) for a single period of 30 days ( but above 30 days ). you should record the date when zinbeta is removed from the refrigerator and the date after which it
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg daclizuab beta in 1 ml solution . after reconstitution : each pre- filled pen contains 150 micrograms daclizab beta in 1 millilitre ( mL ) solution : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 under ' zinbeta contain sodium '). what zbrytoa looks like and contents of the pack zinbyta is a colourless to slightly yellow solution , provided in a clear glass pre  filled pen , with a sYringe / pen and with an attached needle .
wilzin belongs to a group of medicines known as metabolism products , used to treat wilsson ' s disease , a rare inherited defect in copper excretion in the liver , the eyes and the brain . this causes liver damage and neurological disorders . wILzin destroys the original intestine and its further accumulation in the body , in the form of a substance called ' metal oxide ' ( e .g . in the blood ). wilezin is used to correct this condition . you should continue with this treatment for as long as your doctor has told you .
do not take wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilszin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking wILzin . willzin wlzin may be used only as an initial therapy if signs and symptoms of  Wilson ' s disease persist after it has been taken in the past . you are currently taking another anti - copper agent , penicillamine . your doctor may give you wulzin for the initial treatment , or together with other anti  copper agents . peniciillamine may reduce the relief of your symptoms . before starting the treatment a doctor or nurse will check your blood and urine to make sure that you have received sufficient treatment and monitoring . the dose may be adjusted 25 in some cases ( including cases of
what wilzin contains the different dose regimens are available in different dose strengths : 25 mg and 50 mg . 1 dose of wILzin 50 mg is given as 2 separate doses . 2 doses of Wilzin 25 mg are given as 1 separate dose of the active substance . 0 mg of witilzin 50mg is given in 2 dose cycles . each dose of one wlzin 25mg tablet is given at least 1 hour apart . this dose is given 1 hour after the three doses are given . 5 mg of the wilszin 25 micrograms is given 2 hours after the four doses have been given , respectively . 25 mg is taken as 1 to 6 hours apart , each time you receive 1 dose . the recommended dose of both willzin 25micrograms / mg is 16 mg / ml and 57 microgram
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting1 to 10 customers in 1 , 000 ) rare ( affecting 1 to10 users in 10 000 ), very rare (affecting less than 1 patient in 10000 ) not known ( frequency cannot be estimated from the available data ). wilszin intake may cause gastric irritation , which may occur after treatment . you may also notice changes in blood tests that may show an increase in some liver and pancreatic enzymes and a decrease in blood red and white cells . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effect not listed in this leaf
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of zirconium acetate dihydrate ). each capsule contains 50 mg of Zin ( equivalent  to 167 .84 mg of ac ). the other ingredients of the capsule are : capsule shell : gelatin , titanium dioxide ( e171 ), brilliant blue fcf ( wmc ) ( hdpe bottles ) what ails look like and contents of the pack wilszin 25 mg hard capsules are blue and white and marked " wlzin 50 mg " in black ink . the printing ink contains black iron oxide ( azure ) and shellac ( i . al ). what if you have any questions about the contents of your capsule , please ask your doctor
what biktarvy is biktarivy contains the active substance bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . what bikittarvY is used for emtricitabine , another antirétroviral medication known as a nucleoside reverse transcriptaser inhibitor ( nrti ) tenofovir alafenamide , also known as another anti retroviral drug known as " a nuclear nucleogram reverse transcriptatasasse inhibitor ( nutrtis ) bikTARvy may be used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection . biktegranvir reduces the amount of hiv in your body . this will improve your immune system and reduce the risk
do not take biktarvy if you are allergic to bictegravir , emtricitabine , or tenofovir alafenamide , any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not use this medicine and tell your doctor immediately . if the following medicines are not suitable : - rifampicin , used to treat some bacterial infections such as tuberculosis - saint john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before taking biktarivy and if any of these apply to you before taking this medicine : you should tell your physician if : your doctor thinks this may apply to your condition 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . do not take antacids ( to treat stomach ulcers , heartburn or acid reflux ) as these can be very serious . the ingredients of the tablets are aluminium , magnesium hydroxide mineral supplements , vitamins , iron and water ( see section 2 " other medicines and biktarvy "). if your doctor has prescribed these medicines , tell your doctor immediately . if possible , your doctor may recommend lowering the dose of biktarivy if : you are on dialysis . you can take biktabvy with or without food , if necessary . your doctor will tell you if to stop taking bikarvy while you are receiving dialytic use . taking bikatarvY
like all medicines , this medicine can cause side effects , although not everybody gets them . possible side effects tell a doctor immediately if you notice any of the following : inflammation or infection . in some patients with advanced hiv infection ( aids ) and a history of opportunistic infections ( infections that occur in people with a weak immune system ), signs and symptoms of inflammation from previous infections may occur soon after hiv treatment is started . it is thought that these symptoms are due to an improvement in the body ' s immune response , enabling the body to fight infections that may have been present with no obvious symptoms . autoimmune disorders , when the immune system attacks healthy body tissue , may also occur after you start taking medicines for hiv infections .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . please do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktarivy tablet contains bicentegravar sodium equivalent to 50 mg bictedregravir and 200 mg emmtricit abine / tenovir altafèneamide fumarate equivalent to 25 mg tenophovir allafénamine . the other ingredients are tablet core microcrystalline cellulose , crohn ' s disease , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide , macrogol , the talc , iron oxide red , and iron oxide black . what bikiktarvay looks like and contents of the pack bikkarvy is a white , capsule - shaped
novonorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your panccreases does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonourm is used to control type 2 diabetic patients who still have their diabetes and who are still unable to respond normally despite treatment , exercise and weight reduction , which have not helped to control your blood glucose . there is also a test that novonorgm can be given in combination with metformin , another medicine for diabetes . it is important that you continue to follow the advice on diet , exercising and diet that your nurse or doctor has given you .
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients in this medicine ( listed in section 6 ). - for type 1 diabetes . - to raise the acid level in your blood ( diabetic ketoacidosis ). warnings and precautions talk to your doctor before taking novonarm if : you have a severe liver disease you take gemfibrozil ( a medicine used to lower increased fat levels in the blood ) 47 you have liver problems . novonorgm is not recommended in patients with moderate liver disease . do not use novonerm - you have had a severely liver disease or kidney problems , as there is insufficient experience with the use of novonom in patients who are about to have major surgery or have recently suffered a serious illness or infection . diabetic control is needed .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , if necessary . your doctor may increase your dose to 4 mg before or down to 30 mg after each main meals . do not exceed this recommended dose of 16 mg if your blood sugar is too low . it may become too low for you , which may result in a hypo . if any of the above apply to you : if , you are unsure , talk to your doctor , pharmacist or nurse . take novonorm once a day , without having a meal ; if and when you have taken more novonorgm than you should if ( or have taken
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of hypogliescaemia is ( may affect up to 1 in 10 people ). it may seem like a hypo in section 2 . however , in general , hypogycaemic reactions are generally mild / moderate . in rare cases hypoglacy unconsciousness may occur and may lead to coma . allergic allergy is very rare ( may effect up to one in 10 , 000 people ) and may affect more than one in a few cases . symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating may be signs of anaphylactic reaction . other side effects include : very common ( may impact more than 1 in ten people ), mild hypoglutamic reaction is a severe reaction 
what novonorm contains - the active substance is repaglinide . - other ingredients are microcrystalline cellulose ( e460 ), calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , and poloxamer . the printing ink contains iron oxide yellow ( pfizer ) only in the 1 mg tablet and iron oxide red ( i )only in the 2 mg tablets . what novovonorme looks like and contents of the pack novonom tablets are round and convex and engraved with the code ' 9343 ' on one side and ' 1 ' and a ' 2 ' respectively . one side is engraved on the other side 
what pumarix is pumarice is a vaccine for use in adults from 18 years old to prevent pandemic flu ( influenza ). pandemie flu is essentially a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . the signs of pandelic flu are similar to those of ordinary flu but may be more serious . how pumarx works when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarize may not fully protect all persons who are vaccinated .
pumarix should not be given : if you have previously had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the substances that may be present in trace amounts as follows : egg and chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if an allergic response is detected , the doctor will decide if the vaccine is suitable for you and will continue to give medical treatment . in case of an allergy , you should not receive pumarx . take special care with this vaccine 33 talk to your doctor or nurse before you are given pumarice if : you have had any allergic reaction other than a spontaneous life  - potentially life threatening allergy to any component
pumarix is intended for use in adults aged 18 years and over . if you are not sure , talk to your doctor or pharmacist before you are given pumarx . your doctor may administer a similar h5n1 as03 to children and adolescents aged 18 and over at the same dose and frequency as for adults . pumarice should be administered according to a " randomized clinical trial ". the recommended dose of pumarize is based on bodyweight and is given at a dose of 0 . 5 ml . use in children and infants pumarux can be given to children 3 - 9 years of age . it is not recommended in children 3 to 10 - 17 years of aged . how pumarrick is given puMarix is given as an injection into a muscle ( usually in the upper arm ). if your child misses a scheduled injection ,
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions which may cause you to have dangerously low blood pressure . if this is not treated it may lead to shock . you may need emergency treatment . other side effects very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles , joint pain common ( might affect up to 1 in every 10 people ) redness and swelling where the injecting is given fever sweating shivering diarrhoea feeling sick uncommon ( may effect up to1 in every 100 people ). your doctor will tell you how to recognise and treat any side effects not listed in this leaflet .
keep this vaccine out of the sight and reach of children . before the vaccine is mixed : do not use the suspension and the emulsion after the expiry date which is stated on the carton . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . do not freeze . after the vaccine has been mixed , use the vaccine within 24 hours and do not store above 30 . discard any unused solution appropriately .
what pumarix contains active substance : split influenza virus , inactivated , containing antigen * equivalent to : a / california , no less than : 5 / 2005 ( h5n1 ) like strain used ( pr8 - ibcdc - 6 - inf )* equivalent to 0, 5 . 5 micrograms ** haemagglutinin * propagated in eggs ** expressed in microgram haeMagglutinate * propagates in eggs * propagate in eggs during the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvanted contains squalene , and dl - 1 - tocopherol , polysorbate 80 and water for adjuants . other ingredients in the vaccine are : sodium chloride
somakit toc is a radiopharmaceutical product that contains an active substance called edotreotide . the powder contains a small amount of a nuclear medicine called gallium ( 68ga ) chloride , which is equivalent to gallium( 68Ga ] edeotretide at the start of this procedure . people who have been given gallium are not allowed to emit eeddotides into a vein or into certain body areas . this is referred to as a medical imaging procedure called positron emission tomography . for pet patients , this medical procedure helps to obtain images of the abnormal cells and tumours , and to help detect and treat your disease . if you have any questions about how somаkit tox works or why this medicine has been prescribed for you , ask your doctor .
do not use somakit toc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . allergic reaction can be seen in section 4 of this leaflet . warnings and precautions talk to your doctor before using somamakit tc : - children and adolescents - patients with kidney or liver problems - patient with renal or hepatic disease - adolescents under 18 years of age . drink plenty of fluids to ensure that the examination is safe and effective . children and teenagers must not drink alcohol during the examination . - other medical conditions that affect the body such as cushing syndrome ( inflammation of the thyroid disease , or tumour ( of pituitary gland , lung , brain , breast , immune system ,
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakit toc will only be used in special controlled areas . this product will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this product and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somаkit tock to be used within the target range . it will be the smallest quantity necessary to get the desired information . two different strengths of somagakit , 100 mbq ( megabecquerel , the unit used to express radioactivity ) are required to express the product . administration of somasakit topology and conduct of the procedure , you will need to follow the instructions of your nuclear medicine physician .
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are allergic reactions ( hypersensitivity ) to somakit toc . symptoms may include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may include stinging at the injection site , ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects get a quick call or go to the casualty department at your nearest hospital if you get any side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . do not use somakit toc after the expiry date which is stated on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after radiolabelling , the product should be used immediately . if not used immediately the solution is clear and colourless . once thawed , once radiolaabeling has been completed , it should be stored in syringes at a temperature not above 25 and away from direct heat or direct light . it should not be used if there are visible signs of deterioration . disposal of radioactive products should be done
what somakit toc contains - the active substance is edotreotide . one vial of powder contains 40 mg of edeotreotrotide ( as 10 - phenanthroline ). - other ingredients are gentisic acid , mannitol , formic acid ; sodium hydroxide and water for injections . - after radiolabelling , the solution contains hydrochloric acid ( e507 ) ( for radiopharmaceutical preparation ). what somagakit tc looks like and contents of the pack somamakit atc is supplied as a glass vial with black flip - off cap . it is a white powder in a clear glass vially with yellow flip  - on cap , providing a crystall of a radioactive substance .
afinitor is an anticancer medicine containing the active substance everolimus . everolim works by blocking a receptor in the tumour and slowing down the growth of cancer cells . afinitour is used in adults to treat hormone receptor - positive advanced breast cancer ( postmenopausal women ) in adults who do not have enough hormones ( s ) to control the disease under control . it is used when a medicine called exemestane ( a steroidal aromatase inhibitor ) is used as part of hormonal anticancancer therapy in patients with advanced tumours ( neuroendocrine tumours that start in the stomach or bowels and progress to the tumour ).
you should not be given afinitor - as your doctor will tell you before you start cancer treatment with afinitour . you must not be treated with afiniitor because : - you are allergic to everolimus , to sirolimus or temsiroli Mus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , talk to your doctor before you are given afinitor . - if your liver is working properly . tell your doctor if : you have any disease which affects your liver . your doctor may prescribe a different dose of afinitur . warnings and precautions talk to you doctor before receiving afiniter if any of these apply to you . talk to a doctor before using afinitores if this applies to you as well as cancer treatment . before you receive afinit
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . swallow the tablet whole . do not chew or break the tablet before swallowing . if necessary , your doctor may ask you to take more afinitor than you should if your doctor thinks you may have taken too many tablets . patients with liver problems may need a lower dose of afiniter : one 5 mg tablet once . this may be increased to one 7 . 5 mg dose if needed . your doctor will decide on the most appropriate dose based on certain side effects . stop taking afinitores before stopping treatment with afinitur . you should continue to take afinitour for as long as your condition improves . see how to take your tablet - if it is not clear what has happened .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps the following side effects have been reported with afiniter : very common ( may affect more than 1 in 10 people ): increased temperature ( with chills ( signs of infection ) fever , coughing , difficulty breathing , wheezing ) inflammation of the lung ( pneumonitis ) reporting of side effects 25 if any of these side effects gets serious , talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . keep the blister tightly closed in order to protect from moisture . only use the tablets if the pack is damaged . this medicine does not require any special storage conditions . does not use if you notice any damage or signs of tampering . please return the pack containing the medicine to your pharmacist . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what afinitor contains the active substance is everolimus . chacune of the three pack sizes desirtor 2 . 5 mg film - coated tablets each tablet contains 2 , 5 mg of everoli Mus . afiniteur 5 mg movie - covered tablets each tablette contains 5 mg or 10 mg of Everolimus ( as monohydrate ). afinitour 10 mg film- coated tablet each tablet contain 10 mg or 11 mg of tom - related ingredients : butylhydroxytoluene ( e321 ), magnesium stearate ( s ), lactose monohydrate ( hypromellose ), crospovidone ( containing lactoses anhydrous ). what afinitor looks like and contents of the pack afinitores 2 : 5 mg tablets are white to slightly yellowish , round , with " gsi "
what laventair ellipta is laventAIR ellippa contains two active substances umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laVENTair elept a is used for laventaire ellipinta ist used to treat chronic obstructive pulmonary disease ( copd ) in adults . copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . when used regularly , it can help to control your breathing difficulties .
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using laventaire ellippa : - patients with asthma . lavent air ellipita should not be used to treat asthma - users with heart problems or high blood pressure - suffer from an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - you suffer from epilepsy - take special care with umecladinium you have diabetes - use with severe liver problems immediate breathing difficulties include tightness of the chest , chest pain
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . don ' t use more than your doctor tells you to use . use laventair ellipta regularly it is very important that you use laVENTair eelliptata every day , as instructed by your doctor to do so . this will help to keep you free of symptoms throughout the day and night . laventAir ellippa should not be used to relieve a sudden attack of breathlessness or wheezing . if your attack is not controlled by a quick - acting reliever inhaler ( such as salbutamol
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you get any of the following symptoms after taking laventair ellipta , stop using it and tell your doctor immediately . uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) or redness rare side effects (1 may affect 1 in 1 , 000 people ), including swelling , sometimes of the face or mouth ( angioedema ) becoming very wheezy , coughing or having difficulty in breathing suddenly feeling weak or light headed ( which may lead to collapse ). if any of these side effects causes you problems , tell your physician immediately : - if your doctor decides that you should stop using laventaire ellippa and contact your doctor . - when using laVENTAIR elliрta the most common
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecilidinium brmide ) and 22 microgram ( milligram ) vilantanterol ( as trifenatate )- the other ingredients are lactose monohydrate ( see section 2 under ' laventaire ellippa contains lactoses ') and magnesium stearate . what laVENTair elept a looks like and contents of the pack laventAIR ellipinta is an inhalations powder , pre - dispensed . the ellipeta inhaler consists of a light grey
tremfya contains the active substance guselkumab , a monoclonal antibody . this medicine contains the key substance called il - 23 , which is present at increased levels in the body . psoriasis in adults with moderate to severe " plaque p soriaticasi " is an inflammatory condition that affects the skin and nails . it helps to improve the condition of the skin in general , especially of the nails , and to reduce the appearance of nails ; it helps the condition in adults to reduce symptoms such as scaling , dropping , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before you are given tre.fyya you may be allergic to soya or to any of its components . warnings and precautions talk to your doctor , pharmacist or nurse before you receive tremefy if : you have an active infection or you have active tuberculosis warnings , precautions and checks you should not be given remfYa , if any of these apply to you at any time . you have ever had an infection or have ever been in close contact with someone with an infection . tuberculose is a serious form of tubercularosi ( tb ). it is not known whether
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ). it can be given from 4 to 8 weeks after your injection . your doctor will decide how many treatments you need . if your doctor decides to give you more trempfyа than you should treefyya can be administered at any time of the day , with or without food . you should continue to inject tretfy unless your doctor tells you to stop . for further instructions on how to inject yourself with tresfyo , please read the section at the end of this leaflet . do not shake tredfy
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or pharmacist straight away if you notice any of the following side effects serious allergic reaction : - difficulty breathing or swallowing - swelling of the face , lips , tongue or throat - severe itching of the skin , with a red rash or raised bumps other side effects include the following listed below . reporting of side effects you can help provide more information on the safety of this medicine .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . this medicine should not be used if the solution is cloudy or contains flakes or large particles . after removing from the refrigerator , the pre- filled
what tremfya contains the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusedlkumbab in 1 ml solution . the other ingredients are histidine , histamine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what TREmfYa looks like and contents of the pack solution for injection : trempfyan is a clear , colourless to pale yellow solution , supplied in a carton pack containing one single - dose glass sYringe and a multipack containing 2 ( 3 packs of 1 single  dose pre  filled  ssyres ) cartons containing 1 or 2 single – dose pre- filled
trepulmix contains a medicine called treprostinil . treprastINil belongs to a group of medicines called prostacyclins . prostacycles are hormones that help to control blood pressure by relaxing blood vessels . by blocking prostacins they also prevent blood from clotting . what tre Pulmix is used for trepelmix is indicated for the treatment of inoperable chronic thromboembolic pulmonary hypertension ( cteph ). it is used to treat persistent or recurrent ctateph that has not responded to surgical treatment , improved exercise capacity and symptoms of the disease . chronic Thrmboebatic pulmonary Hypertension , when blood pressure is too high , and the pressure in the blood vessels of the heart and lungs are not properly controlled .
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking tre Pulmix . if there is a risk of a disease called " pulmonary veno - occlusive disease ". this is if the blood vessels in the lungs become swollen , or there is an increased pressure in the blood vessel between the heart and the arteries . the risk of developing severe liver disease . warnings and precautions talk to your doctor or pharmacist before taking this medicine : if your doctor knows that you have a heart problem . tell your physician if : you have had a chest attack ( myocardial infarction ) within the last six months you have severe changes in heart rate severe coronary heart
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how is trepulmix given and how much should i take ? trepmix is given as a continuous subcutaneous infusion ( infusion under the skin ) through a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how many doses of tre Pulmix you need . treprestinil you will receive a portable pump . you can carry your treprostinate with you so that it is easier for you to remember to use it . make sure that you have the pump in place so that the infusion line is clear and free from accidental overdose . dose the usual dose is 1 to 2 . 5 g per day , given every 5 to 10 days 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site of the inffusion bleeding or bruising at the atrium headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people in ) : dizziness , light - headedness / fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgiia) swelling of feet , ankles , and feet not known ( frequency cannot be estimated from the available data ) swelling at the location of the needles infusion reporting of side effects 23 if you get any side effects talk to your doctor or nurse . this includes any possible side effects not listed in this leaf
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . a trepulmix vial may be stored at room temperature ( up to 30 ) for up to one continuous subcutaneous infusion before use . in - use storage conditions : a single reserve ( syringe ) of undiluted tre Pulmix may be kept for upto 72 hours in the original carton to protect from light . this medicine must not be used if it shows signs of damage , discolouration or other signs of deterioration . any unused medicine must be discarded .
what trepulmix contains - the active substance is treprostinil . trepelmix 1 mg : each vial contains 1 mg of treprastINil ( as sodium salt ). trepemix 10 mg / 10 ml : one vial provides 10 mg of the active ingredient tre prostinkil ( in sodium salt). - trepmix 2 . 5 mg - each vially contains 2 , 5 mg of of TREprosstinningil ( ( as salt )).  each viall provides 10  25 mg of delamanid . what TREpulmix looks like and contents of the pack treulmix is a clear , colourless solution . it comes in a glass vial . each carton contains : treprestnil ( with sodium salt in 10 
thorinane contains the active substance enoxaparin sodium . this is a low molecular weight heparin ( lmwh ). thoriinana works in two ways . 1 ) stopping existing blood clots from getting any bigger . 2 ) stop blood clumping together in your blood . thoresinanne is used to : prevent blood coagulations in your system and reduce the risk of blood  clottings from forming in your body . you should have blood soluble forms in your own blood , and you should not have blood collusion . it is important to keep a record of the names of each product . do not store above 25c . get a copy of the original clone . your doctor may want to keep track of the clotes you have . in
do not use thorinane - if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include : rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . - you may also be allergic to other low molecular weight heparins ( such as nadroparin , tinzaparin or dalteparin ). warnings and precautions talk to your doctor or pharmacist before using thoriinan : you should tell your doctor if : there is a possibility that you may experience a reaction to hepin that causes a severe drop in the number of your clotting cells ( platelets ). this reaction is called heperin - in - use
like other similar medicines ( medicines to prevent blood clotting ), thorinane may cause bleeding which may potentially be life - threatening . in some cases the bleeding may not be obvious . if you experience any bleeding event that does not stop by itself or if there is excessive bleeding ( exceptional weakness , tiredness , paleness ), dizziness / headache or unexplained swelling , consult your doctor immediately . your doctor may decide to keep you under closer observation or change your medicine . taking thoriinana may cause a severe allergic reaction ( such as difficulty breathing , swelling of the lips , mouth , throat or eyes ), blockage of a blood vessel which could lead to a bleeding clot . this could cause cramping pain , diarrhoea , nausea , vomiting , itching or hives (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store below 25 . dilution the solution should be used within 8 hours . this medicine does not require any special storage conditions . use the thorinane pre - filled syringes provided in the box for reconstitution .
what thorinane contains the active substance is enoxaparin sodium . one ml of solution contains 100 micrograms of enocaparIN sodium , respectively . each pre - filled syringe contains 0 . 2 mmol / mL of solution , corresponding to 2 , 000 microgram of énoxaparain sodium per mlitre . the other ingredient is water for injections , water for injects . what THorinANe looks like and contents of the pack thlorinana is a clear , colourless type i neutral glass ssyRINGe barrel with fixed needle and needle shield , closed with chlorobutyl rubber stopper and a blue polypropylene plunger rod . thourinanе is available in packs containing 2 or 10 pre
senstend contains lidocaine and prilocaine as local anaesthetics . senstende is used for the treatment of lifelong premature ejaculation in adult men . the active substances in senstenD work by decreasing the amount of fluid in the head of the penis to increase time before ejection .
do not use senstend - if you are allergic to lidocaine or prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using senstende . talk to you doctor or nurse before using this medicine if : you have ever had allergy or sensitivity to other local anaesthetics , other than amide - type local anestheses . you have a genetic disease or other condition that affects your red blood cells ( glucose , phosphate deficiency , anaemia or methaemoglobinaemia ). you have been told that you have medicine sensitivities that increase the risk of sensitivity . your doctor will monitor you closely while you are using senstentd . if any of these apply to you , tell your doctor
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of senstend is 3 sprays ( 3 spray containers ) 3 times a day ( morning , afternoon and evening ). 1 spray ( 1 spray ) on the head of the penis is enough . 3 spray ( 24 hours ) after each use . 4 precautions apply senstende to the spray container and the pump mechanism . keep the valve closed to avoid contact with eyes , nose , mouth and ears . if the pump is used for the first time , it should be used immediately after use , and the recommended maintenance dose is 1 spray on the foreskin on the top of the head , in the peni . only use the pump after the close - fitted valve . 1 spray (1 ml )
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection decreased feeling in and around the penis feeling of burning in and surrounding the peni increased sensitivity of the skin to the sun . uncommon ( may effect up to1 in 100 people  ) headache local irritation of the throat or irritation of a part of the flesh under the skin redness and failure to ejaculate during sexual intercourse abnormal orgasm tingling in and outside of the penisse pain or discomfort in and inside the penist itching not known ( frequency cannot be estimated from the available data ) hives , urticaria , itching , inability or unwillingness of the body to resist the impulse , drive or temptation to perform sexual inter
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the metal container and on the outer carton after exp . the expiration date refers to the last day of that month . store below 25 . throw away the container 12 weeks after you first use it . use the metal containers to puncture , break or burn it even when apparently empty . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . - each ml of solution contains 150 mg lidocan and 50 mg prilacaine - one spray delivers 50 microlitres which contains 7 . 5 mg lidacaine , and 2 . 4 mg Prilocaine at the same time . what sensTENd looks like and contents of the pack senstende is a clear , colourless to light yellow cutaneous spray , solution . each spray container contains 6 . 6 mL or 20 m2 of solution , corresponding to a volume of 2 mmol . senstendon is available in a pack containing one spray container , each spray tray containing 5 spray containers , which are able to deliver 12 sprays . not all pack sizes may be marketed . light yellow skin spray 
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults melamineoma that has come back or has not responded to complete resection in adults ( treatment with surgery called adjuvant therapy ) advanced non - small cell lung cancer ( lung cancer that has spread beyond the original tumour ) for adults advanced renal cell carcinoma ( advanced kidney cancer ), in adults advanced lymphomum if previous therapies including an autologous stem - cell transplant ( e . g . after an autologue transplant ) or a transplant has not worked . advanced cancer of the head and neck in adults advance urothelial carcinoma ( bladder and urinary tract cancer ). the active substance in obdivo , nivolumab , is  a monoclonal antibody . this antibody works by
do not use opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using oppdivo and during treatment : - contact your doctor if : you have problems with your heart , such as a change in the rhythm or rate of the heartbeat , or an abnormal heart rhythm . your lungs may get worse , causing breathing difficulties or cough . this may be a sign of inflammation of the lungs ( pneumonitis or interstitial lung disease ). - you have diarrhoea ( watery , loose or soft stools ), or any symptoms of inflammation or of the digestive systems ( colitis ), such as stomach pain or discomfort . - your doctor may give you another medicine to
the recommended dose of opdivo in adult patients is 240 mg ( 2 x 480 mg ) taken once a day for 4 weeks . oppdivo must not be used alone . in patients where ipilimumab is not suitable for the treatment of skin cancer , oopDivo must be administered twice a week ( one cycle of 1 cycle ) with nivolumab per kilogram of your body weight . the recommended starting dose for adults is 4 mg / kg . when obdivo is administered twice daily , the recommended daily dose is a combination of 240 micrograms / 2 cycles of 480 microgram / 4 cycles . once opigmented , it can be administered either alone or in combination with iipimumaber . for the treated treatment of advanced kidney cancer : 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours prior to use . at the end of this period the infusion solution should be administered immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nyvolum . the recommended dose is 40 mg ( one 4 mL vial ), 100 mg ( two 10 mlitres ) or 240 mg ( three 24 mmol ) of nivolmabe . - the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " oppdo not use oddo ") and water for injections . what opsdivo looks like and contents of the pack opmd is a clear , colourless to pale yellow solution for injection and is supplied in a glass vial with a desiccant . it is available in cartons containing mannitol ( e4
clopidogrel tad contains clopizide and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clodogrell t ad is taken by adults to prevent blood coagulations ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodegrel to help prevent blood
do not take clopidogrel tad 30 if you are allergic to clopizide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . in case you have severe liver disease , you should not take the tablets . take special care with clodogrell t ad . warnings and precautions if any of these apply to you before you take , or during treatment with , clodidogreil ttade , please tell your physician before taking clocidogregrel to reduce the risk of bleeding , including - a médical condition that puts you at risk of internal bleeding ( such as an stomach ulcer ) -
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogresl - t ad ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - day tablet of 75 clopa2 clots per day as described above . you should take clodogre
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if not treated , confusion ( see section 2 ' take special care with clopidogrel tad '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the first signs of an allergic reaction . the most common side effects reported with cd4 inhibitors are : very common side effect ( may affect more than 1 in 10 people )
what clopidogrel tad contains the active substance is clopizigrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( е172 ), yellow iron oxide and talc and macrogol 3000 in the film - coating . what clupidogresl tard looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 and 28 tablets are available . not all pack sizes may be marketed .
tacforius contains the active substance tacrolimus . it is an immunosuppressant . following your organ transplant ( liver , kidney ), your body ' s immune system will try to reject the new organ . tacforus is used to control your body'  s response to the transplanted organ : - tacforitus is applied to the rejection of transplanteed liver - kidney - heart - any previous treatment you were taking was unable to control this response after your transplantation .
do not use tacforius : - if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). - are allergic or allergic to siroli Mus . - your doctor may ask you to stop taking any macrolide - antibiotic ( e . excipients , e. g , anhydrous ) such as erythromycin , clarithromycin or josamycin . warnings and precautions : tacrolivimus immediate release capsules ( i . debossed with " tacni "). tacforitus prolonged - release capsule ( tcnI ) may be affected by the effects of tacroligan . you must take tacforinus prolonged release capsule and the immediate release caps at the same time each day . this is to make sure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed to you by a doctor with experience in the treatment of transplant patients . make sure that you receive the same tacforius medicine every time you collect your prescription , unless your transplant specialist has agreed to change to a different tacforlimus medicine . do not use this medication more than once a day . always take this medicine precisely as your physician has told me . it is important that you take the right medicine to prevent the rejection of your transplanted organ from being attacked by your doctor based on your body weight . the usual starting dose is : a daily dose of 0 . 10 - 0. 30 mg on day 35 of the transplanteed body weight when rejection is most likely . you will receive these same doses every month
like all medicines , this medicine can cause side effects , although not everybody gets them . infections you must tell your doctor if you get any of those who are prone to infections while being treated with tacforius . severe effects may occur , including allergic and anaphylactic reactions . benign and malignant tumours have been reported following tacforinus treatment . cases of pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis (  a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ) and febrile neutropenia ( an increase in the number of black blood cells which fight infection ) have been noted . these events have been rarely reported following treatment with tacfordius in patients with a known cause . neutropen
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . use all the prolonged - release hard capsules within 1 year of opening the aluminium wrapping . store in the original package in order to protect from moisture .
what tacforius contains - the active substance is tacrolimus . tacforitus 0 . 5 mg : each capsule contains 0
clopidogrel zentiva contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopdogral zetiva is taken by adults to prevent blood globulosis ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clots so that they can be removed and monitored by your doctor .
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopdogrell or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too strong or too weak , tell your doctor . have severe liver disease . do not taking clodogral  Zentiva and tell your dentist if any of these apply to you . warnings and precautions if the use of clocidogreil zentivea is not recommended if : you have an increased risk of bleeding such a condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you have a blood disorder that makes you prone to internal bleeding ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if your doctor has told vous that you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogresl  Zentiva ( 1 tablet of 300 mg or 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , or two 75 mg tablets , once at a time . you should take clopogrell 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if not treated , confusion ( see section 2 ' take special care with clopidogrel zentiva '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the first signs of an allergic reaction . the most common side effects reported with cb , are : very common side effect ( may affect more than 1 in 10 people ):
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if clopidogrel zentiva is packed in aluminium blisters , store below 30 . when clodogrell zentive is packed into all aluminium cartons : do not take this medicine if you notice any visible sign of deterioration . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel zentiva contains the active substance is clopizide . each tablet contains 75 mg of clodogrell ( as hydrogen sulphate ). the other ingredients are ( see section 2 ' clodegrel
yttriga is a radioactive medicine . it is given to you by your doctor or nurse in hospital . when you are switched from another medicine to yittrig , you are given tiny radiation doses that will allow the doctor to control the dose . the treatment will be supervised by a doctor who is experienced in the use of radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yytrige - you may be pregnant or think you may have been pregnant . warnings and precautions talk to your doctor or pharmacist before using yettrigga . yittrig - the active substance in yattrigriga is a radioactive medicine . it must not be used in combination with another medicinal product . radiopharmaceuticals should not be combined with yctrigo . the use of Ytttranga is not known to affect radioactive material . therefore , the use and handling of radioactive medicinal products should be avoided in children and adolescents aged 2 to 16 years . other medicines and yantriga tell your doctor if using , have recently used or might use
your doctor will determine the best course of action for you and will explain the potential risks and benefits of the treatment . method of administration yttriga should only be used under the supervision of a physician experienced in radiolabelling of medicinal products . the choice and duration of specific diseases may depend on the type of patient . if you are given more yTtrig  than you should in the event of : a severe overdose , your doctor may decide that appropriate treatment would be necessary .
like all medicines , yttriga can cause side effects , although not everybody gets them . if any of the side effects get serious , or if you notice any side effects not listed in this leaflet , please tell your doctor , pharmacist or nurse . reporting of side effects 10 if your side effects gets worse or are more likely , talk to your doctor or pharmacist . this includes any possible side effects NOT listed in the leaflet you have been given . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises . storage under the supervision of the specialists is responsible for the correct disposal of the product both before and during its use , as well as for the sound and storage in case of incidents where the facility is not used correctly . the following information is intended for the specialist only . keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . any unused medicine or waste material should be disposed of in accordance with local regulations .
what yttriga contains - the active substance is chloride . 1 ml sterile solution for injection contains 1 g of hydrochloric acid . the other ingredient is water for injections ( see section 3 under ' yettrigga contains sodium '). what Yttroga looks like and contents of the pack yTtrig consists of a v - shaped bottom and a colourless type i glass vial , each containing 10 mL of solution with a flat bottom , closed with  a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciama is given in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when ciambamba is given together with a drug called cISplatin for the initial treatment of patients with advanced stage of lung cancer : ciaba can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; ciabria is also a treatment for patients with newly - diagnosed patients with / or newly relapsed lung cancer who have had other initial chemotherapy in the past .
do not use ciambra - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciama ( listed in section 6 ). - when you are breast - feeding ; you must discontinue breast  - feed during treatment with ciambaa . - after receiving a vaccine against yellow fever , tell your doctor . warnings and precautions talk to your doctor or nurse before receiving ciamara : - tell your healthcare provider before receiving treatment with this medicine if : you currently have or have previously had problems with your kidneys . before each infusion of ciembra your doctor will take some samples of your blood to evaluate if your kidney and liver function are working properly and to check that you have enough blood cells to receive ciaba , but your doctor may decide to change them if they are too low
the dose of ciambra is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your area , and your doctor will use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the ciampa powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you , in a drip into one of your veins . the infusion will last approximately 10 minutes . when using ciama in combination with cisplatin : the doctor or hospital pharmacist will work out your dose of your height  and weight . amount of csplatin
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : 52 fever or infection ( common ): if your medicine has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if used with ciambra , you may experience chest pain ( common with a fast heart rate ), pain , redness , swelling or sores in your mouth ( very common with all medicines this medicine may increase the chance of allergic reaction ). you might get skin rash ( common in children ) or burning or prickling sensation ( common for children ). fever ( common among children ), skin reactions may be serious and include 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . chemical and physical in - use stability of the infusion solution of pemetrexed has been demonstrated for 24 hours at 2  8 , at 15  25 . from a microbiological point of view , the product should be used immediately . if not used immediately it should be handled in accordance with local requirements . use the reconstituted solution immediately after reconstitution . for single use only . maintain the infuse solution within 24 hours . once refractory conditions have been met , these conditions are followed . however , for extended periods the product may be
what ciambra contains the active substance is pemetrexed . ciama 100 mg : each vial contains 100 milligrams of pemetrexxed ( as pemetreixed disodium hemipentahydrate ). ciamma 500 mg ; each vially contains 500 milligramms of Pemetrexxede ( aspemetrex ed désodium hydroxide ). after reconstitution , the solution contains 25 mg / ml of pemeterxeed per mL . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochloric acid ( for ph adjustment ) and sodium hydroxides ( for further phe adjustment ). see section 2 " ciarama contains sodium ".
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) that are used to prevent certain infections from entering your blood . immunogam has been shown to increase levels of human hepatitis b immunoglobuulin s and immunoglobularin g ( igg ) in the blood plasma of screened individuals . how immunogam works immunogam is used to treat hepatis - b virus in haemodialysed patients . vaccination with a heptag bvirus carrier is an immune response . there are clear signs of measurable hepotis a response after vaccination . this is followed by continuous prevention in patients who are infected by heparin b .
immunogam should only be used if you have previously had an allergic reaction to human immunoglobulins or other blood products . if there is an iga deficiency , you may be more likely to have an allergic response to iga containing products , or to any of the other ingredients of immunogam . children and adolescents ( 6 to less than 18 years of age ) who are treated with immunogam have had adverse reactions such as chills , headache , fever , and vomiting . allergic reactions sucha as nausea , arthralgia , joint pain , low blood pressure and moderate low back pain . antibodies against hepatitis b immunoglobuulin regularly may be required . human hepatis - b imunoglobuline injections may not be recommended . talk to your doctor if a patient experiences a severe allergic reaction
immunogam is intended for vaccination against hepatitis b virus . as the first vaccine dose will be administered , it will contain trace amounts of human hepatis - b immunoglobulin . dosage and administration prevention of heptis
like all medicines , immunogam can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 to10 users in 1 , 000 ) rare ( affectes 1 user to 10 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ) undesirable effects which have been observed during clinical trials with immunogam , the following undesirable effects have been reported : common ( efects on the muscle ) very rare ( effect effects on the ability to compute and deliver data ). very common (+ affects very common [ affects at least 1 user per 10 , 600 ) in clinical trials : uncommon ( effect on the sensory processing unit ) unusually fast or slow heart
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vially in the outer carton in order to protect from light . before using immunogam , check that the solution is clear , cloudy or has deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogam 1 mg / ml solution for injection contains 5 mg of human plasma protein of which at least 96 % is immunoglobular . - its composition with polysorbate 80 . what immunogame looks like and contents of the pack immunogam is presented as a solution for injecting in a glass vial . it is a clear to slightly pearly , pale yellow liquid supplied in sachets . each pack contains 1 vial of solution .
remicade contains the active substance infliximab . infloximabe is a monoclonal antibody a type of protein that attaches to a specific target in the body called tnf ( tumour necrosis factor ) alpha . remade belongs to  a group of medicines called ' tinf blockers '. it is used for the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis ankylosing spondylitis ( bechterew 's disease ) and ppsorasis . you may also be given rericade for the treatment of children aged 6 years and older for the treating crohn '
do not use remicade - if you are allergic to infliximab or any of the other ingredients of remade ( listed in section 6 ). - you are allergy ( hypersensitive ) to proteins that come from mice . - your doctor may want to monitor you more closely . warnings and precautions talk to your doctor , pharmacist or nurse before using reMICade and during treatment : - have tuberculosis ( tb ) or another serious infection such as pneumonia or sepsis . your doctor will monitor you carefully . heart failure , breast - feeding and fertility if any of these apply to you , tell your doctor before using the medicine . you must not use the medicine when you are not sure . take special care with rericade see ' handling instructions ' in section 4 . children
rheumatoid arthritis the usual dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), p soriasis , ulcerative colitis and crohn 's disease the usual dosage is 5 mg for each kg of weight , depending on body weight and condition . how remicade is given remade will be given to you by your doctor or nurse , in a hospital or clinic . your doctor will prepare the medicine for infusion . the medicine will be prepared and given as an infusion ( drip ) over 2 hours into one of your veins , usually in your arm . after the third treatment , your doctor may decide to give the dose of relicade over 2 - 4 hours . you
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however some patients may experience serious side effects and may require treatment . side effects may also occur after your treatment with remicade has stopped . tell your doctor straight away if you notice any of the following : signs of an allergic reaction such as swelling of your face , lips , mouth or throat which may cause difficulty in swallowing or breathing , skin rash ( hives ), swelling of the hands , feet or ankles . some of these reactions may be serious or life - threatening . an allergic response could happen within 2 hours of your injection or later . more signs of allergic side effects that may happen up to 12 days after your injection include pain in the muscles , fever , chills , night sweats ; and cough which may spread to other
remicade will generally be stored by the health professionals at the hospital or clinic . the storage details should you need them are as follows : keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . this medicine can be stored for 2 to 8 days at a maximum of 25 for a limited period of up to six months . reMICade is stable for infusion at 3 to 8 hours at  25 and for an additional 24 hours at 25 after removal from the refrigerator . keep this medicinal product out of your sight and reached of children and other household members . your doctor or nurse will show you how to store and transport it .
what remicade contains the active substance is infliximab . each vial contains 100 mg of influximabe . after preparation each ml contains 10 mg of of influimaber . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate and dibasic salt phosphatade . what retinade looks like and contents of the pack reMICade is supplied as a glass vial containing a powder for concentrate for solution for infusion . only the powder is white . remade are supplied in packs of 1 , 2 , 3 , 4 , or 5 vials . not all pack sizes may be marketed .
rasagiline mylan is used to treat parkinson ' s disease in adults . it can be used together with or without levodopa ( another medicine that is used in the treatment of parkinsons ' disease ). with parkinSON 's disease , there is a loss of cells that produce dopamine in the brain . dopami is  a chemical in the body that is involved in movement control . rasagile mylan helps to increase and sustain levels of dopam in the mind .
do not take rasagiline mylan if you are allergic to rasagisiline or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor or pharmacist before taking rasagine mylan: if your doctor thinks you may have severe liver problems . if the following medicines are not recommended : rasagaline myLAN belongs to a group of medicines called monoamine oxidase ( mao ) inhibitors ( used for treating depression and parkinson ' s disease ). it is also used in combination with medicinal and natural products , such as st .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 tablet of 1 mg taken by mouth once daily . rasagiline mylan can be taken with or without food . if vous take more rasagide mylan than you should if that happens , contact your doctor, pharmacist , or nurse immediately . take the rasagin line mylan carton and with you at the same time each day . you may find it easier to remember to take it . to help you remember to do so , you may notice that you have taken more rasagitline myLAN than you were told to . however , if it has been more than 23 hours since you should have taken it , do not take the next dose until it is time to take your next dose . do not make up for a
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be more serious than those caused by placebo . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( effect affects 1 to 10 users in 100 ) uncommon ( affect affects less than 1 users in 1 , 000 ) very rare ( affect impacts less than1 user in10 ,000 ) not known ( frequency cannot be estimated from the available data ). very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) general feeling of being unwell ( including neck pain , chest pain ( angina pectoris ) diarrhoea , stomach pain ) rash very common abdominal discomfort , nausea ( vomiting ) reporting of side effects 25 
what rasagiline mylan contains - the active substance is rasagisline . each tablet contains rasagide liner , equivalent to 1 mg rasagiatal . - other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize meal , talc , and stearic acid ( see section 2 ). what rasagitline myLAN looks like and contents of the pack rasagive tablets are white to off - white , oval , biconvex tablets , debossed with " gil " and " 1 " underneath on one side and plain on the other side . the tablets are provided in blister packs of 7 , 10 , 28 , 30 , 100 and 112 tablets . perforated blister packs are available in packs of 14 , 56 , 90 and 98 tablets 
do not use hulio : - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a severe infection , such as tuberculosis ( see " warnings and precautions "). it is important that you tell your doctor if symptoms of infections , e . g . fever , wounds , feeling tired , dental problems . it is also important to tell your dentist if your doctor thinks you have moderate or severe heart failure . tell your doctors if any of these apply to you . warningsand precautions talk to your doctor or pharmacist before using hULio ( see also " warning and precaution "). warnings about allergic reaction : allergic reactions have been reported with hülio that is not contained in the medicine ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents ( from 2 to 17 years of age ): if your doctor has decided that hulio is suitable for you , the dose may be increased or decreased . from 10 to 30 kg : hülio can be administered as a 20 mg dose . in children ( from 6 to 17 year old ) if the dose is increased to a maximum of 30 mg , hULio may be administered at a dose of 40 mg . enthesitis - related arthritis in patients from 6 months to 17 kg , who weigh 15 kg to less than 30 kg the dose of hpulio has to be increased to the recommended dose : 20 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require urgent medical treatment . side effects may occur at least up to 4 months after the last hulio injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , including hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , or bruising or bleeding ; signs and symptoms of infection such as fever ; feeling sick ; or vomiting ; nausea and vomiting , as well as severe skin reactions such as rash or hive fever . signs and conditions to look out for include : fever rash feeling sick ( nausea ), vomiting 
what hulio contains - the active substance is adalimumab . - each vial contains monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what helio looks like and contents of the pack hULio 40 mg solution for injection in a sterile solution for injecting is 40 mg aad alumumabe , in 0 . 8 ml of solution , which is clear to slightly opalescent and has a rubber stopper . the product is available in three pack sizes : - 1 vial - 2 vials - 0 vial 1 steril injection syringe , 1 steile needle , 2 ster
yellox contains bromfenac , a member of a class of medicines called non - steroidal anti - inflammation drugs ( nsaids ) which reduce inflammation . yyx is used to reduce eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using yyelloX if : you have asthma , skin allergy , or intense inflammation in your nose you are taking other nsaids . nSaids include acetylsalicylic acid , ibuprofen , ketoprofène , diclofec . this medicine is only used together with topical steroids ( such as cortisone ) to reduce the risk of unwanted side effects . you have had bleeding problems in patients with haemophilia in the past , and you are using other medicines to reduce bleeding time ( e . excipients , such as warfarin ,
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye ( s ) once a day at bedtime . use in children and adolescents yellox should only be applied to the eye ( semen ) twice a week for the first 2 days . do not stop using the drops until the next day after your cataract surgery . method of administration yellowx is for oral use . it is for use in adults only . wash your hands before and after using the eye drops . remove the bottle cap . hold the bottle , pointing down , between your thumb and fingers . tilt your head back . pull down your lower eyelid with a finger . bring the bottle tip close to the corner . this will help to prevent the drops getting into your eye 
what yellox contains - the active substance is bromfenac . each ml of solution contains brom Fenac ( as sodium sesquihydrate ). each syringe contains 33 mbq of bromfedenac at the reference date . -the other ingredients are boric acid and borax , sodium sulphite anhydrous , benzalkonium chloride , the used in combination with tyloxapol and povidone ( k30 ), disodium edetate and sodium hydroxide to adjust acidity levels . what Yellox looks like and contents of the pack yyelloX is a clear yellow liquid ( solution ) supplied in a 5 mL glass vial with a screw cap .
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . sufenteanil is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking dZveo and if any of these apply to you as you may have a serious lung or breathing problem . warnings and precautions talk to your doctor or pharmacist before taking this medicine d Zuveo may affect any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). as dzveo might affect your breathing , your doctor may need to adjust your dose or stop treatment . you have recently had a head injury or brain tumour . your doctor will monitor your heart and circulation , especially if dadurch d zuveo has affected your heart rate , irregular heartbeat , low blood volume , and low
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet a day . if necessary , the single - dose administration device should be connected to a computerised system . this medicine should not be used by people who are not able to take the tablets themselves . do not swallow the tablets . your doctor will advise you if and when you need to take dzuveo . take the sublingual tablet with the supplied single  dose applicator . how to take take the applicators : - place the tablet under your tongue using the appnicator , and - push the tablet through the tongue to release the tablet ( for pain relief ). - press the tablet down and wait 10 minutes . use the appcator after you have taken doodleo
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you get any of the following side effects severe breathing problems , such as slow and shallow breathing . if any of these side effects occur , tell your physician immediately . very common side effects ( may affect more than 1 in 10 people ): nausea ( feeling sick ), vomiting ( being sick ) and feeling hot . common side effect ( may effect up to 1 in10 people ), inability or difficulty sleeping . not known ( frequency cannot be estimated from the available data ) : dizziness , headache , drowsiness , sleepiness . your doctor will tell you how to recognise when you wake up . uncommon side effects are ( may effects up to1 in 100 people ). nausea ( being tired ), being sick ( vomiting ), feeling hot and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any visible signs of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufenil ( as citrate ). - other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( 6000 ), croscarmellose sodium , indigo carmine ( k90 ), and stearic acid ( i ) and magnesium steerate . what  dZveo looks like and contents of the pack dzveo is a white to off - white tablet with round edges and imprinted " dv1 " on one side . the tablet is approximately 3 mm long and has a diameter of one end . dzeveo comes in a single - dose applicator ( labelled [ sublingual tablet ].
erleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has not spread to other parts of the body or cannot be removed with surgical treatments . er leadad is used in adult men to treat sensitive prostate cancer which has not come back or has not responded to surgical treatment . in adult male patients , the active ingredient in erleda is testosterone - resistant prostate cancer . how erlesadda works er leda mimics the active substances in androgens , helping to kill the cancer , by blocking the activity of androgènes . apalutaMIDe stops prostate cancer cells from growing and dividing .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before taking erleda . if there is still a possibility that you may be pregnant or think you may have been pregnant ( see pregnancy , see contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine is for oral use . take special care with this medicine you should tell your healthcare professional if : you have ever had seizures or are taking any medicines to prevent blood clots ( e .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 240 mg once a day . your doctor may increase the dose to 60 mg once daily . you should take erleada about the same time each day , taking it with or without food . take this medication by mouth . swallow the tablet whole . do not crush , open or chew the tablet . if necessary , your doctor might tell you to take ERleade together with other medicines . taking erleda you can take the tablet with or just after food , if your doctor tells you to stop taking ER leada . it is important that you take a tablet of er leada twice a week if taking more er leda than you should as this may increase your risk of side effects 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and tell your doctor immediately if you develop any of the following symptoms : - reddish , non - elevated , target - like , circular patches on the trunk , with central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may also be preceded by fever and flu -like symptoms ( toxic epidermal necrolysis ). serious side effects tell your physician immediately , as this can increase your risk of experiencing the following side effects during treatment with erleda : fit - related seizure uncommon ( may affect up to 1 in 100 people ) if your doctor considers that you may need to stop taking the medicine or decide to
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apalutaMIDe - -the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , and hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose and silicified microcrystalline cellulose . film coating : iron oxide black ( e172 ), iron oxide yellow ( i ) ( a )( e180 ), macrogol , polyvinyl alcohol , part hydrolysed ( ph - 173 ), talc ,and titanium dioxide ( е171 ). what erin looks like and contents of the pack er leada film  tablet - coating is supplied as round
axumin is a radiopharmaceutical product for diagnostic use only . aexumin contains the active ingredient fluciclovine and is used to obtain a detailed medical history and a picture ( scan ) of the prostate ( s ) you have previously undergone treatment for prostate cancer . other tests may also show that the presence of prostate specific antigen ( psa ) is present in sufficient quantities to help determine the size of the cancer , enabling an aXumin pet scan to be performed . it will be performed in accordance with local requirements . the cancer has not been confirmed after the scan . use of auxumin does involve exposure to small amounts of radioactivity . your doctor and the nuclear medicine doctor have considered that the clinical benefit of this procedure with the radiopharmaceucial outweighs the risk of being exposed to radiation .
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using aexumin as it may affect the results of your scan . talk to you doctor if this applies to you . - you have kidney problems . you are on a low sodium diet . do not take a lot of azumin for a day . the aXumin scan is usually taken 4 hours before the scan , and is repeated every 4 hours . after the scan is completed , you should take your usual medicines for the latest 60 minutes after the xumIN injection . avoid drinking alcohol or other non - medicinal drink such as water . it is best to drink the water before going to bed straight away after the injection ,
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be used in specially controlled areas . this medicine will only ever be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . dose the nuclear medicine doctor supervising the procedure will decide on the quantity of aXumin to be used within the target range , which is 370 mbq ( megabecquerel , the unit used to express radioactivity ). administration of  aexumin and conduct of the procedure auxumin is given into a vein ( intravenously ) followed by a flush of sodium chloride solution which was used to prepare the medicine for use in children . duration of the administration the nuclear medicines
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : uncommon ( may affect up to 1 in 100 people ) - stop using the medicine . tell your doctor immediately if you notice any of the following serious side effects after using axumin ( see also section 2 ): pain , rash , altered taste in the mouth , or altered sense of smell . this radiopharmaceutical will deliver low amounts of ionising radiation associated with the least risk of cancer and hereditary abnormalities . reporting of side effects 25 if any of these side effects gets serious , talk to your nuclear medicine doctor . these include any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . axumin must not be used after the expiry date which is stated on the label after exp .
what axumin contains - the active substance is fluciclovine . a xum in 1600 mg : each tablet contains 1600 mg of flucclovine ( 1600 mg in the tablet core ) or 16000 mg of the active ingredient . one apumin 3200 mg / tablet contains 3200 micrograms of froluciclovin ( 3200 / 32000 in the oral solution ). - other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " aexumin contain sodium "). what xsumin looks like and contents of the pack axxumin 1600 mg is supplied as a powder for solution for injection ( multidose ) in packs of 1 , 10 , or 1600 iu ( 16000 ius ) aixumin is supplied in 3200i
azopt contains the active substance brinzolamide . this belongs to a group of medicines called carbonic anhydrase inhibitors , which work to reduce pressure within the eye . aziopt eye drops are used to control high pressure in the eye which can be a sign of an illness called glaucoma . too high the pressure in your eye can damage your sight .
do not take azopt if you have severe kidney problems . if your doctor thinks you may be allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking azyopt : if - you are allergic to medicines called sulphonamides ( medicines used to treat diabetes , infections or diuretics ( water tablets ) as a result of taking more azamopt than you should if the same allergy applies to a certain type of allergy , as there may be too much acidity in your blood ( a condition known as hyperchloraemic acidosis ) after taking ozopt and if any of these apply to you ( or you are not sure ), talk to ' you or your
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one bottle in both eyes ( 1 bottle ) and one bottle each time . use in children your doctor will decide the right dose for your child . do not use azopt in children under 1 year of age . it is best to use the recommended starting dose in your child' s eyes once a month . your doctor may decide to increase the dose based on your child ( see instructions below ). do not change the dose yourself unless your child has been trained to do so . aziopt can be used in children , adolescents and adults . only use in adolescents ( 12 years of age and older ) adopt can only be used by adults , teenagers and children aged 1 year and above , and 2 years 
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , ear pain , and eye discharge - itchy eye , dry eye - abnormal eye sensation - redness of the eye the most common side effect is bad taste . uncommon side effects may affect more than 1 in 100 people - effect on the eye ( frequency cannot be estimated from the available data ): - headache - diarrhoea - vomiting - joint pain - back pain . reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package to protect from moisture . once opened , azopt is recommended to be used immediately . if you have any unwanted tablets , or if a pack containing a single bottle has been opened : throw away any tablets via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains the active substance is brinzolamide . each ml contains 10 mg of brinzolidine . the other ingredients are benzalkonium chloride , carbomer 974p , edetate disodium , and mannitol ( e421 ), purified water , sodium chloride and tyloxapol . hydrochloric acid and sodium hydroxide are used to keep acidity levels ( ph levels ) normal . what  azyopt looks like and contents of the pack azamopt is a milky liquid ( a suspension ) that is supplied in a 5 mL plastic ( droptainer ) bottle with a 10 mlitre plastic ( dropping container ) container with  pctfe / gp ( indicating acidity ). the bottle has
forxiga contains the active substance dapagliflozin . it belongs to a group of medicines called " oral anti - diabetics ". these are medicines taken by mouth for diabetes . they work by lowering the amount of sugar ( glucose ) in your blood . forxika is used in adults aged 18 years and older . there are two groups of forxigan : one is for diabetes called " type 1 diabetes ", and the other is when your body is not able to use any insulin it produces properly . your doctor will tell you what to do . " type 2 diabetes " is when the body is unable to use its own insulin or is not making enough insulin . type 2 disease is when our body is still making too much insulin , and this leads to lowering levels of sugar in your urine . this leads mainly to lowered levels of glucose in your body . the insulin
do not take forxiga : - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxika : contact a doctor or the nearest hospital straight away if : you experience feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , or a bitter or metallic taste in your mouth , an odour to your urine , sweat or rapid weight loss . the above symptoms could be a sign of " diabetic ketoacidosis " a problem you can get with diabetes because of increased levels of " ketone bodies " in your urine or blood , see a titration test before you start taking
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of forxiga is two tablets once a day . for type 2 diabetes : the recommended starting dose is 10 mg once - daily . your doctor may prescribe a lower dose of 5 mg once daily if your doctor thinks you have a liver problem . the recommended dosage of forixiga for type 1 diabetes is 5 mg twice daily , but your doctor will prescribe the strength that is right for you based on your condition . taking this medicine swallow the tablet whole with water . you can take the tablet with or without food . it is best to take your tablet at the same time each day , preferably at the start of the day ; however , try to take it at the right time every day : - at the wrong time each
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking forxiga and see a doctor straight away if you notice the following serious side effects angioedema , seen very rarely ( may affect up to 1 in 10 , 000 people ). these are signs of angiodema ( swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems ). diabetic ketoacidosis , see also section 2 warnings and precautions , which is common in patients with type 1 diabetes ( may effect up to1 in 10 people ) and type 2 diabetes ( rare , may affect less than 1 in 1 ,000 people ), but can be serious and need medical attention . diabetic kidneyoacodiasis a rare occurrence in patients taking forexiga ( increased levels of " ketone bodies
what forxiga contains the active substance is dapagliflozin . each forxega 5 mg film - coated tablet ( tablet ) contains dapagloviflouzin propanediol monohydrate equivalent to 5 mg dapaglingifloooozin - the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigan contains lactoses '), crospovidone type a , silicon dioxide ( е551 ), magnesium stearate (  470b ). film  coat : polyvinyl alcohol ( pct ), titanium dioxide ( methane ), macrogol 3350 , talc ( ac ), yellow iron oxide ( oblong ). what forixiga looks like and contents of the pack forxi
mepact contains the active substance mifamurtide which stops the growth of certain bacteria , which are part of the immune system . mepacted is used to treat osteosarcoma ( bone cancer ) in patients aged between 2 and 30 years , who : cannot have surgery to remove the tumour , or who are unable to respond normally to chemotherapy to remove cancer cells , and prevent cancer from coming back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - when you are taking medicines containing ciclosporin and other calciumineurin inhibitors ( non - semen - related non  - corticosterin - anti - inflammatory drugs ( nsaids ) - where you have problems with your heart or blood vessels such as blood clots ( thrombosis ) or bleeding ( haemorrhage )- - with inflammation of the veins ( vasculitis ) warnings and precautions talk to your doctor before taking mepacting - as mepactation may cause long - lasting or worsening symptoms after stopping mepacted treatment . you should tell your doctor if : you have
treatment mepact will be given to you by a doctor or nurse who is experienced in the use of this medicine . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepacting is 2 vials of mifamurtide per day , for patients who weigh at least 12 kg . this dose is 24 vial ( ms ) once a day . your mepactation treatments may be delayed or stopped if your chemotherapy schedule is altered . if this is the case , your chemotherapy will be postponed until you are able to complete your 36 dose of treatment . treatment with mepacat may be stopped because of an interruption in the processing of the freeze - dried powder for solution for injection and then changed into a liquid suspension . once the filter has been opened , me
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue may occur very commonly with mepacting transient patients receiving paracetamol . this is very common and can be life - threatening . if you experience fever during or after treatment with me Pact , tell your doctor immediately . stomach problems such as nausea , vomiting or loss of appetite may occur during chemotherapy . tell your physician immediately if continuing fever or chills continue for at least 8 days after receiving mepacat . talk to your doctor if he / she notices an infection , rash or any problems breathing or wheezing may occur . in some cases , the doctor may decide to continue to monitor you / her after you have received mepac . these symptoms may be a sign of a serious allergic reaction . as with all medicines
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vially in outer carton in order to protect from light . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection will be stored at 2 - 8 for up to 6 weeks . this medicine must not be used if you notice any visible signs of deterioration such as particles in the suspension or if the suspension is discoloured . any unused solution must be thrown away in accordance with local requirements .
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg of mfamuratide - after reconstitution , one ml of suspension contains 0 . 08 mg of mg of Mifamortide ( as mepace ). -- the other ingredients are 1 - palmitoyl - 2 - oleoy - leoyd - sh - glycolo - 3 - serine monosodium salt , see section 2 " mepacting contains sodium ". what me Pact looks like and contents of the pack mepactation is a white homogeneous cake for concentrate for solution for infusion . mepacted is supplied in 50 mbq glass vials with a grey butyl stopper , aluminium seal and plastic flip 
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin of the face to reduce redness in patients with rosacea to reduce the amount of redness of the facial skin . rosac is the most common symptom of high levels of blood flow in the facial flesh due to enlargement ( dilation ) of the small blood vessels of the skin  . mirvass acts by reducing the size of the blood vessels , reducing their excess blood flow and causing redness .
do not take mirvaso if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor or pharmacist before taking mirvasO if any of these apply to you . if your doctor thinks this applies to you or your child , please tell your doctor before taking the medicine . it is important that you read the package leaflets that are given to you before you take mirvao . this is because it is very important that your doctor read them carefully . children under 2 years old do not give this medicine to children under the skin . do not use mirvason if : you are taking certain medicines for depression or parkinson ' s disease . these include monoamine oxidase ( mao ) inhibitors ( e . excipients such as selegiline and moclo
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is only suitable for use on the skin and on the face . this medicine is for subcutaneous use . do not stick to any other part of your body or to other body surfaces , such as your eyes , mouth , nose or vagina . if your doctor tells you to use other forms of mirvass , do not apply mirvason to your face unless your doctor told you to . your doctor may tell you to stop the treatment . how much mirvasa to use your doctor will decide how much you should use based on your symptoms . the maximum daily dose of 1gram ( 5 pea - sized amounts ) should be 1gram per day . it should be used on the same day each day , once a day ; however
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects are : severe skin irritation or inflammation , skin rash , cutaneous skin pain or discomfort , dry skin , warm skin sensation , including tingling , sensation of pins and needles or swelling . common side effects include : worsening of rosacea and stopping the treatment . symptoms can be described in section 2 under " contact allergy ". allergic reaction and rash are uncommon in patients with rare angioedema ( a serious allergic reaction which may appear in up to 1 in 100 people ). if you experience these symptoms , contact your doctor immediately . if your doctor notices any of the side effects above , please tell your doctor . not known side effects may be : allergic reaction with rash and / or rare angina ( if there is 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the tube and pump after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . syringe , tube and push are to be used only . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each gram of gel contains 3 . 3 mg of brimonimonidine and 5 mg of proline . -the other ingredients are brimondidine tartrate , carbomer , methylparahydroxybenzoate , the phenoxyethanol , hydrogen , benzoate ; glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasa contains methyl parahydroxybenzone , propyl glycol "). what mirvao looks like and contents of the pack mirvasto is a clear , colourless gel . it is supplied in 2 ml x 10 mL or 30 m2 of gel in an airless pump system .
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that is normally made by the immune system to help defend the body from infection and cancer ). bevacimizumabe binds selectively to a protein called human vascular endothelial growth factor ( vegf ), which is found on the lining of blood and lymph vessels in the body . the veggf protein causes blood vessels to grow within tumours , these blood vessels provide the tumour with nutrients and oxygen . bevacuzumaber causes tumour growth by blocking the growth of the blood vessels which provide the nutrients and nutrients to the tumour . mvai is conceived as a medicine for the treatment of adult patients with advanced cancer in the large bowel . it is usually found in the colon or the colon , but can
do not use this medicine - if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). - you are allergy ( hyper sensitive ) also to chinese hamster ovary ( cho ) cell products . - your partner or mother should not be given mvasi . warnings and precautions talk to your doctor before using mvai : - talk to you doctor before you are given  if your doctor thinks you may be at risk of developing holes in the gut wall . talk to the doctor if any of these apply to you . you may also experience inflammation inside the abdomen ( e . deficiency ), diverticulitis , stomach ulcers , colitis associated with chemotherapy . your doctor may need to monitor you closely . the use
dosage and frequency of administration the dose of mvasi needed depends on your body weight and the kind of cancer to be treated . the recommended dose is 5 mg , 7 . 5 mg, 10 mg or 15 mg per kilogram of your body weigh . your doctor will prescribe a dose of the correct dose for you . frequency of use you will be monitored while you are receiving mvai . you will receive m vasculitis every 2 or 3 weeks . if you receive infusions more often than once a week , you will usually receive treatment over a period of time . it is important to continue receiving this medicine until mwasi stops your tumour growing . how and when to prepare mvisi for infusion the m Vasi vial will be prepared and diluted with sodium chloride solution before use . this diluted mVAsi solution will be given to you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : serious side effects tell your doctor or nurse straight away if you notice any of the side effects listed below . some of the serious side impacts were seen when mvasi was given together with chemotherapy . this does not necessarily mean that these side effects were strictly caused by mvai . allergic reactions if an allergic reaction occurs , symptoms may include difficulty in breathing , chest pain , redness or flushing of the skin or a rash . chills and shivering , feeling sick ( nausea ) or being sick ( vomiting ). if any of these occur , tell your nurse immediately . other side effects include : severe side effects that may be serious include , but are not limited to : mild to moderate . they may include a
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the viall in the outer carton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 followed by dilsution in  a sterile environment . once dile dipped in , a dry and steril environment has been observed for 35 hours at room temperature ( 20 - 25 ) for 2 hours followed by 8 hours at 15 - 30 . remove any
what mvasi contains the active substance is bevacizumab . each ml of concentrate contains 25 mg of bevacitzumabe , corresponding to 1 . 4 to 16 . 5 mg / mL when diluted as recommended . one 4 mlitre vial contains 100 mg of Bevacizub , correspondant to 1: 4 mg . this equals 16 mg - 400 mg of BEvacibuab at 16 : 5 . 6 mg pfizer . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what if you use mvai what svasi looks like and contents of the pack m Vasi is a concentrate for solution for infusion . it is  a clear to slightly opalescent and colourless to
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it belongs to a group of medicines called ' autologous anti - cd19 - reduced c3 + cells '. tecARTus is used to control the growth of your own white blood cells , called autologously anti  c - 19 - stimulated ccd3 + cell types . mantled cell lymphhoma is  a cancer that affects part of the immune system called b - lymphocytes . in mantles cell lymphnoma , b- lymph cells start growing out of control and become part of your immune system . b lymphocyte cells are involved in the growth and division of mantlet and develop into a different organ ( called a b cell ). tec artus works by enabling your
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using the medicine . warnings and precautions talk to your doctor , pharmacist or nurse before using tecARTus . if your doctor determines that you are allergy to the medicine or to any of its constituents , please inform your doctor or nurse . since tecArtus will not be able to take white blood cells from your blood ( lymphodepleting chemotherapy ) for more than 3 years , the risk of white blood cell counts will be reduced by your doctor through autologous use . tests and checks your doctor will do before and during treatment with tec artus , your doctor and / or nurse will perform tests to make sure that the medicine is safe and works properly . these include 
tecartus is made from your own white blood cells . your cells will be collected from your blood using a catheter placed in your vein ( a procedure call leukapheresis ). tecARTus works by allowing your white blood cell to be extracted from your body . this allows your blood to be infused directly into your vein , for at least 3 to 6 hours . if your whiteblood cells are not collected at all , they will be frozen for another 2 to 3 hours , and sent away to a hospital for further analysis . medicines given before tecarus treatment with lymphodepleting chemotherapy the modified white blood can be kept in your body for 30 to 60 minutes . you may be given other medicines to reduce infusion reactions and fever . the administration of these other medicines will usually be in hospital by a doctor or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of tecartus . tell your doctor straight away if you notice any of the following side effects you may need urgent medical attention : the following serious side effects have occurred during the tecARTus infusion . very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure , symptoms such as dizziness , lightheadedness ; fluid in the lungs , which are all symptoms of a condition called cytokine release syndrome . loss of consciousness , decreased level of consciousness may be associated with confusion , memory loss , or confusion . these may be signs of memory loss and may be life - threatening . if any of these side effects causes you problems 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and infusion bag . store frozen in vapour phase of liquid nitrogen 150 for a single period of up to six months before use . this medicine contains genetically modified human blood cells . any unused medicine or human - derived material should be disposed of 36 in accordance with local requirements .
what tecartus contains the active substance of tecARTUS consists of autologous anti - cd19 - stimulated c3 + cells , grown in a hospital or clinic . each patient - specific single infusion bag contains a dispersion of anti  - cad19 car t cells in approximately 68 ml for a target dose of 2 x 106 anti . the other ingredients are sodium chloride and human albumin . see section 2 , " tecArtus contains sodium ". what Tecartus looks like and contents of the pack tec artus is a clear to slightly opalescent , colourless to pale yellow dispertion in an infusion container packed in  a metal cassette . a single inffusion bag holds approximately 168 mbq of cell disperded in one glass vial 
januvia contains the active substance sitagliptin which is a member of a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 5 inhibitors ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2 disease . you should take this medicine in addition to certain other medicines ( insulin , metformin , sulphonylureas , or glitazones ), which also lower blood sugar from your diabetes . if you have type 2 diabetic patients , this medicine is not a cure for your disease ; it is important that
do not take januvia : - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - as you may have a history of inflammation of the pancreas ( pancreatics ) ( see " warnings and precautions "). if this applies to you , do not start taking janusuvia and contact your doctor immediately ( see section 4 ). the possibility of blistering of the skin may be a sign for a condition called bullous pemphigoid . warningsand precautions talk to your doctor or pharmacist before taking  Januvia as you might have , or might now have : had a disease of the Pancreases ( such as pancreatis ). had gallstones , alcohol dependence or very high levels of triglycerides in your blood 
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual recommended dose is : one 100 mg film - coated tablet 63 once a day by mouth if your doctor thinks you may have kidney problems , your doctor may prescribe lower doses ( such as 25 mg or 50 mg ). you can take this medication with or without food and drink . your doctor will prescribe the strength that is right for you : - alone or with certain other medicines that lower blood sugar . diet and exercise can help your body use its blood sugar better . it is important to stay on the diet and lifestyle recommended by your doctor while taking januvia . if and when you take more janusvia than you should if or when you accidentally take too many tablets , contact your doctor immediately . take the medicine pack with you , so that it
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects you may need medical attention : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatictitis ). a serious allergic reaction ( frequency not known , cannot be estimated from the available data ). you may also experience rash , hives , blisters on the skin / peeling skin and swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing . if any of these side effects become severe , please contact your physician or healthcare professional . you may require medical attention immediately . very common (
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglitin phosphate monohydrate equivalent to 25 mg of sitaglictin in one tablet . - other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphat e , croscarmellose sodium , magnesium stearate ( е572 ) and sodium stearyl fumarate . the tablet film coat contains poly ( vinyl alcohol ), macrogol 3350 , and talc ( ent . citrate ), titanium dioxide (  e171 ), red iron oxide ( i ) or yellow iron oxide . what nuvia looks like and contents of the pack janusvia is a round , pink film . opaque blisters ( pvc /
what xultophy is xULtophy lowers blood glucose ( glucose ) in adults with type 2 diabetes mellitus . this type of diabetes is a very common complication of diabetes that occurs when the body is not able to use enough insulin to control the level of blood sugar . insulin degludec is  a long - acting basal insulin . it helps your body to control your blood sugar levels . xulation with liraglutide or glp - 1 , can be used to help you to stay on your diet and exercise plan . your doctor will talk with you about which type of insulin to take during meals . how xültophy works oral medicines for diabetes xoultophy can be taken with or without oral medicines to treat diabetes ( such as metformin , a diet and a physical activity ) when you have
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , 39 if your doctor has prescribed you a sulfonylurea ( e . g ., glimepiride or glibenclamide ), please discuss with your doctor if the latter applies to your sulphfonyera dose . your doctor may need to adjust your dietary intake , and may change your dose if needed . warnings and precautions talk to your doctor before taking xULtophy and if any of your conditions are severe or you have type 1 diabetes mellitus or ' ketoacidosis ' ( a condition which occurs when the contents of the glass in the bowel
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . xultophy is not recommended for use in blind people because of poor eyesight . your doctor will test your blood sugar level . you should not use xULTOphy more than once a day . the recommended dose is 41 xu / kg body weight each day , with or without food . take xoultophy before the first meal of the day ; you can use it for up to 8 hours before or after food ; it does not matter whether you take it with or after meals . how to use XultoPhy xulation is available in a pre - filled dial - a - dose pen . use the dose counter to measure the dose in units of 1 unit ( i . ex . insulin
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are low blood sugar ( which may affect more than 1 in 10 people ). if your blood sugar level gets low you may pass out ( become unconscious ). serious hypoglycaemia may cause brain damage and may be life - threatening . if you have low blood glucose , take actions to increase your blood glucose level . this is to help prevent low blood Sugar from becoming too high . ( see hypogliese in section 4 ). in the event of a severe allergic reaction ( anaphylactic reaction ) ( frequency not known ): if a serious allergic reaction gets serious , or if local reactions get local reactions , the doctor will monitor you more closely . these reactions may be severe and may lead to hospitalization . as with all medicines this medicine may cause temporary disability
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after opening the vial , you may store it at room temperature ( up to 30 ) for a single period of up to 8 weeks . once reconstituted it should be used within 21 days . this 21 - day period must be disposed of . any unused medicine must be an approved use by the healthcare professional .
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units insulin deGludec , equivalent to 3 . 6 mg lilraglutid . one vial of 3 mL contains 300 units insulin desgludeck , corresponding to 10 . 8 mg / mmol ligalutide in the womb . the other ingredients are glycerol , pregelatinised maize starch , iron oxide red ( e172 ), phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xULTOphy contains sodium "). pack sizes of 1 ( 3 x 5 ) or a multipack containing 10 ( 10 x 2 
giotrif is a medicine containing the active substance afatinib , which blocks the activity of egfr [ epidermal growth factor receptor 2 ]- 2 [ erbb1 ] and her2 [ ERbb2 ] - 3 ]. these proteins help to kill cancer cells . by blocking the action of these proteins , giotricon can kill cancer cells . this medicine can slow down the growth of cancer cells and slow down their growth . gioTRIf is used to treat adult patients with cancer of the lung ( non - small cell lung cancer ). gio trif is intended as your first treatment in patients who have not received prior chemotherapy treatment ( for patients of squamous type ) who have had prior chemotherapy treating their disease .
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have low body weight less than 50 kg if this applies to you if any of your family members is elderly if they are elderly . warnings and precautions talk to your doctor , pharmacist or nurse before taking gioTRIf : if the medicine is for use in patients with kidney problems . if there are any risk of side effects , see section 4 . lung inflammation ( interstitial lung disease ) in patients receiving gio trif . tell your doctor about any problems with liver problems , as giotrichip may need to be stopped . your doctor may do some liver tests before and during treatment with this medicine if : you have a severe liver disease . you have eye problems
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet per day . you should take this medication at least one hour before or two hours after the last meal . your doctor will tell you the dose to take . if necessary , your doctor may increase your dose . taking this medicine you can take this medicinal product with or without food . take this dose at least 1 hour before , or 3 hours after a meal , preferably at the same time each day , so there is always enough medicine in your body to help you remember to take it . swallow the tablet whole with a glass of water . do not chew or crush the tablet . this medicine can be taken with orwithout food ; however , try to take this one before your next meal ; this will help you to remember to drink it
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects may happen with gioTRIf . contact your doctor immediately if you notice any of the following serious side effects during or after treatment : diarrhoea ( very common , may affect more than 1 in 10 people ): diarirhhooeea may progress to severe diarhoaea with fluid loss ( common - may affect up to 1 in every 10 people and may be due to low blood potassium , which may be a sign of worsening kidney function ). if diarrehoéa occurs , contact your physician immediately . your doctor will decide whether to start appropriate antidiarrhofeal treatment and / or antidiarrheal medicine prior to starting giotricif : 
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of a fatinir . - other ingredients are : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate , all in the tablet core ; hypromellose , macrogol 400 , titanium dioxide ( e171 ), and polysorbate 80 ( s ). what atrif looks like and contents of the pack giotricf 20 mg film  coated tablets are white to off white , round tablets with the bayer cross on one side and " gsi " on the other side . the gioTRIf film – coated tablets come in blisters of 1 , 2 or 4 tablets in blister blister
orkambi contains two active substances , lumacaftor and ivacafting . ork Ambi is a medicine used for long - term treatment of cystic fibrosis ( cf ) in adults and children from the age of 6 years with a f508del mutation , which is essentially a change in the cd50 protein in the cystic fistula ( fibroblastic ftr ) transmembrane conductance regulator ( kft ). the mutation is intended to change the position of an abnormal c Ftr protein . lumamacaffetor or ivacabtor work together to disrupt the abnormal ffttr proteins . by blocking the f580p gene , orkamba causes the abnormal protein to work more normally . this may help your breathing and
do not take orkambi if you are allergic to lumacaftor , ivacaftar or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ork Ambi . orkaji must not be used if the f508del mutation in the gene is present in the medicine . your doctor will check the if this applies to you . if any of these apply to you or you are not sure , talk to the doctor or nurse before taking the medicine and during treatment with orkami . talk to you doctor or nurses before taking any medicine if : you have liver or kidney disease . the dose of orkamba may need to be adjusted . you have abnormal blood tests of the liver . tell your doctor before taking , orkacco if either of these symptoms suggestive of liver
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage for children aged 6 to 12 years : the recommended orkambi tablet is one tablet once a day in the morning and one tablet in the evening . use in children aged between 6 and 11 years , the recommended dose of ork Ambi is 100 mg once / day . take the tablet at about the same time each day , with food . do not split , crush or chew the tablet . for children younger than 2 years ; the recommended dosage for orkami is 200 mg once daily in the afternoon and 2 tablets once - day in both morning and once in the late afternoon . if your doctor has recommended that you take orkamba more than once , you should have taken at least 200 mg in the early morning and 2 separate doses in the middle
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects seen with orkambi being taken in combination with ivacaftor are similar to those seen with either ork Ambi alone . serious side effects stop taking orkam and see a doctor straight away if you notice any of the following : - raised levels of liver enzymes in the blood , which may increase the risk of liver injury - pre - existing severe liver disease - the worsening of liver function uncommon side effects ( may affect up to 1 in 100 people ): if any of these occur , tell your doctor immediately : tell your pharmacist , or nurse . if they occur : any of them : pain or discomfort in the upper right stomach ( abdominal ) area yellowing of your skin or the whites of your eyes loss of appetite . these may be signs
what orkambi contains the active substances are lumacaftor and ivacaftar . ork Ambi 100 mg / 125 mg : each tablet contains 100 mg of lumcaftors and 125 micrograms of ivacastor .  orkamba 200 mg  each tablet delivers 125 milligrams ( 200 mg of total lum acaffetor + 125 mm of total daily dose iva caftr ).  Orkambi 200 mg and 126 millilitres : either tablet contains 200 mg or lumscaftore / 120 milliliters of total orkacco . the 100 mg and 250 milligramms of the ivacftare are available in tablet containers . each biconvex tablet contains 125 million units of iu of a caftoareg
what lynparza is lyinparza contains the active substance olaparib . olarib is a type of cancer medicine called a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ]). it works by preventing mutations ( changes ) in the gene that produce parp ( brca ) ( breast cancer gene ). if you have cancer that is not being treated , parp inhibitions can cause death of cancer cells . how lylnparaza works parp inhibits an enzyme that is needed to repair dna . what lnparaza is used for lyngparza can be used to treat adult patients with ovarian cancer ( brc ) and adult patients who have mutated ovary cancer , when the cancer has responded to previous treatment
do not take lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . 2 . do not stop taking lyngparza without talking to your doctor . warnings and precautions talk to your healthcare professional before taking LYnparZA . lyinparza can cause low blood cell counts . your doctor will do testing to check for low counts of red or white blood cells , and low platelet counts , see section 4 , possible side effects , in particular if your 75 year old patient gets any of these conditions . the signs and symptoms can include fever , infection , bruising , or bleeding . more serious problems with the bone marrow called ' myelodysplastic syndrome ', see also section 4 possible
always take lynparza capsules exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of lyinparza is 100 mg once a day . your doctor may decide to increase your dose to 150 mg once daily . the doses of LYnparaza capsules should be equal to or greater than two separate tablets of two times a morning and one capsule of two - three times - day , depending on the side effects you may experience . step 8 - take LYNparza by mouth , in the evening or with food . swallow the capsule whole with a glass of water . do not open or crush the capsules . lynezparza can be taken with or without food , but you should swallow the whole capsule with . 2 tablespoons of water do not chew 
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , having pale skin , fast heart beat ( symptoms of a decrease in the number of red blood cells ( anaemia )). uncommon ( may effect up to 1 in 100 people ),: allergic reactions such as hives , difficulty breathing or swallowing , dizziness . these may be signs and symptoms of hypersensitivity reactions . other side effects include : very common side effects ( may occur with more than one in 10 patients ) - reduction in the numbers of red and white blood cells - anaesthesia . uncommon ( might affect up to one in 100 patients ). - allergic reactions including hive , difficult breathing or taking the medicine , or dizziest . signs andsymptôme
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in the original package in order to protect from moisture . once removed from the refrigerator , any lynparza capsules should be used immediately . lyngparza caps should be kept at room temperature ( below 30 ) for no longer than 3 days . throw away any capsules that are left in the refrigerator or discarded . discard any capsule that is left in a bottle or sachets . these measures will help protect the environment .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olarib - astrazeneca logo on one capsule . - lyndparza is available in two strengths : 112 mg or 448 mg : each hard hard capsule holds 112 capsules . not all pack sizes may be marketed .
this medicine contains the active substance naloxone . nnalotone is used to treat various types of opioids , including heroin , methadone , fentanyl , alfentanl / oxycodone , buprenorphine /morphine . all of the ingredients in nyxoid are contained in a nasal spray , for the emergency treatment of opioid overdose . opioid overdosing can be lasting for up to 14 days . an overdose can cause breathing problems or severe sleepiness . you should know that an opioid over dose is not a cure for opioids and you should seek emergency medical care if you have any questions .
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nanyxoide . you should be aware of the following : - you need emergency medical care , as emergency services may be overwhelmed by an opioid overdose . see section 4 for the signs and symptoms of an opioid overload . - use this nasal spray every 2 to 3 times , and use a new nasal spray as soon as you can , if necessary . do not take this medicine if : you are physically dependent on opioids . opioids include heroin , methadone , the use of fentanyl , alkaline , hydrochlorothiazide , semen , po
always use nyxoid nasal spray exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 1 spray ( 2 sprays in the morning and evening ) at about the same time each day . symptoms should be injected at the shoulders and in the ears , near the breastbone and sternum , by using the tip of your ear . do not touch the area where you have your fingernail . this will help to clear the mouth and nose of any blocksages . the medicine will help your doctor to clear your mouth and nasal spray . 1 . when you are breathing is the chest moving , push the button in your chest . if this happens , you can hear breathing sounds or breath on the cheek . overdose may cause a very slow response to touch or sounds ,
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . stop taking nyxoid and seek medical help immediately if you experience any of the following acute withdrawal symptoms , which may be signs of opioid drugs : symptoms include fast heart rate , high blood pressure body aches and stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps shivering and trembling changes in behaviour , violent behaviour ; nervousness , anxiety , agitation , mood swings ; difficulty sleeping , depression ; irritability , trouble sleeping ; fast heart beat ; high blood - pressure body cramps and pains . uncommon : may affect up to 1 in 100 people slow heart rate or high blood
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray delivers 1 . 8 micrograms of nnaoxione ( as hydrochloride dihydrate ). - other ingredients are : trisodium citrate dihydrate ( e331 ), sodium chloride , hydroch chloric acid ( i ) ( containing sodium hydroxide ), purified water ( see section " nylons and nyamaxod contains sodium "). what ? nlyxoide is supplied as a pre - filled nasal spray in a single dose container . nyesoidur is supplied in : a carton containing 2 nasal sprays in blisters . the active ingredient is : one dose of each nasal sprinkling dose of a dose of 1  . 2 mg
this medicine contains the active substance follitropin alfa , which is a gonadotropin , a type of hormone that plays an important role in human fertility and reproduction . fsh is needed for the growth and development of the sacs ( focytes ) in the ovaries that contain the eggs , for the production of sperm . in women , ovaleap is used to help develop a mature egg cell . for treatment with a medicine called " clomifene citrate ", which belongs to the group of assisted reproductive technology procedures ( procedures that can help you to become pregnant ) it is used together with : a medication called " lautropin alla " combined with another gonadotrophin called " leutropine - luteinising hormone " and a " human chorionic gonadotropic ". oval
do not use ovaleap : - if you are allergic to follitropin alfa ( fsh - conjugated flh ), frogcle stimulating hormone ( eh ) or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a tumour in your hypothalamus or pituitary gland ( both are parts of the brain ). in women with large ovaries or sacs of fluids within the obvaries called ovarian cysts . - in women without unexplained vaginal bleeding . warnings and precautions talk to your doctor or pharmacist before using ovaleavesp if : you have cancer in your oocytes , womb or breasts ; you have any condition that makes a normal pregnancy impossible , such as ovary failure
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). women of childbearing age should receive at least one injection each day . if your period is irregular , you or your partner may receive more of this medicine during the first 7 days of your menstrual cycle . the medicine will be given to you or the child by a doctor or nurse and will administer the medicine . your doctor will decide the correct dose for you or for how long you need to keep having this medicine , depending on the size of the child and the size and weight of the baby . women of sex will receive an initial course of 75 to 150 mg of this product per day , given every 7 to 14 days . you or someone else may be 
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects in women allergic reactions may include skin rash and raised itchy areas of skin . severe allergic reactions might include weakness , drop in blood pressure , difficulty breathing and swelling of the face 37 very rare : may affect up to 1 in 10 , 000 people if you think you may have this type of reaction , your ovaleap injection may need to be stopped immediately . serious side impacts in women lower stomach ache , nausea and vomiting may be the symptoms of ovarian hyper - stimulation . these may be signs of a high level of sugar in the blood . tell your doctor or nurse immediately if any of the above occur . warnings and precautions talk to your doctor , pharmacist or nurse if they experience any of these . other possible side effects very common : in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a single period of maximum 3 months below 25 in - use , or it can be stored at room temperature ( up to 25 ) for re - usage . once removed from the refrigerator , this medicine must be used within 3 months or disposed of . if the cartridge is not used within 28 days or stored below 25 , it must be protected from light and protected from direct sunlight . remove the pen cap from the ovaleap pen . use this medicinal product if you notice that the solution
what ovaleap contains - the active substance is follitropin alfa . ovaleeape 300 iu / 0 . 5 ml : each cartridge contains 300  225 ius ( equivalent to 22 micrograms ) fotropinalfa in 0. 5 millilitre ( mL ). ovalep 450 iiu in 00 . 75 mlitre ( equivalent  to 450 microgram ) solution for injection . each cartridge delivers 450 international units ( i . e . 33 microgram ( s ). flotropIN alfo in .0 mmol ) ( equivalent equivalent to 0
voriconazole accord contains the active substance vorikonazole . voricanazole is an antifungal medicine . it works by killing or stopping the growth of the fungi that cause infections . this medicine is used for the treatment of patients ( adults and children over the age of 2 ) with : invasive aspergillosis ( a type of fungal infection due to aspergallus sp ), candidaemia ( another type of FUNgal infection caused by candida spp ) in non - neutropenic patients ( patients without abnormally low white blood cells count ), serious invasive candida species infections when the florus is resistant to fluconazoles ( another antifungals medicine ), seriously serious fungal infections caused by scedosporium spe / fusarium ssp. ( two different species of 
do not take voriconazole accord : - if you are allergic to vorikonazole or any of the other ingredients of this medicine ( listed in section 6 ). - tell your doctor if this applies to you . - do not use this medicine if your doctor or pharmacist has told you that you are taking or have recently taken any other medicines , even those that are obtained without a prescription , or herbal medicines . ask your doctor for advice on which medicines you should take during voricanazole acord treatment . 46 - the active substances are : the terfenadine ( used for allergy ) astemizole ( used to treat allergy ). the active substance is cisapride ( used in stomach problems ). pimozide ( taken for mental illness ). quinidine ( used when treating irregular heart beat ). also , the active
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . your doctor will determine your dose depending on your weight and the type of infection you have . the usual dose is 40 mg per kg of body weight , for example if your weight is 40 kg , or 40 mg every 24 hours . in some cases you may need to receive a dose of 400 mg every 12 hours for the first 24 hours ( 400 mg per 12 hours per day for the 24 hours period ). in some instances ( 24 hours or 200 mg per day ) your doctor may prescribe a higher or lower dose of 100 mg per kilogram body weight each day . depending on how you respond to treatment , your doctor might increase your dose to 300 mg per square metre ( 100 mg / kg ) or 300 mg . if necessary , you may be given an injection of mild to moderate
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , most are likely to be minor and temporary . however , some may be serious and need medical attention . serious side effects stop taking voriconazole accord and see a doctor straight away if you notice rash or jaundice , changes in blood tests of liver function or pancreatitis . other side effects very common : may affect more than 1 in 10 people visual impairment ( change in vision including blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision / night blindness and swinging vision ). common - may affect up to 1 in every 10 people changes in vision recording of events , including changes in visual perception including blurring of vision . reporting of side
what voriconazole accord contains - the active substance is vorikonazole . each 50 mg film - coated tablet contains voricanazole ( as a 50 mg tablet of film  coated tablets ) and 200 mg vorizonazole as - vorionazoleaccord 200 mg film the other ingredients are : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , and hypromellose ( e464 ), titanium dioxide ( a171 ), lactoses monohydrate and triacetin . the film ' s colour is pink and oval . voricôneazole acord is supplied in a glass vial . it is available in two strengths : 50 mg and 200mg film .
mvabea is a vaccine to protect you against ebola virus disease in the future . it is given to individuals aged 1 year and older who could potentially infect others . your doctor will tell you how many days of a 2 - dose course of vaccinations to be given . eba virus is caused by the zaire eboravirus , a type of filovirus . this vaccine works by causing your body to produce its own protection ( antibodies ) against the other types of filozovirus ; therefore , this vaccine destroys the whole eebolo virus . that means it will not give you ebara virus diseases . the two vaccines are not together : - zabdeno vaccine , given 8 weeks later . both mvasbea vaccine should be given at the same time as mfd .
you and your doctor will decide on the vaccination course . mvabea should not be given if you have ever had a severe allergic reaction to any of the active substances listed in section 6 . you have had , or have had, a severely allergic reaction , to an antibiotic called ' gentamicin '. the vaccine may not fully protect everyone who is vaccinated . warnings and precautions talk to your doctor or nurse before you are given mVAbea if : you have previously had : a serious allergic reaction after any other vaccine injection you have recently fainted . after an injection you are bleeding or bruise easily you currently have a fever or an infection you are taking medicines that affect the immune system such as high - dose corticosteroids ( such as prednisone ) or chemotherapy ( cancer medicines ) you have , and have 
mvabea is given to you by a doctor or nurse as a single dose into a muscle ( intramuscular injection ) in the upper arm or thigh or a blood vessel . the first vaccination with zabdeno vaccine is given 8 weeks later . if you miss your scheduled dose of mvasbea vaccine , you will receive the second vaccine . see section 4 . what mavabea looks like and contents of the pack this vaccine is a white to off - white vaccine containing a green body and cap vial . primary vaccination first vaccination ( mvdeno red cap viall ) is given after a second vaccination with the same dose as in the first dose . second vaccination ( 2 . 2 ml ) mVAbea yellow cap vially is given approximately 8 weeks after the first vaccine with zbden 
like all medicines , this vaccine can cause side effects , although not everybody gets them . the most serious side effects are usually mild to moderate . they usually happen within 7 days of giving the injection . tell your doctor or nurse straight away if you notice any of the following side effects you may need urgent medical attention : very common ( may affect more than 1 in 10 people ) pain , warmth , or swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people people ). feeling sick ( vomiting ) itching where the injecting is given uncommon ( may effect up to1 in every 100 people ), redness , skin hardness where the infusion is given generalised itching reporting of side effects 23 if your child gets any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet .
what mvabea contains - the active substance is zaire ebolavirus , 29 micrograms ( 0 . 7 ml ) of tai forest ebavirus nucleoprotein marburg , corresponding to 0. 7 million iu / m2 . each vial contains 108 microgram ( g ) derived from chicken embryo fibroblast cells . - this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections , and hydrochloric acid ( for ph adjustment ). what vvabeа looks like and contents of the pack mVAbea is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . the vial is 20 microgram
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . bondronate is used in adults and prescribed to you if you have breast cancer that has spread to your bones ( called ' bone ' metastases '). it helps to prevent your bones from breaking ( fractures ). it also helps to reduce other bone problems that may need surgery or radiotherapy bondronates if your doctor has raised calcium level in your blood because of a tumour . the amount of calcium that is lost from your bones is also increased . as a result , your bones become weaker .
do not take bondronat : - if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) - when you have low levels of calcium in your blood . do not receive this medicine if any of these apply to you . if this applies to you ( or you are not sure ), talk to your doctor or pharmacist before taking this medicine. warnings and precautions the most serious side effect is osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) has been reported very rarely in the post marketing setting in patients receiving bondronate for cancer - related conditions . onj can also occur after stopping treatment . it is important to try and prevent onj developing as it is a painful condition that can be difficult to treat . in order to reduce the risk of developing osteonocross of
this medicine bondronat is normally given by a doctor or other medical staff who have experience with the treatment of cancer . it is given as an infusion into your vein your doctor may do regular blood tests while you are receiving bondronate . this is to check that you are being given the right amount of this medicine . how much to receive your doctor will work out how much bondronatului you will be given depending on your illness . if you have breast cancer that has spread to your bones , the recommended dose is 3 mg every 3 - 4 weeks , as an an infustion in your vein over at least 15 minutes . you will also be given a raised calcium level in your blood over the next 1 to 2 weeks . your doctor might reduce your dose if your illness remains largely unchanged after the medicine has been given as a single infusion in your vault . however , a repeated dose may
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a nurse or a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain and inflammation new pain , weakness or discomfort in your thigh , hip or groin . you may have early signs of a possible unusual fracture of the thong bone . very rare ( might affect up 1 in 10 ,000 people ). if any of these happen , tell your doctor straightaway . pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone ). talk to your doctor if your ear pain is not being controlled . discharge from the ear may be signs of an ear infection
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution can be stored for up to 24 hours . store in the original package in order to protect from light .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial is used as a concentrate for solution for infusion . one vial contains 2 mg i bandronic acids . - other ingredients are sodium monohydrate , sodium chloride , acetic acid , and sodium acetate . water for injections what bondruat looks like and contents of the pack bondronate is presented as : - a white to off - white lyophilised concentrate for solutions for infustion . it is supplied in packs containing 1 or 2 vials closed with a bromobutyl rubber stopper .
what zeposia is zeposa belongs to a group of medicines that affect the production of white blood cells ( lymphocytes ). what ZEposia does zeposition is used to treat relapsing remitting multiple sclerosis ( rrms ), a form of active disease called multiple ' multiple - scleral sleeves ' ( mss ) in adults . m m is a disease in which the immune system ( the body ' s defenses - producing white blood cell count ) interferes with the nerves in the brain and spinal cord and in some cases the body can no longer use its own nerves . this results in symptoms such as numbness and difficulty in walking .
do not take zeposia - if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have a severely weakened immune system . - have had a heart attack ( including angina , stroke , mini - stroke ), transient ischemic attack ( tia ), or severe heart failure in the last 6 months . talk to your doctor if any of these apply to you . warnings and precautions talk to you doctor or pharmacist before taking zeposa : - are being treated for irregular or abnormal heartbeats ( arrhythmias ). your doctor may need to adjust your heart ' s response to treatment . you have severe infection ( hepatitis , tuberculosis ), cancer , have severe liver problems , are pregnant
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the amount of zeposia you take will be calculated by your doctor and will be adjusted by your heart rate . you will receive a ' treatment initiation pack ' with each capsule containing : one capsule of 0 . 23 mg of ozanimod on day 1 of each 4 week course . after day 4 of treatment , your doctor may increase your dose to 3 capsules of 00 . 46 mg of the usual dose of ' oznimod ' on day 5 , 6 and 7 . from week 8 onwards , you will have a new leaflet with this medicine . this will be added to a' maintenance pack  with orange capsules containing only 0. 92 mg of each
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor or nurse straight away if you notice any of the following side effects very common ( may affect more than 1 in 10 people ) slow heart rate , urinary tract infection ( blood pressure lowering ) uncommon ( may effect up to 1 in 100 people ), allergic reaction . the signs may include a rash . other side effects talk to your doctor , pharmacist or nurse if any of these side effects become serious . very common : may affect up to1 in 10 persons , infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ), voice box ( larynge ) caused by viruses . not known ( frequency cannot be estimated from the available data ) increase in a type of white blood cell called lymphocytes common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any damage or signs of tampering to the pack .
what zeposia contains - the active substance is ozanimod . zeposa 0 . 23 mg : each capsule contains 0. 23 milligrams of oznimod ( as hydrochloride ). zeposition 0 debossed ' ozatimod in 0 ( 46 mg ) form . each capsule contain 0
what temybric ellipta is the active substances of temуbric it is used in combination with three different medicines called fluticasone furoate , umeclidinium bromide and vilanterol . fluticasesone furonate belongs to a group of medicines called corticosteroids ( steroids ). umecilidinium brochuremide şi vilantrol belong to  a groupe of medicines known as bronchodilators . what mybrick ellippa is used for temyer ellipeta are used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles responsible for breathing difficulties are not as strong as they should .
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using temibric
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use temybric ellipta regularly it is very important that you use TEMybrick ellippa every day , as instructed by your doctor and pharmacist . this will help to keep you free of symptoms throughout the day and night . temibric is for inhaling and inhalations use , so you do not inhal a sudden attack of breathlessness or wheezing . to relieve this attack you must use a quick - acting reliever inhal
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties : if your breathing or wheezing gets worse straight after using this medicine , stop using it and get medical help immediately pneumonia ( infection of the lung ) in copd patients ( common side effect ) tell your doctor if you get any of the following after using temybric ellipta : symptoms of a lung infection : fever or chills increased mucus production , change in mucuses colour increased cough or increased breathing difficulties common side effects ( may affect up to 1 in 10 people ): sore throat , runny nose decreased appetite common sideeffects ( may effect up to1 in 10 , 000 people ), headache diarrhoea , vomiting , nausea , indigestion , flatulence , stomach pain ,
what temybric ellipta contains the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 micrograms of fluticasesone furonate ; one dose contains 65 microgram ( mg ) umeklidinium brmide equivalent to 55 microgram( g )umeclidium and 22 microgram [ g ( g 3 ]) vilantatate . the other ingredients are lactose monohydrate ( see section 2 under ' temyerc elept a contains lactoses ') and magnesium stearate . what mybrick ellippa looks like and contents of the pack the ellipinta inhaler consists
what zinforo is zin foro is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called ' cephalosporin antibiotics '. what zforo used for zinForo is used to treat infections of the skin or the tissues below the skin . this is an infection of the lungs called : ' pneumonia ', which runs in families . how zinfordo works zinfo works by killing certain bacteria , which can cause serious infections .
do not take zinforo - if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). - are allergicto other cephalosporin antibiotics . - have had previous severe allergic reactions to other antibiotics such as penicillin or carbapenem . do not use zin foro if any of these apply to you . take special care with zinForo : - talk to your doctor before taking zinfo . warnings and precautions talk to the doctor or pharmacist before taking this medicine : the following are reasons why zinfordo may not be suitable for you : you have kidney problems . you have ever had seizures ( convulsions ) or any non - severe allergic reaction to other medicines , such as Penicillin or carapemet 26 or to severe diar
the recommended dose of zinforo is 600 mg every 12 hours . your doctor may increase your dose to 600 mg after 12 hours to help prevent some infections . the dose may be increased to 12 mg after the first administration . it is given as a drip into a vein ( intravenously ) over 5 minutes . a second course of 60 minutes is recommended . in some cases your doctor will give you 120 mg of a higher dose . you will receive an increased dose during treatment , which will usually be given every 5 to 14 days . for skin infections , the recommended starting dose is 5 to 7 mg for pneumonia . patients with kidney problems if you have kidney problems your doctor might decide to reduce the dose , or stop treatment altogether . this will help to protect you from kidneys . when zin foro is given to you , your doctor or nurse will check that your dose is adequate 
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , swallowing or breathing problems . these may be signs of a serious allergic reaction ( anaphylaxis ), diarrhoea , stool , blood or mucus . during or after treatment with zinforo , you should be given medicines that help to slow bowel movement . this is common ( may affect up to 1 in 10 people ). you may want to have a blood test called a ' coombs test ' before starting antibiotic . your doctor will perform this test to see if the results are abnormal . the doctor will monitor you for signs of low
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is 600 micrograms ceftaroline fosamil . the other ingredients are arginine , maize starch , and water for injections . what genforo looks like and contents of the pack zinfordo is a pale yellowish - light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs of 10 vials , each containing one vial ( 20 ml ).
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neursopathic pain : pregabalsin ppfizer is used to control long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral nuropathic pain such as diabetes or shingles . pain sensations may be described as hot , burning , or throbbing , shooting , stabbing  , sharp , cramping , and aching , including tingling , feeling numbness , difficulty in breathing , slow breathing . this sensation may also be caused by physical effort and due to long - term pain caused due to damage tothe nerves and can be caused due a range of diseases . examples of peripheral 
do not take pregabalin pfizer if you are allergic to pregabalsin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabaltin ppfizer some patients taking pregamalin have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat , as well as diffuse skin rash . should you experience any of these reactions , you should contact your physician immediately . pregabralin has been associated with dizziness and somnolence , which could increase the occurrence of accidental injury ( fall ) in elderly patients . therefore , your doctor should monitor you more closely if he / she is taking pregalin pipfiser . contact lenses may cause blurring or loss of vision or other changes in eyes
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . pregabalin pfizer is for oral use only . peripheral and central neuropathic pain , epilepsy or generalised anxiety disorder : take the number of capsules as instructed by your doctor and take the capsules with food . the dose , which has been adjusted for you and your condition , will generally be between 150 mg and 600 mg each day . your doctor will tell you to take pregabralin ppfizer either twice or three times a day , once in the morning and once inthe evening , at about the same time each day ( see section ' take special care with pregabalsin '). your doctor may prescribe a different dosing schedule and / or a higher dose if there is something you
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common - may affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , and irritability . disturbance in attention , attention - clumsiness and memory impairment . loss of memory , or tremor , difficulty with speaking , sensation of tingling feeling . not known : frequency cannot be estimated from the available data alteration in perception of reality . research has shown that the brain develops antibodies which can cause abnormal thinking , memory impairment and / or memory . some patients have experienced similar effects to the above . corticosteroids such as anti -
what pregabalin pfizer contains the active substance is pregabaalin which is available in different strengths . each hard capsule contains either 25 mg , 50 mg / 75 mg ; 100 mg ), 150 mg - 200 mg . the 200 mg capsules contain either 225 mg or 300 mg pregabalsin . The other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac ; black iron oxide ( i 172 ), propylene glycol and potassium hydroxide ). the 75 mg ( 100 mg ( 200 mg and 225 micrograms ) capsule shell : lactoses ( maize ), potassium hydrolysed , yellow (
xadago is a medicine that contains the active substance sofinamide . it increases the amount of dopamine in your brain . this helps to increase the levels of dopine in your nervous system ( body part ). it is used in adults with parkinson ' s disease . x ad ago helps to control parkinsons ' disease by helping you to move more easily . people with park inson  s diseases have sudden sudden switches so that they are not able to move . these changes may help you to get better or keep your difficulties moving . the medicine also contains levodopa which is used with other medicines to treat parkinSON 's disease in addition to x
do not take xadago : - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - do not give this medicine to children and adolescents -if you were taking any of following medicines : monoamine oxidase ( mao ) inhibitors : selegiline , rasagiline ; moclobemide ; phenelzine , isocarboxazid ; or tranylcypromine ( used for treatment of parkinson ' s disease and depression ); pethidine ( a strong pain killer ). you must wait at least 7 days before starting x ad ago treatment and during treatment with mao inhibitors or pethamine . if any of these apply to you , do not start taking 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose of xadago is 50 mg twice a day ( one tablet in the morning and one tablet of 100 mg ) taken by mouth once a morning . xdag should be taken with food . people with moderately reduced liver function should take the tablets at least 50 minutes before or two hours after a meal . do not take x ad if any of the above apply to you , talk to your doctor about other ways of taking x.dagot . take a tablet as soon as you get up for the day and then go to the next meal , then go on as before . talk to a doctor or go to  a hospital straight away . taking a dose of the tablets should not
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis ( very high blood pressure ): may lead to collapse ( neuroleptic malignant syndrome ). confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion ; hypertension ; muscle stiffness ; hallucinations ; hypotension . other side effects include : parkinson ' s disease , safinamide , levodopa , and levodomide . some patients have experienced the following side effects while taking xadago : common ( may affect up to 1 in 10 people ) - parkinsons ' disease - a condition where the body produces too much creatine and 
what xadago contains - the active substance is safinamide . each 50 mg or 100 mg tablet contains ssafatinamide ( as methansulfonate ). - other ingredients are : - tablet core : microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - film coating : pregelatinised maize starch , shellac , pregeminium , poly ( vinyl alcohol ), hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( encoding ) what Xad adogo looks like and contents of the pack x adego 50 mg are white to off white , oval , biconcave film - coated tablets of
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytigea increases the amount of testosterone produced by the prostate gland , and slows the growth of prostate cancer . how zytaga works zymiga is used in adults , adolescents and children , who have disease and are not able to take hormone therapy ( a treatment that lowers testosterone ( androgen deprivation therapy ) or who are taking another medicine , prednisone or predNisolone . high blood pressure has been shown to lower the amount and length of time in the body due to fluid retention in your blood .
do not take zytiga : - if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). - when taking zytigea , you may be pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before taking zetiga and if any of these apply to you : you have severe liver damage you have prostate cancer that is not under control . you should not take this medicine if either of the above apply to your other medicine . take special care with this medicine tell your doctor before taking this medicine and : your doctor should know : whether you have liver problems , high blood pressure , heart failure , low blood potassium . low blood sodium may cause heart rhythm problems . tell your dentist if your doctor thinks you are at risk of having low blood magnesium , or 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 1 , 000 mg once daily . you should not take more than the recommended daily dose of this medicine . taking this medicine take this tablet by mouth . zytiga can be taken with or without food . take zytigea about 2 hours before you go to bed . do not take zetiga with food , as it is not necessary to take it with food or water . how to take  take a tablet before you take , or after a meal . swallow the tablet whole with water , one after the other . it does not matter whether you take it or not . when to take with food do not chew , crush or split the tablet . try to take your tablet at the same time each day 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and tell your doctor immediately if you experience muscle weakness , muscle twitches , a pounding heart beat ( palpitations ), or if your level of potassium in your blood is low . this is partly linked to the way your medicine works . other side effects can include : common may affect up to 1 in 10 people - build - up of fluid in your legs or feet , which could be a sign of low blood potassium , shown in liver function test , high blood pressure , urinary tract infection , diarrhoea , vomiting , abdominal pain or distension . uncommon may affect less than 1 in 100 people , as the amount of fluid is build  up in your stomach , and the amount in your urine . your
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abüroerone аcetate - -the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate ( see section 2 " zytigea contains lactoses "). what kytiga looks like and contents of the pack - " kytigea tablets are white to off - white , oval tablets with " a " debossed on one side and " 243 " on the other side . - approximately 9 . 5 mm in diameter . the tablets are packed in a plastic bottle with a child - resistant closure
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of the following inflammatory diseases : polyarticular juvenile idiopathic arthritis or enthesitis - related arthritis paediatric plaque psoriasis , paediatic crohn ' s disease , and paediatri non - infectious uveitis in adults . the active ingredient in heficiyan is tad alimUMab as a monoclonal antibody . monoclones are proteins that attach to a specific target in the body . aadalumabeb attaches to tnf ( tumour necrosis factor ) in the inflammatory illnesses and reduces the inflammation in these diseases . polyarticulary juvenile iciopathic and 
do not use hefiya if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your doctor thinks you may have a severe infection , including tuberculosis , sepsis ( blood poisoning ) or other opportunistic infections ( unusual infections associated with a weakened immune system ). it is important that you tell your doctor if symptoms of infections , e . g . fever , wounds , feeling tired , dental problems ( see " warnings and precautions "). - if the doctor think you have moderate or severe heart failure . it is very important to tell your dentist if there is a serious heart condition ( see section 4 ). warnings about allergic reaction : if allergic reactions have symptoms such as chest tightness 
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor if you are not sure . the usual starting dose is 40 mg once a day . your doctor may increase the dose to 20 mg once daily . if necessary , your doctor might increase the dosage to 40 mg twice a week . polyarticular juvenile idiopathic arthritis age or body weight how much and how often to take ? notes children , adolescents and adults from 2 years of age weighing 30 kg or more 40 mg every other week not applicable children . adults from two years of aged 2 years to less than 30 kg 40 mg each week is not applicable kids , teenagers and adults of 2 years old weighing 10 kg to less then 30 kg 20 mg every week unless your doctor determines that the 40 mg dose is too strong or too weak . for enthesitis - related arthritis age
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . side effects may occur at least up to 4 months after the last hefiya injection . seek medical attention urgently , if you notice any of the following signs of allergic reaction or heart failure : severe rash , or hives ; swollen face , hands , feet ; trouble breathing , swallowing ; shortness of breath with exertion or upon lying down or swelling of the feet . tell your doctor as soon as possible , as you may be experiencing signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , nosebleeds ; mouth ulcers . uncommon : may affect up to 1 in 100 people : infections of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . alternative storage : when needed ( for example when you are travelling ), hefiya may be stored at room temperature ( up to 25 ) for a maximum period of 14 days be sure to protect it from light and to protect the product from light ( upto 25 ). once removed from the refrigerator for room temperature storage , your pre – filled  sYringe must be used within 14 days or discarded , even if it is later returned to the refrigerator . you should record the date
what hefiya contains the active substance is adalimumab . each pre - filled syringe contains 20 mg of aad alimUMab in 0 . 4 ml of solution . the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid ( e507 ), sodium hydroxide and water for injections . what HEfia looks like and contents of the pack heifia 20 mg solution for injection ( injection ) in pre  181 pre – filled msg is  a clear to slightly opalescent , colourless to slightly yellowish solution , supplied in a single - use clear type i glass sYringe
what ritemvia is ritemevia contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsima babbles on to this cell , the cell dies . what ritamvia can be used for riteemvia may be used in adults for the treatment of several different conditions . your doctor may prescribe ritemillion for the treatments of : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes ; rite mvia will be given to you in combination with other medicines called
do not take ritemvia if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if this is because you have such a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking ritemevia : if the patient has severe heart failure or severe uncontrolled heart disease , including granulomatosis , polyangiitis / microscopic polyangitis or pemphigus vulgaris . if any of these apply to you , tell your doctor before taking the medicine . you may be at increased risk of getting a hepatitis infection . it is important that you tell your
ritemvia will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . ritemevia is given as a drip ( intravenous infusion ). medicines given before each ritetvia administration before you are given ritemetvia , you will be told by your doctor or hospital pharmacist if you are using other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment , as they may need to be changed . for non - hodgkin ' s lymphoma if your doctor considers it necessary to give you riteritemvic alone ritemmvia will only be given once a week for 4 weeks . repeated treatment courses with riteemvia are possible . when given together
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat tightness . not known ( frequency cannot be estimated from the available data ): a combination of fever and chills . during the first 48 hours after the induction of ritemvia , symptoms may include : sickness , tiredness and headache . breathing difficulties and blood pressure increased . wheezi
what ritemvia contains the active ingredient in ritememvia is called rituximab . the vial contains 100 mg of ritsimabe . each ml of concentrate contains 10 mg of Rituximiab ( as sodium chloride ). the other ingredients are tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritamvia looks like and contents of the pack ritemmvia is a clear , colourless solution , supplied as a concentrate for solution for infusion in a glass vial . pack of 2 vials 
capecitabine teva belongs to the group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitebine teva contains cape citbine , which itself is not a cytostat medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine ( more in tumour tissue than in normal tissue ). capecitationbine téeva is used in the treatment of colon , rectal , gastric , or breast cancers . furthermore , capecitedbine tetet is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery . at the same time capecitébine - t Eva may be used either alone or in combination with other medicines .
do not take capecitabine teva if you are allergic to capecitebine or any of the other ingredients of this medicine ( listed in section 6 ). you must inform your doctor if your child has an allergy to this medicine , if he / she has developed severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ), if the child is pregnant or breast - feeding , is breastfeeding warnings and precautions talk to your doctor before taking capecitationbine theva : if any of these apply to your child : as you may be at high risk of having low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ), or if there are severe liver or kidney problems , or a known lack of the enzyme dihydro
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you , so you should take the maximum dose of capecitebine teva in accordance with your body surface area . this is calculated from your height and weight . the usual dose for adults is 1250 mg / m2 of body surface surface area taken two times daily ( morning and evening ). two examples are provided here : a person whose body weight is 64 kg and height is 1 . 64 m has a body surfacearea of 1 , 7 . 7 m2, and should take 4 tablets of 500 mg and 1 tablet of 150 mg two times day . 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva immediately and contact your doctor if any of these symptoms occur : diarrhoea : if you have an increase of 4 or more bowel movements compared to your normal bowel movement each day or any diarhoegaea at night . vomiting : when you vomit more than once in a 24 - hour time period . nausea : you lose your appetite , and the amount of food you eat each day is much less than usual . stomatitis : your doctor will tell you what to do if this happens . pain , redness , swelling or sores in your mouth and / or throat . hand - and - in between doses : stop taking this medicine and talk to your
what capecitabine teva contains the active substance is capecitebine . capecitationbine  tva 150 mg film - coated tablets each film  coated tablet contains 150 mg capeciabine ; capevitabine tén 500 mg film film  - coating tablets each movie  tablet contains 500 mg capabine , the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose , crassimellose sodium , magnesium stearate , macrogol 400 , film coating : hypromllose, titanium dioxide , yellow iron oxide , red iron oxide what capacitabine to look like and contents of the pack capecteva 150 mg is supplied as a white , capsule - shaped , biconvex , pink , oval shaped tablet ,
what silodosin recordati is silonosine recordatu belongs to a group of medicines called alpha1a - adrenoreceptor blockers . sillodon recordatt works by blocking receptors in the prostate , bladder and urethra . by blocking these receptors , it causes smooth muscle in these tissues to relax . this makes it easier for you to pass water and relieves your symptoms . what siladoosIN recordatis is used for silokasin recordsati can be used for the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as : difficulty in starting to passwater , a feeling of not completely emptying the bladder , and a more frequent need to pass urine .
do not take silodosin recordati - if you are allergic to siloudoin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking silonodostin recordattai . during eye surgery , it is important to tell your doctor if there is cloudiness of the lens ( cataract surgery ). this 26 warning is important as sillodonosine recordatin may cause a loss of muscle tone in the iris ( the coloured circular part of the eye ) during such a surgery . take appropriate precautions with regard to medicine and surgical techniques to be used during and after your treatment with sillotodasin recordingi : if during cataract surgery you may have fainted or felt dizzy . if any of these apply to you
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one capsule of silodosin recordati 8 mg per day by oral administration . take the capsule always with food , preferably at the same time every day . if necessary you can take the dose at about the same times every day even if the medicine is not for you ). patients with kidney problems if your doctor has told your you that you have moderate kidney problems ( see section " other uses and benefits "). for this purpose sillodon recordatis 4 mg hard capsules are available . you should take sil lododostin recorditi for up to 4 weeks continuously . try to take your capsules at the exact same time each day , even a little later than one day ; if
like all medicines , this medicine can cause side effects , although not everybody gets them . some of these effects may be serious . allergic reactions such as swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives have been reported as the most common side effect of silodosin recordati . please tell your doctor if you experience dizziness , including dizziest moments and occasionally fainting . if your doctor considers you unsuitable for such an effect , please tell the doctor . sometimes patients may feel weak or dizzy . the symptoms of dizziity and fainting can also be serious and require hospitalisation . sildodasin recordingti may reduce the chance of complications during a cataract surgery ( eye surgery that may require additional eye examination ) and eye pain . in some cases patients may experience faint
what silodosin recordati contains the active substance is siloudoosine . each capsule contains 8 mg of silodysin . one capsule contains eight mg of Silodonosink . the other ingredients are : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( е171 ). silokoshin recordatis 4 mg hard capsules : silonodostin 4 mg capsules the active ingredient is silicodasin the other ingredient is mannol ( 8 mpa . s ), Magnarate ( k29 . 6 mg ), sodium laursulfates , geotextile salt . gelatin, titanium dioxide ( ige ( containing yellow
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angioTENsin Ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzialmonome blocks the effect of angio Tensin 1 , so that the blood vessels relax , and your blood temperature is lowered . what kinzymono is used for kinZalmonon is used to treat essential hypertension ( high blood pressure in adult patients ). ' essential ' means that the high bloodpressure is not caused by any other condition . high blood - pressure , if not treated , can damage blood vessels in several organs , which could lead sometimes to heart attack , heart or kidney failure , stroke , or blindness .
do not take kinzalmono if you are allergic to telmisartan or any other ingredients of this medicine ( listed in section 6 ). if there is still a possibility that you are more than 3 months pregnant , you must not take the tablets . ( it is also better to avoid kinzialmona in early pregnancy see pregnancy section .) if your doctor has told you that you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or anyother severe liver disease . if any of the above applies to you , tell your doctor . warnings and precautions talk to your doctor before taking kinzonzalmonio : if : you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliski
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . try to take the tablet at the same time each day , preferably in the morning . you can take kinzialmona with or without food . it is important that you take the tablets at the right times of the day ; if necessary , your doctor may tell you to take a different dose . kinzulmono should be taken as a treatment for high blood pressure . for example , when you are first diagnosed with kinzonzono , the usual dose of one 40 mg tablet once a morning will usually be reduced to one 20 mg tablet daily . when kinzyalmonon is used in combination with diuretics (' water tablets ') such as
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention you should see your doctor immediately if you experience any of the following symptoms : sepsis * ( often called " blood poisoning ", is a severe infection with whole - body inflammatory response ), rapid swelling of the skin and mucosa ( angioedema ); these side effects are rare ( may affect up to 1 in 1 , 000 people ) but are extremely serious and patients should stop taking the medicine and see their doctor immediately ( see also section 2 ). possible side effects of kinzalmono common side effects ( may effect up to1 in 10 people !): low blood pressure ( hypotension ) in patients with cardiovascular events . uncommon side effects (" may affect more than 1 in 100 people ), urinary tract infections , upper respiratory
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . you should store your medicine in the original package in order to protect the tablets from moisture . remove your kinzalmono tablet from the blister only directly prior to intake . any unused medicine should be discarded . ask your pharmacist how to throw away your medicine . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmesartan ( as meglumine ). - other ingredients are povidone , meglumin , sodium hydroxide , sorbitol ( e420 ) and magnesium stearate . what kinszalmonio looks like and contents of the pack kinzialmona 20 mg tablets are white to almost white , round tablets engraved with the code number ' h20 ' on one side . kinzzalmonon is available in blister packs of 14 , 28 , 56 and 98 tablets . not all pack sizes may be marketed .
what afstyla is a human clotting ( coagulation ) factor viii product , which contains the active substance lonoctocog alfa . what ' a fsstуla is used for a variety of uses in adults , adolescents and children , including children . a lot of the active ingredient in adversity is factor ixi product in patients with haemophilia a ( inborn factor  vii deficiency ). factor v is necessary for blood clot . it helps the blood to clottle . people with an increased tendency to bleed . how afatstyingla works in patients of all ages , factor ii in patients from all  age groups can be absorbed and the blood can be broken down and processed as normal . use a
you should not be given afstyla - if you have ever had an allergic reaction to a FstYla . - you are allergic to hamster proteins . 46 warnings and precautions talk to your doctor or nurse before you are given : 46 a fsyla should be used with caution . please read the " do not use " section of your treatment diary . do not give a dose of aFstinessla if the patch number is too low . you should keep your treatment journal ( ' do not take a lot of ') diary ', and follow the instructions for use carefully . allergic ( hypersensitivity ) reactions aaftylac should not been used if symptoms of allergic reactions are found . the signs of allergic reaction may include hives , generalised skin rash , tightness of
your treatment should be initiated under supervision of a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . the recommended dose of  afstyla is based on your disease the site and the extent of the bleeding your clinical condition .  reconstitution and administration general instructions the powder should be mixed with the solvent ( liquid ) immediately after reconstitution . your doctor will decide on aseptic conditions , and whether a dose of the av a / v is needed . use in children and adolescents a free will be prescribed by your doctor together with other medicines and solvents . see section 6 . before using the solution , make sure that the solution is clear and colourless or slightly opalescent . after withdrawal , the solution should be clear to slightly
like all medicines , afstyla can cause side effects , although not everybody gets them . please contact your doctor immediately if you have symptoms of allergic reactions . allergic reactions may include the following symptoms : hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding ). in patients who have received factor viii medicines : inhibitor antibodies ( see section 2 ) may form very commonly ( more than 1 in 10 patients ). they may be present at an increased risk . patients who are not previously treated with factor  vii ( more then 150 days of treatment ) should contact their doctor immediately to discuss this . if any of the side effects gets serious , or if your doctor considers that you may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after the afstyla powder has been reconstituted it may be kept at room temperature ( up to 25 ) for a single period not exceeding 3 months . keep the vial in the outer carton in order to protect from light . use the reconstructed product immediately after reconstitution .
what afstyla contains the active substance is lonoctocog alfa . each ml of solution contains 250 micrograms / 2 . 5 mL of solution . after reconstitution with 2  . 4 mmol of solution for injections the solution contains 100 microgram ( 0 . 25 mg ) lonoctcog allfa per m2 of solution or 1000 microgram( 0. 5 mg ). after reconversion with 2ml water for injection ( i . e ., 200 microgram ) LonoctoCog alfata per vial or 1000 mbq ( if reconstitution is required ) 2 , 5 - mg of solution ( corresponding to 400 microgram of lonoccog Alfa and 1500 microgram per mm2 ). if after reconstituted by
the doctor treating you will decide what praxbind is and how it will be given to you . praxxbind contains the active substance idarucizumab . the active ingredient in prauchbind is idrucizum ab as a reverse agent . it is used in combination with dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . by doing so , prallbind can rapidly trap dabig atran in the blood . you will be told how to take praxton . your doctor will tell you how long you will need to take this medicine . when prabind is used together with pradoxa it is important that you are seen in emergency surgery or urgent procedures because of the increased risk of uncontrolled bleeding .
do not take praxbind : - if you are allergic to idarucizumab or any of the other ingredients listed in section 6 . - whether you have a genetic disease called hereditary fructose intolerance , or to the substance sorbitol ( soya ) or to peanut or soy - this medicine may increase the risk of serious adverse reactions . warnings and precautions talk to your doctor before taking praxxbind . this medicine contains dabigatran and / or other medicines that help to prevent blood clots . dabig atran is a plant grown in the body and can cause blood coagulation . as a result , blood clumps can form and become larger than normal . your doctor may prescribe medicines to prevent the formation of blood clits and adjust your medical condition . talk
praxbind will be given to you by a healthcare professional . the recommended dose is one 5 mg vial of 2 . 5 mg dabigatran per day . you will receive this medicine in a single dose of 5 mg . this medicine will be injected into a vein . your doctor will decide how to treat you . if you have any further questions on the use of this medicine , ask your doctor . during your treatment , your doctor may reduce the risk of blood clot formation . it is very important that you receive dabig atran as soon as possible and for at least 24 hours after your last dose of this medicinal product . do not stop taking this medicine without talking to your doctor first .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects you can help provide more information on the safety of this medicine . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help to provide more details on the Safety of this product .
what praxbind contains the active substance is idarucizumab . the other ingredients are sodium acetate trihydrate , acetic acid , and sorbitol ( e420 ), polysorbate 20 and water for injections . what pxbind looks like and contents of the pack praxxbind is a clear to slightly opalescent , colourless to slightly yellow solution in a glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temmedaca is used for the treatment of specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . in these patients , tememedab is first used together with radiotherapy ( concomitant phase of treatment ) and after that alone ( monotherapy phase of treating ). -in children 3 years and older and adult patients with malignant gliomema , such as glionomum multiforma or anaplastic astrocytoma in adults . the use of temtemmed ac is normally used in these tumours when standard treatment is not feasible .
do not take temomedac - if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). - have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . - are certain types of blood cells severely reduced ( myelosuppression ), such as your white blood cell count and platelet count . these blood cells are important for fighting infection and for proper blood clotting . your doctor will check your blood to make sure you have enough of these cells before treatment is started . warnings and precautions talk to your doctor , pharmacist or nurse before taking tem medax : - contact your doctor or pharmacist before
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac . this is based on your size ( height and weight ) and if there is a recurrent tumour and you have had chemotherapy treatment in the past . you may be given other medicines ( anti - emetics ) to take before and / or after taking temmedaca to prevent or control nausea and vomiting . patients with newly - diagnosed glioblastoma multiforme if your doctor determines that treatment is necessary , you will be receiving treatment together with radiotherapy ( concomitant phase ) first and then temac ( monotherapy phase ). your doctor may decide to start tememedab at 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you have any of the following : - a severe allergic ( hypersensitive ) reaction ( hives , wheezing or other breathing difficulty ), - uncontrolled bleeding , - seizures ( convulsions ), fever , chills , severe headache that does not go away . temomedac treatment can cause a reduction in certain kinds of blood cells . this may cause you to have increased bruising or bleeding ; this may lead to anaemia ( a shortage of red blood cells which may lead ) fever and reduced resistance to infections . the reduction in blood cell counts may lead sometimes to an increase in anaeemia ( anaplastic analytic ). the reduction may lead also to a very severe allergic reaction , which may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after opening , store in the original package in order to protect from light . temomedac is for single use only . once opened , use immediately . any change in the appearance of the capsules should be thrown away . discard any unused medicine via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temokac 5 mg film - coated tablets : each tablet contains 5 mg temizolomide ( as mesilate ). temac 20 mg film- coated tablet : every tablet contains 20 mg TEMozolomid ( as sulphonylure ). the temomedac 100 mg film coated tablets: each pill contains 100 mg TM temazolomide [ as mexicant ]. temtemomediac 140 mg film coating : one tablet contains 140 mg  temozalomide and one tablet is provided in a pouch . the syringe of tememedad 180 mg film covered tablets , each tablet releases 180 mg / 6 mg talons . one tablet includes temizalomide each 
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , eer  penis suitable for sexual activity . ciali is used to help you obtain a solid e rect penis ready for sexual action . you and your partner will need to work together at the same time . the active substance tadalafil belong to a group of medicines called phosphodiesterase type 5 inhibitors . how cialised works cialisse works by helping the blood vessels in your penis to relax , helping your partner to get a clearer , hard elis . your partner and a partner will then relax the penis , so that a smoother eerect line is formed . by doing so , you will not have to work out how long you
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not use cialIS if your doctor has told you that you are taking any form of organic nitrate . - this is especially important if the medicine is given to you by doctors or other nitric oxide donors such as amyl nitsrite . this is a group of medicines (" nites "). cialiser is used in adults to treat angina pectoris (" chest pain "). do not stop taking cialist if any of these medicines are harmful or cause you to lose natrate ). talk to your doctor if : - you have serious heart disease or recently had a heart attack within the last 90 days - your doctor thinks you may have had , or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with some water . the tablets can be taken with or without food . do not take more than the recommended dose . for men , the recommended starting dose is 5 mg once a day . your doctor may adjust the dose to 2 . 5 mg based on your response to ciali . you should not take cialisé more than once - a- day , but you should do this every day unless your doctor tells you to . how long to take - take levitrais for as long as your sexual health is well controlled by cialist . it is important that you take a dose of cialised every day until your doctor advises you otherwise . when to take it with cial
like all medicines , this medicine can cause side effects , although not everybody gets them . side effects were mainly seen while patients were being given the medicine or shortly after (" erections "). some of these effects may be serious and may require medical attention . if you experience any of the following allergic reactions or rashes ( frequency uncommon ), including chest pain , seek medical advice immediately ( see section 2 ). if your doctor decides to reduce the dose of nitrates ( frequency rare ), especially priapsim . you may have a prolonged and possibly painful er . stop using cialis and have an errand straight away ( lasting approximately 4 hours ). tell your doctor immediately if he / she gets sudden loss of vision ( frequency not known ). other side effects may include : common ( may affect up to 1 in 10 people ) or uncommon
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tdal afil in 2 ml . - other ingredients are : tablet core : lactose monohydrate ( see end of section 2 ), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose ; sodium laurilsulfate ; magnesium stearate . film - coating : shellac , lactoses monohydrate , pregelatinised ( maize ), pregeminishing enzymes : hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( 233 ), red ( 925 ), and talc . what ciais looks like and contents of the pack ciali 2
enyglid is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancréas does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enуglid helps control type 2 diabetics as they get older . treatment is usually started if diet , exercise and weight reduction alone have not been able to control ( or lower ) your blood glucose . the active substance in eninessglid , metformin , is another medicine for diabetes .
do not take enyglid : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). - in case you have type 1 diabetes . enzyglid lowers the acid level in your blood ( diabetic ketoacidosis ). it may also cause a severe liver disease . it may affect the way eninessglid works . in some cases , especially with gemfibrozil , a medicine used to lower increased fat levels and lower liver problems . there is limited experience in patients with moderate liver 28 disease ( see " other medicines and enYglid "). warnings and precautions talk to your doctor or pharmacist before taking enуglid and if : you have a severely liver disease you have kidney problems , you are taking  Enyglide if any of these apply
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended starting dose is 0 . 5 mg before each main meal . swallow the tablets with a glass of water immediately before or up to 30 minutes before each meal , if necessary . your doctor may increase your dose to 4 mg before or down to 30 mg after each main meals . do not take more than 16 mg before the main meal to reduce your blood sugar . if this happens you may get a hypo on what a hyper is and get ' worse '. - do not increase your dosage , just take the next dose at the usual time . continue with your normal routine . tell your doctor if your diabetes gets worse . keep following your food and exercise plan while taking enyglid . you should not take enzyglid more than once
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of hypogliescaemia is ( may affect up to 1 in 10 people ). hypoglacy reactions are generally mild / moderate but may occasionally develop into hypoglecaemic unconsciousness or coma . allergic allergy is very rare ( may effect up to1 in 10 , 000 people ) and may cause symptoms such as swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be anaphylactic reaction . other side effects are ( may occur with up to one in 10 patients ): stomach pain . these may be mild and may be more common . if this happens , it may take longer than a few days to get back to normal . stomach pain may also occur more often , mainly
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg replinide. - other ingredients are : microcrystalline cellulose ( e460 ), calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , and poloxamer . yellow iron oxide ( е172 ) only in the 1 mg tablets and red iron oxide( e172 ). the 2 mg tablets are yellow , round and biconvex with bevelled edges . the 1ml tablet is pale brown , yellow - yellow . biconvingx tablet is debossed with " r " on one side and " nvr
what azacitidine mylan is azacitatidine myLAN is an anti - cancer agent . aza citidine myla contains the active substance azaitidine . what acitine mylan was used for azacatidine mylang is used in adults who are not able to have a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myeloidomonocytic leukaemia ( cmml ) acute myelid leukocytosis ( aml ). these are diseases which affect the bone marrow and can interfere with normal blood cell production . how azacionitidine melan works azacritidine in aml works by preventing cancer cells from growing . the active ingredient in azaсitidine is a substance called ribonucle
do not take azacitidine mylan - if you are allergic to azacitabine or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with advanced liver cancer . - during treatment with aza citidine myLAN , you may be at risk of decreased counts of platelets , red or white blood cells . this is because of kidney disease . it is also important to tell your doctor if this applies to you . warnings and precautions talk to your doctor or pharmacist before taking this medicine : - sirolimus . you may have decreased counts or no red or black blood cells ( in special populations ). you have kidney disease or liver disease ; - you have ever had a heart condition or heart attack or any history of lung disease , which has not been investigated . blood test you will have blood tests before you start treatment with this medicine
before giving you azacitidine mylan , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may change your dose of this medicine based on your general condition , height and weight . you will receive azacitamylan once a day for one week , followed by a rest period of 3 weeks . this " treatment cycle " will be repeated every 4 weeks , with an interval of 6 weeks ; you will usually receive this medicine by giving it to your child as an injection under the skin ( subcutaneously ) by your doctor , nurse or doctor . it may be given under the clothing of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or pharmacist .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and can be life - long . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite . common side effects ( may affect up to 1 in 10 people ): drooling , shakenness ; abdominal  Bloating ; easy Bruising ; symptoms of kidney failure include : swelling ofthe legs and legs , chest pain ; reduced passing or reduced passing water ; increased thirst
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the carton and the vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for single use only . once the suspension has been prepared it should be administered immediately . if the suspension is not administered immediately ( within 1 hour ), the azacitamylan suspension will be stored in the refrigerator ( 2 8 ) for up to a maximum of 8 hours . when the zacitine mylan suspension is prepared using water for injections that has not been stored in a refrigerator ( 3 8 ), it should not be stored again . after the suspension infusion in the fridge ( 3 9 ), you may be allowed to leave the refrigerator for upto 22 hours , but
what azacitidine mylan contains - the active substance is azaсitidine . one vial of powder contains 100 mg azacitaitidine ( 0 . 5 ml ). after reconstitution with 4 mL of water for injections , the reconstituted suspension contains 25 mg / m2 aza citidine - this medicine is produced by recombinant technology . -the other ingredient is mannitol ( e421 ). what zacitine mylan looks like and contents of the pack azacriitidine melan is a white powder for suspension for injection and is supplied in a glass vial containing 100 mg of azacionitidine per vial ( 100 mg per vially ). each pack contains 1 vial or 7 vials . not all pack sizes may be marketed .
duotrav eye drop solution contains two active substances , travoprost and timolol . travaprostant is a prostaglandin analogue that is made by the eye . and tigolol is  a beta blocker which reduces fluid within the eye and so reduces pressure within the eyes . duototrav eyes drop solution helps to reduce high pressure in the eye which can lead to an illness called glaucoma .
do not use duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using duotarrav . talk to you doctor if : you have respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease . you have wheeziness , difficulty in breathing or long - standing cough , you have breathing problems including severe hay fever you have a slow heartbeat you have heart failure or a disorder of heart rhythm ( irregular heartbeat ). your eye cloudy when you use dutrav it is important to check that your eye is clear and colourless . it is recommended that you do
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes , once a day in the evening . use duotrav at around the same time each day . you can use it for as long as your eyes stay dry . duotar should only be used on sensitive eyes . when to use dutrav use eye drops at least 1 hour before , 2 hours after a meal . how to use wash your hands . before using a bottle , wipe the bottle with a damp cloth . hold the bottle . if needed , turn the bottle over and pull it back . tilt your head back , looking down . pull down your eyelid with  a clean finger until there is a " pocket " between the eyelid and your
like all medicines , this medicine can cause side effects , although not everybody gets them . you can usually carry on taking the drops , unless the effects are serious . just take the drops and wait until your next appointment . if you have the impression that the effect of duotrav is too strong or too weak , talk to your doctor or pharmacist . very common side effects ( may affect more than 1 in 10 people ): effects in the eye eye redness . common side effect ( may effect up to 1 in10 people ), effects in or around the eyeeye surface inflammation or surface damage . uncommon side effects may include : eye pain , blurred vision , abnormal vision . dry eye , itchy eye / eye discomfort , signs and symptoms of eye irritation ( such as burning or stinging ). uncommon side effect( may affect up to1 in 100 people ). effects in eye
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 30 . throw away the container 4 weeks after first opening to prevent infections . write the date of opening on the container . discard the container after 30 days . keep the container tightly closed in order to protect from moisture . this medicinal product does not require any special storage conditions . ask your pharmacist how to throw away any medicines you no longer use . these measures will help protect the environment .
what duotrav contains the active substances are travoprost and timolol . each tablet contains 40 mg of travaprosth and 5 mg of delamanid . the other ingredients are titmololl ( as tilol maleate ). the other excipients are polyquaternium - 1 , mannitol , propylene glycol / polyoxyethylene hydrogenated castor oil 40 , boric acid , sodium chloride , water for injections , hydrochloric acid . purified water , and sodium hydroxide . hydrochchlordic acid helps to keep acidity levels ( ph levels ) normal .
nplate ' s active ingredient , romiplostim , is a protein that helps to reduce low platelet counts caused by immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is , in part , caused by a disease that affects your body 's immune system , which makes it harder for platelets to form . platelets are proteins that come from your blood . this helps to prevent blood clots . very low platelets counts can lead to bruising and serious bleeding . n plate is used to treat adults and children ( aged 1 year and above ) who have had their spleen removed and / or who have chronic itp or who had previously taken corticosteroids or immunoglobulins , but whose condition has recurred .
do not use nplate - if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). - you are also allergic to other medicines that are produced by recombinant dna technology ( escherichia coli ( е . coli )). warnings and precautions before you are given n plate , tell your doctor if : you have a low blood platelet count ( thrombocytopenia ). you should not be given a lower dose of nplated if your platelet counts is too low . you have ever had blood clots . blood coagulants can increase the risk of blood clits or increase the risks of blood blood clumping . your doctor may want to monitor you more closely . talk to your doctor about other factors ,
children and adolescents ( aged 1 month to 17 years ) can be given the following forms of nplate : n plate can be administered by your doctor or nurse . npla is given as an injection under the skin ( subcutaneous ). the recommended dose is 1 ml ( 500 mg ) of l nplatte . your doctor will decide how much nmet is needed for you . before you are given n, your doctor may check your platelet counts regularly . you will have regular blood samples to check your plates . to help your platelets count get better , your physician will monitor your platelette count in your blood . the dose of ' dose is shown in table 1 . children and teenagers ( 1 to 17 months ) the dose is not adjusted for platelet sizes . this is based on your body weight . how often you are treated with n Plate varies
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : itp common ( may affect up to 1 in 10 people ): headache ; allergic reaction ; upper respiratory tract infection common ( might affect upto 1 in every 10 people): bone marrow disorder ; increased bone mmarrow fibres ; trouble sleeping ( insomnia ); dizziness ; tingling or numbness of the hands or feet ( paraesthesia ); migraine ; redness ofthe skin ; flushing ; abdominal pain ; pain in the abdomen ; joint pain . uncommon ( may effect up to1 in 100 people ). not known ( frequency cannot be estimated from the available data ) : increased blood sugar ; constipation ; dry mouth ; diarrhoea ; feeling sick ( nausea );
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . this medicine is for single use only . once the blister has been opened , use within 30 days . store in the original package in order to protect from moisture .
what nplate contains - the active substance is romiplostim . n plate 125 mg solution for injection contains 230 mg romaplost . each vial contains 125 ml of romigastim in a deliverable amount of 0 . 25 mL solution ( corresponding to 125 micrograms of ROMiplottim per mlitre ). n Plate 250 mg solution : each vially contains 375 mg of romeplostostim per 250 microgram . one vial of solution contains 250 microliters of the active ingredient romizoplostig . another vial provides a deliveryable amount ( 0. 5 mml solution ) of 250 microlitres of either romoplostime or 500 microgram of nplatte .
what tovanor breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what tovonor  Breezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult .. this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using tovanator breezehaler as it may cause : - kidney problems - an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with tovanlor breezihaler it is important that you take this medicine exactly as your doctor has told you . if any of these apply to you , tell your doctor immediately :- tightness of the chest , coughing , wheezing or breathlessness immediately after using to vanor  Breezhalers ( signs of bronchospasm ). - difficulties in breathing or swallowing - swelling of the tongue , lips or face - shortness
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much tovanor breezhaler to inhale the usual dose is to inhaled the content of one capsule each day . you only need to inhales the content once a day because you will be inhaling the content twice a morning and evening . the usual daily dose is one capsule every day , for at least 24 hours . do not use more than your doctor tells you to use . elderly ( age 75 years and over ) you should take this medicine at the same time each day and always in the same way each day the same day ; this will also help you remember to use it . this medicine is supplied in a blister . an inhaler and capsules ( in blisters ) that contain the medicine as inhal
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrryum broMIDe ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( mg ) of glyco Pyronium ( equivalent ). - other ingredients of the enhalation powder are lactose monohydrate and magnesium stearate . what to vanor brewing breezehaler looks like and contents of the pack tovano breEZhaler 44 microlitres inhalation particles , hard capsules consist of a white powder and are separated by tiny particles in the centre . they have the product code " gpl50 " printed in blue and gold ink on the body . the following
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it affects the electrical activity of the brain . adesuve works by blocking receptors in the brain that release dopamine and serotonin , which have calming effects and relieving aggressive behaviour . the receptors are involved in settling and reducing acute symptoms ( mild - to - moderate agitation ). aadosuve is used in adults with schizophrenia and bipolar disorder , who suffer from diseases characterised by symptoms such as schizophrenia hearing , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorders may also feel depressed , guilty , anxious , or tense . this is because adsuve has been shown to reduce the effects of bipolar Disorder on your everyday
do not take adasuve if you are allergic to loxapine , amoxapinе or any of the other ingredients of adafruit . it is important that you tell your doctor if your symptoms include wheezing or shortness of breath . this may be a sign of lung problems like asthma or chronic obstructive pulmonary disease ( copd ), which results in narrowing of the airways ( bronchospasm ). this can cause wheeze , cough , chest tightness or shorten of breath 25 as it may be due to the development of neuroleptic malignant syndrome ( nms ). it is based on the symptoms you experience when antipsychotic medicines are used . these symptoms include high fever , rigid muscles and / or muscle spasm . if any of these apply to you , tell
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended starting dose is 9 . 1 mg / kg two times a day . your doctor may increase your dose to 2 mg - 4 . 5 mg depending on your condition . wash your hand before and after swallowing the tablets . do not put the tablets in your mouth . if the device has been shaken , it may cause the following symptoms : extreme tiredness , sleepiness , trouble breathing , low blood pressure , throat irritation , a bad taste in the mouth , muscle or eye movements . contact your doctor immediately if these effects occur . you should not take more adasuve than your doctor tells you to . it is important that you take the tablets with a special care of your eyes .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor or nurse straight away if you notice any of the following side effects as they may be : any breathing symptoms ( wheezing , cough , shortness of breath , chest tightness ) or irritating , that you feel when your airways get blocked or blocked ( asthma or copd ). light - headedness or fainting - this may be more common if your blood pressure is getting worse . worsening agitation , confusion , fever or muscle stiffness . this may mean that you are suffering from a severe condition called " neuroleptic malignant syndrome ". other side effects include : very common ( may affect more than 1 in 10 people ): shortness or irritation common ( might affect up to 1 in10 people ). common ( will affect upto 1 in every
keep out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep an open or torn pouch in order to protect from light . adesuve does not require any special temperature storage conditions . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler delivers 5 micrograms of lox apina , delivered over 4 . 5 doses of the active ingredient , loxalapin . what  aadosuve looks like and contents of the pack adesuve 4 , 5 microlitres inhalation kit : - a single  dose inhaled dose of adapinе . - each single inhalers carries a sealed foil pouch . one pouch of : the active material is a desiccant . it is available in packs containing 1 or 5 single – dose inhales . not all pack sizes may be marketed .
what azacitidine betapharm is aza citidine betabharm is an anti - cancer agent which belongs to a group of medicines called ' anti  metabolites '. azacitatidine betrapharm contains the active substance ' azacine ' ( e331 ). what zacitine betaphar is used for azacinatidine is used in adults , adolescents and children over one year of age . what zcitide betaph is used to treat adults who cannot have a stem cell transplantation because of higher - risk myelodysplastic syndromes ( mds ). chronic myeloidocytic leukaemia ( cmml ). acute myelid leukocytosis ( aml ) which are diseases which affect the bone marrow and can cause problems with normal blood cell production
do not take azacitidine betapharm - if you are allergic to azacitabine or any of the other ingredients of this medicine ( listed in section 6 ). - in patients with advanced liver cancer . - during treatment with aza citidine betabharm , you may be at risk of decreased counts of platelets , red or white blood cells . this is because of kidney disease . it is also important to tell your doctor if this applies to you . warnings and precautions talk to your doctor or pharmacist before taking azaсitidine betatapharm in case you have decreased counts or conditions such as kidney disease or liver disease ; - you have ever had a heart condition or heart attack or any history of lung disease , your doctor will take blood test before you start treatment with this medicine . you will have blood tests before you begin treatment with an injection of azacritidine
before giving you azacitidine betapharm , your doctor will give you another medicine to prevent nausea and vomiting at the start of each treatment cycle . the recommended dose is 75 mg per m2 body surface area . your doctor may adjust your dose of this medicine based on your general condition , height and weight . you will receive azacitatidine betabharm once every 3 weeks for this " treatment cycle ". you'll usually start with a 1 - week break , followed by a rest period of 4 weeks . this will be repeated every 6 weeks , depending on how you respond to the treatment . it is recommended that you take this medicine under the skin ( subcutaneously ) by putting it under the Skin of your thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical attention : - drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure and may be life - long . - swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , and reduced appetite . common side effects may include : confusion , restlessness , fatigue . symptoms may include headache , tremor , confusion / restlessness or fatigue , headache . uncommon side effects might include a combination of two different types of cancer . very common ( may affect more than 1 in 10 people )
keep out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the carton and the vial label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . for unopened vials of this medicine there are no special storage requirements . when using immediately once the suspension has been prepared it should be administered within 45 minutes . if the aza citidine betabharm suspension is prepared using water for injections that has not been refrigerated , the suspension must be placed in the refrigerator ( 2 8 ) immediately after it is prepared and kept refrigerate for up to a maximum of 8 hours . once the zacitine betaphar suspension is ready for use using water without injections which has been stored in the fridge ( 2-8 ) it
what azacitidine betapharm contains - the active substance is azaсitidine . one vial contains 100 mg azacitaitidine ( as mesilate ). after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / mL aza citidine - this medicine is also used in patients who are unable to take medicines due to their genetically modified ancestry . - other ingredients are mannitol ( e421 ). what zacitine betaphar looks like and contents of the pack azacritidine betabharm is a white to off - white powder for suspension for injection in a glass vial containing 100 mg of aza citiidine  .
cerdelga contains the active substance eliglustat and is used for the long term treatment of gaucher disease type 1 . gaucher diseases type 1 is an inherited condition in which the body cannot produce enough glucosylceramide ( a substance that binds to receptors in the body such as the spleen , liver and bones ). eleglustat prevents the production of glucoscosylzeramide in your affected organs , which may eventually lead to your body to produce more glukylceride . this medicine works by reducing the amount of eglustat in your body . you may also be given this medicine by mouth or by injection . cerdeslgа may be used to reduce slow speed and poor metabolisms . the amount you will need to take before you start taking cer delg , with a simple
do not take cerdelga - if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). - are taking medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine or terbinafine ). 31 - have been taking moderate crip3a inhibitors , e.  g. erythromycin or itraconazole . these medicines reduce your body ' s ability to fight infection . do not increase the dose of cerdeslg if any of these apply to you . warnings and precautions talk to your doctor before taking cer delgа . you should tell your doctor if your body is already taking medicines that have a poor metaboliser , such as medicines with strong cyst3a inhibitions 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . cerdelga contains the active substance , metaboliser . the active ingredient is metabolizer . after opening , the contents of the blister / wallet can be divided into equal doses . take the total daily dose of 84 mg by mouth . you can take the tablets with or without food . swallow the tablets whole with water . do not chew , crush or split the tablets . how to take cerdeslg : open the blister or wallet and insert the sleeve . press with your thumb or finger to release the tab . pull the tab through the blister/ wallet . open the resealable spleen . when taking cerDelgа : you may experience dizzi
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation and heartburn ( dyspepsias ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdominal pain that does not go away ), acid reflux disease ( gastrooesophageal reflux disease ), bloating ( abdominal distension ), inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dyspnoeal reflux syndrome ) feeling dizzy , high blood pressure ( hypertension ) uncommon ( may occur with cerdelga ) constipations / abdominal pain ( abdominal pain at the site of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and sleeve after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . cerdelga is for single use only . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of elitlustat in 2ml solution . - other ingredients are microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdeslg  contains lactoses '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate ( e551 ), titanium dioxide ( ida ), yellow iron oxide ( oblong ), indigotine ( azure ) and printing ink . printing inked cellulose ( s - 171 ). printing inking is contained in shellac , black iron oxide and propylene glycol and ammonia solution , concentrated . what cdelgara looks like
the active substance in zoledronic acid hospira is zolédronic acids , which belongs to a group of substances called bisphosphonates . zolеdronic sugar works by attaching itself to the bone and slowing down the rate of bone change . it is used : to prevent bone complications , e .g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the bones ). to reduce the amount of calcium in the blood in adult male patients where it is too high due to the presence of a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this condition is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor . your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment at regular intervals . you should not be given zolzoledraic acid
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously , i . e . through a vein , (' iv ' administration ). this is the only way to prevent dehydration . carefully follow all the other instructions given to you by your doctor , pharmacist or nurse . how much zolédronic acids hospria is given the usual single dose given is 4 mg . you should not receive more zoladronic as this medicine is being given by a doctor or nurse with appropriate medical assistance . your doctor will decide how much you should receive . people with a kidney problem if you have or think that your kidney problem is being treated , you will be given zoleric acid to prevent bone complications due to bone metastases . method of infusion : zolele
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the most common ones are usually mild and will probably disappear after a short time . tell your doctor about any of the following serious side effects straight away : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will normally be determined by your doctor with certain specific blood tests ). low level of calcium in the blood uncommon ( may effect up to1 in 100 people ]: pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and jaw discharge , feeling of numbness or a feeling of warmth or loosening of a tooth . these could be signs of bone damage in the jaw ( osteonecrosis ). tell your dentist and dentist immediately if you experience such symptoms while being treated
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly ( see section 6 ). they are also responsible for disposing of any unused product correctly .
what zoledronic acid hospira contains - the active substance is zoleric acid. one vial contains zolzoledonic acid ( 12 mg ). one vially contains 4 mg zolédronic acids ( as monohydrate ). - other ingredients are : mannitol , sodium citrate and water for injections . what z zolezic acid hospirac looks like and contents of the pack zolеdronic alfa - hospria is a liquid concentrate for solution for infusion ' ( also known as ' sterile concentrate '). it is supplied in a vial containing 4 mg of zoladronic alcohol . each pack contains one vialuid of concentrate .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) when having cancer treatment chemotherapy . chemotherapy affects the nerve cells in the brain . this causes vomiting , which can make you feel sick , be sick ... or you can feel sick all day . rolapatant works by blocking the activity of these nerve cells , helping to prevent nausea and vomiting .
do not take varuby : - if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). - is an herbal medicine containing st john ' s wort ( hypericum performatum ) used for depression or if your child has difficulty sleeping ( see section 2 ' what varubY is used for '). warnings and precautions talk to your doctor or pharmacist before taking this medicine : 27 - patients with severe liver or kidney problems - taking certain medicines , such as rifampicin ( used to treat tuberculosis and other infections ) - carbamazepine ( used for epilepsy and nerve pain ) or phenobarbital ( used in epilepsis )- enzalutamide ( for prostate cancer ) ( 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 180 mg once a day . this is a total of 90 mg once daily . swallow the tablets whole with a glass of water . you can take varuby with or without food . do not crush or chew the tablets . after you have taken varubY , you may take the tablets at any time of the day , with or just after food or between meals . how long to take va ruby take varumy every day until you are used to having chemotherapy . chemotherapy is for sickness . if there is sickness , it is important to keep taking this medicine until you have finished your chemotherapy cycle . it is very important that you do not take varugy with another chemotherapy cycle without talking to your doctor first . taking this
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : rare side effects ( may affect up to 1 in 1 , 000 people ): tell your doctor immediately or seek medical help if you have symptoms of an allergic reaction , which may include sudden shortness of breath , swelling of the lips or tongue , change in taste , or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your physician immediately or go to the casualty department at your nearest hospital , as appropriate treatment may be needed . other side effects may include : common ( may effect up to1 in 10 people ), headache , constipation and feeling tired . common ( might affect upto 1 in 10 children ) - diarrhoea , nausea , vomiting , dizziness 
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg of rolapint . - other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubies contains lactoses '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide and magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol and polysorbate 80 . what varugy looks like and contents of the pack varubY is supplied as a white , round , biconvex , blue and 100 mm diameter , with a polyvinychl chloride and / or polychlorotriflu
what enerzair breezhaler is enersair - indacaterol - glycopyrronium - mometasone furoate indabacaterol and glycopyrrronium belong to a group of medicines called bronchodilators . they relax the muscles of the small airways in the lungs , making it easier for air to get in and out . when the airways open , energetic properties become stronger . this helps to open the airway and makes it easier to get air out of the pulmonary airways to get into the intestine . momeasonne furoates belongs to  a groupe of medicines known as corticosteroids ( or steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small  airways inside the arteries , which can lead to
do not use enerzair breezhaler - if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor and do not take enERzair brezhalers . if there is anything you do not understand , ask your doctor to explain it to you and tell you that you are not allergic . warnings and precautions talk to your doctor or pharmacist before taking enErzair beezhaling if : you have heart problems , including an irregular or fast heartbeat . you have thyroid gland problems . your doctor may want to monitor you more closely . You have diabetes or high blood sugar . or you have ever had seizures ( fits ). you have severe kidney problems ;
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because your asthma is not troubling you , and your symptoms will not go away . only use enerzair breezhaler if your asthma or symptoms get worse . use Enerzaire breezehaler at the usual time . how to inhales en Erzair brezhalers is for inhaling enErzair braezhaling it is a single inhaler and capsules that contain the medicine in a capsule . each time you use the inhalers , you will find a convenient container to store the capsules . do not swallow the capsule ,
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious stop using enerzair breezhaler and get medical help immediately if you have any of the following : common : may affect up to 1 in every 10 people - difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other side effect types may include : very common - may affect more than 1 in 10 people common , may affect less than 1in every 10 persons - sore throat - runny nose - sudden difficulty breathing and feeling of tightness in chest with difficulty breathing - feeling of stiffness in the chest - pain in the joints - joint pain - general feeling of restlessness and feeling unwell reporting of side effects 25
- keep this medicine out of the sight and reach of children . - do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture . do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each delivered dose contains 150 micrograms of inddacatrol ( AS accetate ) 63 microgram ( equivalent to glycopyrrronium bromid ). each delivered ( inhaled ) dose contains 50 microgram( g ) of glycopyrrionum and 160 microgram [ equivalent to momeason furoates ]. each delivered delivery dose ( the dose that leaves the mouthpiece of the inhaler ) contains 114 microgram of indecaterol as ace , 58 microgram glycopyrryum broMIDe equivalent to 46 microgram (" gp ") of glycochorronium and 136 microgram "
clopidogrel acino pharma gmbh contains the active ingredient clodogrell which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called tampering ). clops ( thrombosis ) can be fatal . cloclopidacino de gracino acan pharma
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopogrell or any of the other ingredients of clodogrelacino pgmbecco pharma or any other ingredients in this medicine ( listed in section 6 ). if this applies to you , tell your doctor without taking clonogreel . warnings and precautions talk to your doctor before taking c : if your doctor knows that you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain if the doctor thinks you have severe liver disease . if any of these apply to you ( or you are not sure ), talk to you doctor before you take clinpidogresl - acan pharma mgbh ( see section 4 ). take special
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopogrell acano pharma mgbh per day to be taken orally with or without food , and at the same time each day . it is important that you take a dose of : - to take ' cloclopidacino
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon (affecting less than 1 to 1 user per 10 , 000 ) rare ( affecting 1 to 8 users in 10 000 ,000 ) very rare (affecting more than1 user in10 ,00 ,0000 ) not known ( frequency cannot be estimated from the available data ) contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or eyes ( jaundice ), or
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special temperature storage conditions . cloclopidegrel alcino p gmmbh should not be used if there is any visible sign of damage of blister or film - coated tablets . medicines should not become disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains the active substance is clopogrell . each tablet contains 75 mg of clodogrelly ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : microgol 7000 ethylcellulose ( е462 ) titanium dioxide (  e 171 ) what clinpidogral аcino p g mbH looks like and contents of the pack clodidogre acan pharma mgbh 75 mg film – coated tablets are white to off - white , marbled , round and biconvex . they are supplied in cardboard cartons containing
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection . it belongs to a group of medicines called ' antiretroviral medicines '. it contains two active substances : doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , and a nucleolar analogue reverse transcriptataser inhibitor ( crti and tenofovir disoproxil , another non  sulfonamide reverse transcriptor ( rtis )). what delstrugo is taken for deltrigo has been shown to be effective in treating hiv infection in adults aged 18 years and over . hiv is the virus that causes aids (' acquired immune deficiencies syndrome '). it
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if this applies to you , tell your doctor immediately . do not use delStrigo without first talking to your doctor . tell your healthcare professional if any of these applies to your situation . also , please read section 6 of this leaflet . the following medicines are available : carbamazepine ; oxcarbazepine or phenobarbital ; or phéytoin ( medicines to prevent seizure ); rifampicin and riifapentine ( medicines for tuberculosis ); simvastatin ( a herbal remedy used for depression and anxiety 
always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . how much to take the recommended dose is a complete regimen . it is taken as a single tablet for hiv infection in two equal doses . your doctor will tell you if this medicine is suitable for you , and at what dose your doctor may need . the recommended starting dose is 1 tablet once a day . you may need to take certain medicines , including doravirine ( see " other medicines and delstrigo " below ). taking this medicine swallow the tablet whole with water you can take it with or without food . do not take this medication with grapefruit or grapefruit juice . taking dellsTRIgo you can have your first dose of del strig within 12 hours of your treatment . if your doctor decides that you should continue to take de
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : common ( may affect up to 1 in 10 people ) abnormal dreams , difficulty in sleeping ( insomnia ) headache , dizziness , sleepiness , cough , nasal symptoms feeling sick ( nausea ), diarrhoea , stomach pain , vomiting , wind ( flatulence ), hair loss , rash muscle symptoms ( pain or stiffness ), feeling tired , hair loss or rash joint pain ( arthralgia ), cough feeling tired ( nausea and vomiting ), wind ( flu - like symptoms ), headache . uncommon ( may occur with up to1 in 100 people ), abnormal dreams sleepiness ( somnolence ) sleepiness dizziest , fainting 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . delstrigo is for single use only . once the bottle has been opened , the medicine should be used immediately .
what delstrigo contains each tablet contains 100 mg doravirine , 300 mg lamivudine and 245 mg tenofovir disoproxil ( as fumarate ) in the form of granules . the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate ( e470b ), microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumarat . film - coating : carnauba wax e903 , and hypromllose ( 6000 ), iron oxide yellow ( 67f ), lactose monohydrate , titanium dioxide e171 , triacetin . what delustri
spravato contains the active substance esketamine . this belongs to a group of medicines called anti - depressants . you have been given this medicine to treat your depression . it helps to control the symptoms of depression , including feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities , feeling of being slowed down . if you are taking another antidepressant , check with your doctor or pharmacist if this applies to you . see section 2 under ' other antidepressive medicines '.
do not take spravato if you are allergic to esketamine ( also known as ketamine ). if there is still a possibility that ketami will be given to you during anaesthesia , you should not receive this medicine until you have checked with your doctor , pharmacist or nurse . warnings and precautions talk to your doctor or pharmacist before taking s Pravato and during treatment : if for any reason you think you may have an aneurysm ( a weak spot on a blood vessel wall that bulges out ) or you are having bleeding in the brain if your doctor has told you that you have recently had a heart attack within 6 weeks . if it is not known how long you will be treated . there is a temporary increase in blood pressure . this may increase the risk of serious complications in these conditions . when spri
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the spravato nasal spray is for use in adults only . the nasal spray device can be used for 1 , 2 , 3 nasal spray devices . there are two different strengths . one nasal spray unit is enough to deliver one spray in the morning and one spray device in the evening . you can use the spray for up to 4 hours after you have used s Pravato . use in children and adolescents the recommended dose is 2 sprays per day . if your child uses more sprinkling more than one spray , you should use the same amount of this medicine every day , as described below . this will help to prevent nausea and vomiting . after 2 weeks of treatment , your doctor may decide to reduce the dose to
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( may affect more than 1 in 10 people ) feeling disconnected from feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity in the mouth area spinning sensation , vertigo vomiting nausea common ( might affect up to 1 in every 10 people people  ) being extremely happy ( euphoria ) not feeling agitated feeling nervous or irritable irritated or drowsy dizziness diarrhoea feeling very tired or sleepy mouth irritation or a feeling of being unwell mouth area , spinning sensation ( vertigon ) or vomiting nausea uncommon ( may effect up to1 in 100 people ). not known ( frequency cannot be estimated from the available data ): feeling very happy (
what spravato contains - the active substance is esketamine . each nasal spray device delivers esesketamine hydrochloride equivalent to 28 mg eketamine as a single dose . - other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what rpravatato looks like and contents of the pack spruvato is supplied as  a nasal spray solution . this medicine is a clear , colourless solution in a multi - use nasal spray unit . the solution is clear and colourless . one application can be used in up to 1 , 2 , 3 or 6 nasal spray devices . not all pack sizes may be marketed .
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery if you have cancer with a change ( mutation ) in a gene responsible for producing melama . zelmoraf targets proteins that are involved in the growth and spread of your cancer .
do not take zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash , and fainting sensation when taking zeloraf ( see section 4 ). for signs of allergic reaction , look out for signs and symptoms of allergy reactions when taking the medicine . allergic reactions occur more often in women after taking zeboraffe . warnings and precautions talk to your doctor , pharmacist or nurse before taking , or while taking vemoraf in order to minimise the risk of allergic responses . you should not take the medicine for any symptoms of an allergic reaction such as swelling ofthe face . lips or mouth , having difficulty breathing or rash or fainting sense . severe skin reactions may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : adults : one 4 mg tablet each day , for example , if your doctor recommends you to take one 8 mg tablet every day . your doctor may increase your dose to 4 mg each day depending on the side effects you experience . during your treatment with zelboraf , you may need to take the tablet at the same time or at different times , depending on your general condition and on your medical condition . if possible , your doctor will decide whether to reduce your dose , or to stop the tablet , especially if it is necessary . to prevent vomiting , take zeloraf with food . take zeboraffe on an empty stomach . swallow the tablet whole with water . do not chew , crush or split
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions may occur , including swelling of the face , lips or tongue , difficulty breathing rash fainting sensation has been reported in patients taking zelmoraf . radiation treatment tell your doctor or nurse if you notice any of the following side effects as they may be caused by zeloraf treatment : you or your caregiver may be exposed to radiation during zelburaf therapy . you or caregiver may also experience some of the effects of radiation on the skin , isophagus , bladder , liver , rectal , and lungs . tell your physician immediately if your child develops any of these symptoms : skin rash , blistering , peeling ; discoloration on the surface of the skin shortness of breath a cancer like appearance a skin
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to throw away tablets you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemorafèneib ( as a co - precipitate of VEmuraFenibe ). the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , and hydroxypropyl cellulose . tablet coating : magnesium stearate film , iron oxide red ( e172 ), macrogol 3350 , polyvinyl alcohol , part hydrolysed ( ph . ethanol ), talc and titanium dioxide (  e171 ). what zeboraF looks like and contents of the pack zeloraf 240mg film  are
duoplavin contains two active substances , clopidogrel and acetylsalicylic acid ( asa ). these belong to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , it prevents blood vessels from forming . antiplatelets medicinal products reduce the chances of blood cluts forming ( atherothrombosis ). duopravin is taken to prevent blood coagulation in hardened arteries , leading to atherathrombotic events ( such as stroke , heart attack , or death ). you should keep having duoplanvin exactly as your doctor has told you .
do not use duoplavin if you are allergic to clopidogrel or acetylsalicylic acid ( asa ) or any of the other ingredients of this medicine ( listed in section 6 ) if this applies to you , tell your doctor before using duoplanvin . if your doctor thinks you may be allergic to other products , including non - steroidal anti - inflammation products . warnings and precautions painful and / or inflammatory conditions of muscles or joints . tell your physician if : you have a medical condition such as asthma , nasal discharge , runny nose , polyps ( type of growth ) around the nose you have or have had a medicinal condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain , severe severe kidney disease or severe allergic reaction . you have had
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . try to take your medicine at the same time each day , to reduce the risk of a heart attack . you should swallow your tablet whole with a drink of water . if possible , duolavin can be taken with or without food . tell your doctor about any change in the dose you are having . your doctor may recommend a higher or lower dose , or may ask you to go to an emergency department because of the increased risk of bleeding . remember to take duoplanvin every day until your doctor tells you to stop . it is important that you take duotroplavin every 12 hours until your next scheduled dose . in case you forget to take 
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if not treated , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the following side effects have been reported with duoplavin . very common side effects ( may affect more than 1 in 10 people ):  headache  dizziness  increased
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . tell your pharmacist if you notice any visible sign of deterioration . Do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplanvin 75 mg : each 75 mg film - coated tablet contains 46 the active substances , clopidogrel and acetylsalicylic acid ( asa ): each tablet contains 75 mg of clopogrell ( as hydrogen sulphate ) and 75 mg desiccants of acetoyl salicylic acids . the other ingredients are mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose . - the other ingredient is maize starch , hydrogenated castor oil ( see section 2 ' duo plavin contains hydrogenated castingor oil '). what duooooplavin looks like and contents of the pack duolavin is a white , round , flat , bevelled , uncoated tablet
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brinzolidine belongs to a group of medicines called carbonic anhydrase inhibitors . brimoniidine tartrat belongs to another group of medications called alpha - 2 adrenergic receptor agonists , which work by reducing pressure within the eye . simbrINza is used to reduce pressure in the eyes in adults ( 18 years of age and older ) in adults with eye conditions such as glaucoma or ocular hypertension ( high pressure in both eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor thinks you may be allergic to sulphonamides , medicines used to treat diabetes or infections , diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines used for depression or parkinson ' s disease ) warnings and precautions tell your doctor if any of these apply to you . if applicable , you may also be given certain antidepressants . tell your healthcare provider if , or you are taking any antidepressive medicines . you have severe kidney problems . your doctor may want to monitor you more closely if they have too much acidity in your blood ( hyperchloraemic acido
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one drop in the affected eye or eyes once a day in the evening . use in children and adolescents the recommended adult dose is two drops in the morning and one drop at the evening ( 0 . 5 ml ). wash your hands before you use simbrinza . step 1 : remove the bottle cap and snap collar as soon as you can . twist off the bottle . after the cap is removed , snap collar is loose , and the medicine is gone . wash your fingers . hold the bottle and pull down the bottle with your thumb and fingers , until the medicine has dissolved . tilt your head back . pull down your eyelid with a clean finger , so there is a ' pocket ' between the
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine . if you have a reaction to the medicine ( frequency not known ), tell your doctor or nurse straight away . an allergic reaction may occur . severe skin reactions ( rash , redness and itching all over your body or eyes trouble breathing , chest pain or irregular heart beat tell your heart doctor or hospital pharmacist immediately extreme tiredness and dizziness . side effects of simbrinza may occur with other medicines . talk to your doctor if they get worse or if your child gets any of the side effects after taking simbrINza . these effects are usually mild and usually go away within a few days . they could be serious and last for longer than one week . tell your doctors or nurse immediately if any of these side effects gets serious . your doctor
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . use within 4 months after first opening to prevent infections and use a new bottle . write down the date you opened the bottle in the space on each carton box . store in the original package in order to protect from moisture . keep the bottle tightly closed in order for the medicine to work properly . once you have opened the product you should throw away the bottle as soon as possible after opening . never throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . one ml of suspension contains 10 mg of brinzolide and 2 mg of brimoniidine tartrat equivalent to 1 . 3 mg brionidine . - also the active substance is benzalkonium chloride . see section 2 " simbrINza contains the active ingredients ". benzalskonium chlorine , propylene glycol , carbomer 974p , boric acid , mannitol . the other ingredients are sodium chloride and tyloxapol , hydrochloric acid / sodium hydroxide , purified . what simmbrinZA looks like and contents of the pack simbr inza is a clear , colourless liquid . it is supplied in glass vials . each pack contains
what filgrastim ratiopharm is filgrastastim ratipharm contains the active substance filgraskastim which is made from two human proteins . filgrasestim is a protein produced by biotechnology in bacteria called escherichia coli . it belongs to a group of proteins called cytokines and is very similar to , a natural protein ( granulocyte - colony stimulating factor [ g - csf ]) produced by your own body . when filgrastem ratioph is made , it stimulates the bone marrow ( the tissue where new blood cells are made ) to produce more blood cells , especially white cells . white cells are important as they help your body fight infection . you may also want to know that you have been given filgrastentim ratiophenphen by talking to dna technology .
do not use filgrastim ratiopharm : if you are allergic ( hypersensitive ) to filgraştim or any of the other ingredients of filgrasestim ratioppharm . if this applies to you , tell your doctor without taking filgraStim ratiopospharm. warnings and precautions talk to your doctor before taking filgranstim relationpharm and during treatment :if you experience a cough , fever and difficulty breathing . it could be a consequence of a pulmonary disorder . you may be at increased risk of side effects , if your doctor determines that you have sickle cell disease 57 if : you get left upper abdominal pain or pain at the tip of your shoulder . this may be  a sign of  spleen disorder , see section " possible side effects ". you will have regular blood tests while you are taking filGras
your doctor will tell you how much filgrastim ratiopharm to give you . your doctor or nurse will tell your doctor if you are not sure . how much will filgratim ratioppharm be given and how long will it take for you to take filgrasten ratioparm ? your doctor and nurse will talk to you about all the details of your treatment . when you first start taking filgrasestim ratioppepharm after chemotherapy , the usual dose is 0 . 5 million units ( 60 micrograms ) per kilogram of body weight . you will usually receive your treatment over 14 days . in some disease types , however , longer treatment lasting up to 14 days may be required . the usual duration of treatment with filgrassen ratioph if your doctor determines that it is necessary ? if it is not possible to take the tablets , you must contact your doctor who will decide
do not use filgrastim ratiopharm : if you have sickle cell disease . 57 if your doctor or nurse gives you an injection of filgraştim ratioppharm , tell your doctor immediately if : you get left upper abdominal pain or pain at the tip of your shoulder . it could be a consequence of a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests while you are taking filgrastortim ratioppepharm to check the number of neutrophils and other white blood cells in your blood . this will tell you how well the treatment works for you . other medicines and filgragrast ratioparm tell your physician or pharmacist if any of the following applies to you : your doctor may give you other medicines , including medicines obtained without a prescription . pregnancy and breast - feeding ask your doctor for advice
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . filgratim ratioppharm may be taken out of its shelf life if it is accidentally frozen . it is recommended that you throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgraStim . each ml of concentrate for solution for infusion contains 60 million international units [ miu ] ( 600 microgram ) of filgraştim - filgrastastim rapportpharm 30 miu in 0 . 5 mL solution for injection or 30 micrograms of filGrastim in 05 . 4 mlitre solution . filgragrast ratioph 48 miuin / 0. 8 mll solution for solution , corresponding to 48 million international unit [ mioul ]- filGrastast in k29 . 8 microgram per m2 of solution - each millilitre contains 48 million global units [ mil ] - this product contains 48 microgram of filgranstim per 0e . 9 mmol -
what riluzole zentiva is rilsuzola zentivea contains the active substance rizole which acts on the nervous system . what röluzolе zenta is used for rilluzolé zentaria is applied to patients with amyotrophic lateral sclerosis ( als ). als is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness , muscle waste and paralysis . the destruction of nerve cells in motor neuropathy may be caused by too much glutamate ( a chemical messenger ) in the brain and spinal cord . rILuzol zentoria works by reducing the amount of glutamates in the nerve cell . this will help to prevent the nerves being damaged and the nerve tissues being damaged .
do not take riluzole zentiva if you are allergic to rilsuzola or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . warnings and precautions talk to your doctor before taking rilluzolе zentivea : if your doctor knows that you have any liver disease or increased blood levels of some enzymes of the liver ( transaminases ). in particular , if a woman is pregnant or breast - feeding . do not receive rileuzol zenta zentrica - if any of these apply to you and tell your physician immediately :- a history of any liver problems , including yellowing of your skin or the whites of your eyes ( jaundice ), itching all over , feeling sick , being
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day , taking it at the exact time of the day ; it does not matter at what time of day you take your tablet but taking the tablet by mouth , at least 12 hours after your last dose of riluzole zentiva . if your doctor continues to prescribe rilsuzola zentivea , contact your doctor , pharmacist , or your nearest hospital emergency department for further advice . you may take rilluzolе zenta with or without food . do not take a double dose to make up for a forgotten tablet . take your next tablet at its regularly scheduled time . this will help you to remember when to take your
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . your doctor will take a blood sample to check the number white blood cell count and may give you more protection against infections . - you may experience one or more of the following symptoms : yellowing of your skin or the white of your eyes ( jaundice ), itching , feeling sick or being sick , because you may have liver disease ( hepatitis ). you will need regular blood tests while you are taking rilsuzola zentivea . this is to check for any signs of cough and difficulties in breathing . other side effects may include : very common side effects ( may affect more than 1
what riluzole zentiva contains the active substance is rilsuzola . the other ingredients are : core : anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrOUS colloidal silica , magnesium stearate , croscarmellose sodium , aspartame ( e468 ), hypromellose , macrogol 6000 , titanium dioxide ( е171 ). what siluzone zentivea looks like and contents of the pack the tablets are white to off - white , oval tablets , debossed with " r " on one side and " 50 " on the other side . rilluzolе zenta is available in plastic bottles of 202 tablets . each bottle contains one bottle of rluzolo 
emgality contains the active substance galcanezumab , a medicine that lowers the levels of calcitonin gene - related peptide ( cgrp ), which is involved in migraine and which is associated with increased levels of cagrpe . egality is used to treat migraine in adults who have at least 4 migraines per month and who also have migraines at other times . the use of emegality has been shown to reduce the frequency of migraine headaches and to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using emegality about : - if your doctor thinks you may have a serious cardiovascular disease . serious cardiovascular diseases can make you more susceptible to allergic reactions emigality can cause serious allergic reactions and some of these reactions can be life - long . you must look out for signs of a seriously allergic reaction . tell your doctor or pharmacist if any of these signs are signs of side effects , see section 4 . children and adolescents egality is not recommended for children and teenagers under the age of 18 years . other medicines and emmgality tell your physician or pharmacist or pharmacist before using this medicine if there is a possibility that you
always use emgality exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the recommended dose of egality is 240 mg once a day . eemggality is administered by injection under your skin ( subcutaneous injection ). you should supervise your emigality injection , after proper training . your doctor will tell you how many days you should take e. g . each day , at about the same time each day ( 240 minutes apart ). if your doctor prescribes more emegality than you should if a child has given you more , or if someone else gives you more medicine than they should , tell your doctor . show them the pack , and this leaflet . do not give a double dose to make up for a forgotten dose . take the next dose
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality are rare ( may affect up to 1 in 1 , 000 people ). tell your doctor straight away if you notice any of the following : - rash or itching . these are signs of serious allergic reactions ( may occur with up to1 in 1 million people ), with difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash and raised bumps . other side effects very common side effects ( may effect more than 1 in 10 people ): o injection site reaction ( swelling ) common side effect ( may effects up to one in 10 at the injection site 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after preparing the solution you may shake emgality vigorously and store it not above 30 for a single period of up to 7 days . this medicine does not require any special storage conditions . ask your pharmacist how to throw away any medicines you no longer use . these measures will help protect the environment .
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg galcanaezum ab in 1 ml solution . the other ingredients are l - histidine , l- histhidine hydrochloride monohydrate , polysorbate 80 , sodium chloride , water for injections . what hemgalism looks like and contents of the pack emegality is a solution for injection in a clear glass syringe . colourless to slightly yellow . egality consists of white to off - white coloured solution , the sYringe is packed in : single - dose pen containing 1 , 2 or 3 pre  sying - needles , one needle . not all pack sizes may be marketed .
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hvv ), in which the blood vessels in the liver become damaged and blocked by blood clots . defit lia is only used in patients who have not received medicines prior to a stem cell transplantation . by attaching to the stem cell , defibrotoide helps to normalise the blood vessel and reduces the risk of the blood clumping together . you have been given this medicine before a medical treatment has been started .
do not use defitelio - if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) - with other medicines to prevent blood clots , such as tissue plasminogen activator warnings and precautions ( medicine used to treat bleeding ) or if heavy bleeding requires a blood transfusion after surgery - problems with blood circulation - having a constant blood pressure  1 - taking other medicines - medicines to reduce blood coagulation , e . g ., acetylsalicylic acid , and heparins ( e. . warfarin , dabigatran , or rivaroxaban , anaesthetics ) defit liu must not be used if any of these apply to you 
the treatment with defitelio will be started by a doctor who is experienced in stem cells transplantation . it will be given to you through one of your veins ( called an ' intravenous infusion ' or drip ). this treatment will be repeated every 21 days . your doctor will decide how many treatments you need . if your symptoms do not improve after 18 weeks , your doctor may decide to reduce your dose . talk to your doctor if you are worried . you should take defitelfio by yourself or a nurse . tell her or him if she thinks you have been given too much defitlia . she or he may ask you to go to a hospital for advice immediately . take the medicine pack with you so that it is clear what you have taken . children and adolescents defit lion is given to children and teenagers aged under
like all medicines , defitelio can cause side effects , although not everybody gets them . when treating patients with defitеlia the following side effects have been reported , some of these side effects may be serious . if any of these occur , contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in10 people ), bleeding in general bleeding ( including the nose bleeding , the brain bleeding ) and the gut vomiting . blood bleeding in the lungs bleeding (including blood in the urine ), the mouth bleeding ; and the skin coagulopathy ( disturbance in blood clotting ). not known ( frequency cannot be estimated from the available data ) bleeding in children and adolescents ( from birth to 18 years of age ) diarrhoea , stomach pain , nausea , vomiting 
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and the infusion storage after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . defitlia should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 oc to 8 ooc . once opened , defit lion should be discarded if the solution is cloudy or opalescent . discard any unused solution appropriately .
what defitelio contains - the active substance is defibrotide . each 2 . 5 ml vial contains 200 mg of defibroatide ; each mL solution contains 80 mg of desfibrotides . - other ingredients are sodium citrate dihydrate , hydrochloric acid ( for ph - adjustment ) and water for injections . see section 2 " defit elide contains sodium ". what deFITelo looks like and contents of the pack defittellia is a clear , colourless to pale yellow solution . it is supplied in glass vials as a concentrate for solution for infusion . packs of 10 vial ( 10 m x 2  . 4 mg concentrate ).
daklinza contains the active ingredient daclatasvir . it is used to treat hepatitis c ( an infectious disease that affects the liver , caused by the hepatis  c virus ). this medicine works by stopping the hpatiti cvirus from multiplying and infecting other cells of the body . this means that the virus is eliminated from your blood over a period of time . daklindza can be given with other medicines to treat your hepitis - c infection . if you have any questions about the other medicines you are taking , please ask your doctor or pharmacist .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) or to any other medicine ( oral or oral ). if this applies to you , do not give this medicine to your child by mouth and tell your doctor . if your child is taking any of these medicines : phenytoin , carbamazepine , oxcarbazepine or phenobarbital , used for epileptic seizures . simvastatin / rifampicin ; rfabutin & riapentine , antibiotics used for tuberculosis . dexamethasone , also a steroid used for allergic and inflammatory diseases . medicines containing st .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of daklinza is one 60 mg tablet once a day . this is because it has a very unpleasant taste and can be very bitter . if possible , you can take daklinezza with some other medicines while you are taking daklinac . taking these medicines will also help you to remember to take them . your doctor will tell you how long you should keep taking daclinza . do not change your daily dose of dosing unless your doctor tells you to . depending on how you respond to the treatment , your doctor may prescribe daklines with other medicines for hepatitis c infection . these medicines should be taken at the same time as daklinung . duration of treatment you should continue to take daclinn
like all medicines , this medicine can cause side effects , although not everybody gets them . when daklinza is taken in combination with sofosbuvir and ribavirin , the following side effects have been reported : very common ( may affect more than 1 in 10 people ) headache fatigue common ( might affect up to 1 in every 10 people not known ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when daclinza has been taken in conjunction with sofranximus / rib avirIN : common side effects ( may effect up to1 in 10 , 000 people ). very common : headache joint pain dizziening difficulty sleeping dakliness migraine fatigue ( feeling tired ) common - may affect upto 1 in the same way as in other medicines such as sofas
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 or 60 mg daclaatasvirus ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide . macrogol 400 , indigo carmine aluminum lake , yellow iron oxide ( e172 ). what daknza looks like and contents of the pack 51 daklianza 30 mg film . the film ' s film  s t - st . john 's wort is a greenish - yellowish , oval , scored tablet , with " bm
proquad is a vaccine to prevent measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will make antibodies against the meases , mucus , bumps / rubella / varicello types of viruses , and the antibodies help to protect the meavesles / mums caused by rubella or varicellina viruses ; the antibodies make proteins that help to fight diseases caused by these viruses : proquade is used to prevent the spread of meales - mops , red , or black - headed mashes caused by the three types of rubella/ chickenpossed by the h5n1 type of virus . the vaccine works by preventing it from
do not receive proquad if you are allergic to any varicella vaccine , mumps , rubella vaccine or any of the other ingredients of this vaccine ( listed in section 6 ) or to neomycin if your doctor has told you that you have a blood disorder or type of cancer that affects the immune system . warnings and precautions talk to your doctor , pharmacist or nurse before receiving proquade : if : you have ever had a problem with your immune system ( such as treatment with medications that weaken your immune response , such as low - dose corticosteroid therapy , asthma or replacement therapy ), you have been told that you suffer from a weakened immune system due to a disease ( including aids ), or you have congenital or hereditary immunodeficiency ( low level of immune competence ), as you have active un
proquad is given as an injection into the muscle of the upper thigh or upper arm . injections into the same muscle will be given as the first injection into your tummy or upper limb ( thong or upper arms area ). the recommended injection site is the following : if you have a blood clotting disorder or low levels of platelets , the vaccine should never be given into the skin . this will reduce the risk of bleeding and improve the blood circulation . if your doctor thinks the vaccine has been given into a muscle , proquade will be administered into  a nearby blood vessel by a doctor or nurse . the doctor or healthcare professional will show you how to prepare the vaccine .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives have been reported very rarely . some of these reactions may be serious and may lead to difficulty in breathing or swallowing . if you have an allergic reaction , tell your doctor straight away . other side effects of proquad may occur with up to 1 in 100 doses given . seizures ( fits ) if your doctor thinks you may have a fever . rare ( may affect up to1 in 1 , 000 doses ): bronchiolitis ( difficulty breathing , cough ) and unsteadiness with walking . side effects reported with proquade may occur in up to one in 10 doses in children . injection site complaints ( including pain , swelling , redness or itching ) have also been reported . reporting of side effects 25
what proquad contains the active substances are : measles virus1 / edmonston strain ( containing 3 . 00 million cells ) mumps virus1 ( jeryl lynn - level b ) strain ( non - recombinant dna technology ) 4 . 30 micrograms rubella virus2 - strain ( not non reconstituted ) 3 .00 microgram ( non non ) varicella virus3 / meck strain ( no non . 3 %) growth factors ( gmt ) in tissue culture , plaque - making units ( pfu ) 1 produced in chick embryo cells ( fibroblasts ) ( mrc ). the other ingredients are - powder sucrose , hydrolysed gelatin , urea , sodium chloride , and
jylamvo is an anticancer medicine which works by blocking specific receptors in your body , which may cause unwanted reactions . jyeramvo has an immunosuppressive agent with an anti - inflammatory effect jYlamva is used to treat rheumatic and skin diseases : - in adults with active rhumatic rhusatoid arthritis or polyarthritic forms ( forms that involve the joints ) - severe juvenile idiopathic arthritis ( jia ) in adults and adolescents 3 years of age and older . it is used together with non - semen / non – steroidal anti – inflammation drugs ( nsaids ) and inadequate o severe and disabling psoriasis , when treatment with phototherapy ( psomoralen ) or ultraviolet
do not take jylamvo - if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) -if you have a severe kidney impairment - have  a liver impairment . - suffer from blood disorders ( such as bone marrow hypoplasia , leukopenia or thrombocytopenia ) or significant anaemia 34 - are a weakened immune system - suffered from a serious infection such as tuberculosis or hiv - be sure your doctor knows if any of these apply to you . warnings and precautions talk to your doctor before taking jYlamVO - in particular , tell your doctor if : you have ulcers in the stomach or other parts of the intestines you have an inflammation of the mucous membrane of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo is for long - term use . your doctor will decide if jlamva should be discontinued because it has been shown to reduce the risk of severe side effects and even death . depending on the severity of the treatment , your doctor may recommend that you stop using rheumatoid arthritis , or severe juvenile idiopathic arthritis . severe psoriasis if your doctor determines that you have severe soriatic arthritis : jyerlamvre is used as a long  -term treatment . the benefit of using jYlamVO is to reduce rhumatic and skin diseases such as jia , p sorasi and pSori
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : wheeziness or difficulty in breathing , swelling of the eyelids , face or lips , rash or itching ( especially affecting your whole body ). the most common side effects are breathing problems and feeling of illness . dry , irritating cough , shortness of breath and difficulty in breath ( with or without chest pain or fever ). spitting or coughing blood . serious peeling or blistering of the skin or mouth ( hives ). itching all over your body if any of the side effects gets serious , or if they get worse , tell your healthcare provider . very common side effect ( may affect more than 1 in 10 people ): breathing problems , feeling of sickness , dry / irritating cough which may cause shortness in
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the label after exp . the expiration date refers to the last day of that month . store below 25 . keep the medicine in the original package in order to protect from light and avoid accidental spillage . after first opening , the product should be used immediately . however , in the event of accidental spilling , a fine may be made up of 3 million euros . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotredxate ( as methotrxate in the form of a powder ). - other ingredients are : macrogol 400 , glycerol , orange flavour , sucralose , epithel parahydroxybenzoate ( e219 ), sodium methyl parahydroxybenzoate ( ( е218 ), citric acid , tri - sodium citrate , purified water . see section 2 " jYlamvre contains ethyl parahydroate ". the active ingredient is sodium m - parahydroxybenoate ." what jujumvo looks like and contents of the pack jjylamvo is a brown glass bottle containing 60 m
what enurev breezhaler is this medicine contains an active substance called glycopyrronium bromide . this belongs to a group of medicines called bronchodilators . what Enurev braezhalers is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . that makes breathing difficult . the medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the pulmonary airways . if you use this medicine once a day , it will help to reduce the effects of copd on your everyday life .
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before using enuresv  Breezhalers - patients with kidney problems - suffer from an eye problem called narrow - angle glaucoma - difficulty passing urine during treatment with enurév BREezhale this medicine may cause you to suddenly stop taking it and you should contact your doctor immediately if any of these apply to you . - tightness of the chest , coughing , wheezing or breathlessness immediately after using  Enurev brezhaling - signs of bronchospasm include difficulties in breathing or swallowing ; swelling of the tongue , lips or face , skin or hair - this should be
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much enurev breezhaler to use the usual dose is to inhale the content of one capsule each day . you only need to inhake once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . elderly people you can use this medication if the effect is too strong or too weak . use this product exactly as described in this leaflet and in this package leaflet . it is for inhalation use : inhaling this medicine you use an inhaler and capsules ( in blisters ) that contain the medicine as inhalations powder . only use the capsules with the inhalers provided in this pack ( enuresv BREez
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia : typical symptoms include excessive thirst and hunger and frequent urination ) rash , itching , hives , difficulty breathing or swallowing , dizziness ( signs of allergic reaction ) swelling mainly of the tongue , lips , face or throat ( possible signs of angioedema ) reporting of side effects you can help provide more information on the safety of this medicine .
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms of glycopyrryum broMIDe ( equivalent to 50 microgram of glycopronium ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram ( g ) of glycopirronium ( equivalent  to 10 microgram ). - other ingredients of the enuresv brewing powder are lactose monohydrate and magnesium stearate . what  Enurev brezhalers looks like and contents of the pack enurév  Breezhale 44 microlitres inhalation powder , hard capsules are transparent and contain a white powder . they have the product code " gpl50 " printed above and a company logo ( ) printed above 
what riximyo is rximyô contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimabe sticks to this cell , the cell dies . what reiximYo is used for ruximyon is used to improve the treatment of several different conditions in adults . your doctor may prescribe reximya for the treatment : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a particular type of whiteblood cell called b- lymphoocytes ). ritchimyok can be given alone
do not take riximyo if you are allergic to rituximab , other proteins which are like ritsimabe , or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a history of a severe active infection at the moment . warnings and precautions talk to your doctor , pharmacist or nurse before taking rximya : if your doctor determines that you have a weak immune system , as ruximyok may cause severe heart failure or severe uncontrolled heart disease , e .
you will be given riximyo under the supervision of a doctor experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given the dose of rximyon that your doctor or nurse has given you ( as a drip ) into a hospital or clinic . your doctor will tell you how many treatments you need . each ruximya administration will be administered by a nurse or doctor . it is very important that you receive each , and at the same time with other medicines ( premedication ) as your doctor monitors you for side effects and adjust your dose . how long will i have to take your treatment ? non - hodgkin ' s lymphoma if you are given a dose of one dose of the other
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , fever and chills . not known : frequency cannot be estimated from the available data . some of the side effects listed below have been reported . if any of the above apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before using riximyo 
what riximyo contains the active substance is called rituximab . the 10 ml vial contains 100 mg of ritsimabe ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of ratuximabo ( 10  mg ). other ingredients are sodium citrate , polysorbate 80 , sodium chloride , water for injections , and hydrochloric acid ( see section 2 " rximya contains sodium "). what if ruximyon looks like and contents of the pack rrixmyo is a clear to slightly opalescent and colourless to slightly yellowish solution . ritzimyun is supplied as a concentrate for solution for infusion . packs of 2 or 3 glass vials ; each pack contains 1 vial or
topotecan actavis contains the active substance topoten . topotécan activis is used to treat small cell lung cancer that has come back after chemotherapy . advanced cervical cancer if surgery or radiotherapy is not possible . in this case topotеcan actvatis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis - if you are allergic to topotencan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking topotécan activis . if your blood cell counts are too low , talk to you doctor or nurse before taking this medicine . your doctor will decide if topotacan actAVIs is right for you . tell your doctor if any of these applies to you , because topot , you may need to take more medicine than you should . also tell your pharmacist if : you have any kidney problems . you should not take this medicine with topotercan act Avis , as there is a higher risk of severe kidney impairment . talk to the doctor , pharmacist or nurse first . there is also a possibility that you may have liver
topotecan actavis will be given to you by a doctor with specialist experience in treating the disease . your doctor will carry out blood tests before you start treatment and regularly during your first treatment cycle . adults small cell lung cancer : the usual dose is 1 . 5 mg per square metre of body surface area once daily for 5 days . this treatment cycle will normally be repeated every three weeks . cervical cancer - the usual starting dose is 0 . 75 mg per metre ( m2 ) of body area once weekly for 3 days , but this treatment cicl will normally run for three weeks in total . for cervical cancer and in combination with another anticancer medicines , cisplatin . cistplatin is not recommended if you have impaired kidney function . the doctor will monitor your kidney function during treatment . how topotécan actAVIs is given topotacan
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side - effects : infections ( very common : may affect more than 1 in 10 people ): - fever - signs of your general condition including local symptoms , such as sore throat or burning sensation when urinating - severe stomach pain - febrile or diarrhoea ( rare : bowel inflammation called neutropenic colitis ) topotecan actavis may reduce your ability to fight infections ( rare in rare cases ). - lung inflammation ( rare may affect up to 1 in 1 , 000 people ), including difficulty in breathing - diarseminated or sputum ( a sign of a condition called stomatitis ) - a medical
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the expiration date refers to the last day of that month . keep the viall in the outer carton in order to protect from light . store in a refrigerator ( 2 - 8 ). do not freeze . after reconstitution and dilution chemical and physical stability of the concentrate has been demonstrated for 24 hours at 25  2 , and 24 hours below 2  8 , protected from light and protected from direct sunlight . in the event of difution in solutions for infusion ( nacl 0 . 9 % and glucose 5 %) has been recorded for 4 hours at room temperature ( 15 - 25 ) and in the case of exposure to temperatures of up to 25 ° c . from a
what topotecan actavis contains - the active substance is topotécan . each vial contains 1 mg or 4 mg of topotеcan ( as hydrochloride ). after reconstitution 1 ml concentrate contains 1 g of to potecan - - other ingredients ( excipients ) are mannitol ( e421 ), tartaric acid ( a type of hydroch chloric acid ) and sodium hydroxide . what totopotekan actavises looks like and contents of the pack topotacan activis is supplied in clear glass vials with grey bromobutylic stopper and aluminium seals with plastic flip - off caps , which are secured in a protective sleeve . the pack contains 1 vial , 1 vially or 5 vial ( 1 viall )
the active substance of rivastigmine hexal is rivassim . rivazastigmin belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson 's disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivizastigine works by blocking the enzymes that break down acetoline : acettingylcholcholineesterase and butyrylcholineSterase . by blocking these enzymes , the concentration of rastigemine enables levels of acetétylaline to be increased in the body , helping to reduce the symptoms of adult patients .
do not take rivastigmine hexal - if you are allergic to rivassimine ( the active substance in rivascamin heexal ) or any of the other ingredients of this medicine ( listed in section 6 ). - had a previous skin reaction suggestive of allergic contact dermatitis with rivizastigmin . if this applies to you , tell your doctor and do not taking rivage heXal . warnings and precautions talk to your doctor before taking rastigemine HExal and if any of these apply to you an alternative , alternatively , treatment with r - 3rd dose . patients with irregular or slow heartbeat should be evaluated before taking the medicine if they have an active stomach ulcer . difficulties in passing urine . seizures . asthma or severe respiratory disease . impaired kidney function
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . your doctor may slowly increase your dose depending on how you respond to treatment . the highest dose that should be taken is 6 . 0 mg twice a day . my doctor will regularly check if the medicine is working for you , and will also monitor your weight whilst you are taking this medicine . do not take riv astigemine HExal for more than three days . take the medicine pack with you so that you can easily describe what you have taken . taking this medication tell your caregiver that you are being treated with rivatidine heexal . to benefit from your medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . you may have side effects more often when you start your medicine or when your dose is increased . usually , the side effects will slowly go away as your body gets used to the medicine . very common ( may affect more than 1 in 10 people ) feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ), diarrhoea common ( might affect up to 1 in10 people ). anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling difficulty sleeping common ( will affect upto 1 in 100 people  ) tremor dizziness feeling sleepy or fainting diarrectum feeling sick( nausea ). common ( can affect upt ) headache stomach pain indigestion feeling tired , feeling weak 
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister . the expiration date refers to the last day of that month . store below 30 .
what rivastigmine hexal contains 64 - the active substance is rivassimine hydrogen tartrate . - other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ) and titanium dioxide (  e171 ) printing ink : shellac . each rivástigmin heXal 1 . 5 mg capsule contains 1 , 5 mg of rivattigmine the active ingredient is : each rvt 3 mg capsule contain 3 mg of the active substances rivustigmine each . the other ingredients of each v6 . 4 mg capsule is 4 . 6 mg of pure white rivostigine the other ingredient is gelatin and , titanium dioxide
what cabometyx is cabrometyux is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer when a specific anticancer medicine , called sorafenib ( s ) is not suitable . what scabomettingyx looks like and contents of the pack cabômetyxx blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the growth of cells and the development of new blood vessels that supply them . these proteins can be present in high amounts in cancer cells . cabmetychyx is for use in adults .
do not take cabometyx 45 - if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabrometyc : - patients with high blood pressure , or have had an aneurysm ( enlargement and weakening of a blood vessel wall ) or a tear in a wall of sass . - suffer from diarrhoea . recent or significant bleeding . surgery . within the last month , certain surgical procedures ( including dental surgery ). - people with inflammatory bowel disease ( crohn ' s disease or coccidioid ) prior to surgery , including dental implants . it is important to tell your doctor if cabômet
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will monitor you and adjust your dose . this will ensure that your treatment is fully effective and no serious side effects are observed during treatment . the recommended dose of cabometyx is 60 mg taken once a day . you should take cabrometyxx for at least 2 hours before you go to bed . take a tablet of robes with you and this leaflet so that they can easily describe what you have taken . how long to take - take ' cabômetyc for as long as your condition improves . - wait at least 1 hour before taking the medicine . swallow the tablet whole with some water . do not chew or break the tablet before swallowing . to make sure you have eaten all the tablets 
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you and will explain the potential risks and benefits of taking cabometyx with other medicines . sometimes your doctor may also give you other medicines to reduce your side impacts . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : symptoms include pain in the abdomen , nausea ( feeling sick ), vomiting , constipation , fever and / or a gastrointestinal perforation ( a hole developing in the stomach and intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stomachs , red or black stools , or cough . these side effects may be serious . if they happen , tell your endocrinologist or pharmacist . reporting of side effects 25 
what cabometyx contains the active substance is cabozantinib ( s )- malate . cabombometych 20 mg tablet contains cabazantine (  ) ( as malate 20 mg ) cabonzantib . the tablet is a 40 mg tablet containing cab zantinerinia ( h ) + malate 40 mg cabantininid . each tablet of cabrometyck 60 mg tablet includes cabolinib( s) + ( as a malate 60 mg ), cabonetinir . its ingredients are microcrystalline cellulose , lactose anhydrous , maize starch , glucose - free skimmed milk . what a cabômetyX looks like and contents of the pack 
pemetrexed hospira is a medicine used in the treatment of cancer . pemetreexed hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . when pemetreexed hompira was given in combination mit cISplatin for the initial treatment of patients with advanced stage of lung cancer : pemetreced houpira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy ; pemetreed
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreexed or any of the other ingredients of this medicine ( listed in section 6 ). -if you plan to continue breast - feeding during treatment with pemetreexed hompira please tell your doctor if a vaccine against yellow fever is recommended . warnings and precautions talk to your doctor or hospital pharmacist before receiving pemetreced houpira as you may already be receiving treatment with Pemetrex hospria . if your doctor determines that you have problems with your kidneys , talk to you doctor or hospitals as you will be given pemetrexxed infusion . before each infusion you will have samples of your blood taken to evaluate if there is enough medicine in your body to work properly . your doctor may decide to check your kidney and liver function and
the dose of pemetrexed hospira is 500 milligrams for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your area , and your doctor will use this body surface area to workout the right dose for you . this dose may be adjusted , or treatment may be delayed depending on your blood cell counts and on your general condition . a hospital pharmacist , nurse or doctor will have mixed the pemetreexed hospi powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection before it is given to you , in a healthcare facility . you will always receive pemetreexed hompira by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetreced houpira in combination with
like all medicines , this medicine can cause side effects , although not everybody gets them . you must contact your doctor immediately if you notice any of the following : fever or infection ( common ): if your medicine has a temperature of 38oc or greater , sweating or other signs of infection ( since you might have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if caught early , you may start feeling chest pain ( common in patients with a fast heart rate ), pain , redness , swelling or sores in your mouth ( very common in people ). allergic reaction : - skin rash ( common with burning or prickling sensation ) or fever ( common among patients with skin reactions ) - death - chest pain or a high temperature ( common for patients with severe skin
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . when prepared as directed , chemical and physical in - use stability of recombinant dilution of infusion solutions of pemetrexed was demonstrated for 24 hours at refrigerated temperature . the reconstructed solution must be used within the manufacturer ' s instructions . parenteral medicines : do not store pemetreexed hospira in the original package because it would be unlikely that discolouration prior to administration . you must dispose of this medicine correctly , any unused solution must go to the hospital .
what pemetrexed hospira contains the active substance is pemetreexed ( as pemetreuxed disodium hemipentahydrate ). pemetreexed hompira 100 mg : each vial contains 100 milligrams of pemetreXed (" as pemeterxeded disonnaissance hemitahydrate "). pemeterexed
ganfort contains two active substances , bimatoprost and timolol , which work together to reduce pressure in the eye . bimataprostic belongs to a group of medicines called prostamides and is a prostaglandin analogue . timimololl belongs to the group of drugs called beta - blockers . it helps to keep the eye moist . your doctor has prescribed ganfordt because it delivers a clear , watery liquid that is constantly being drained out of the eye each day . this helps to lower pressure in your eye and help to prevent glaucoma . you should keep using ganft eye drops every day to reduce high pressure inthe eye , and help prevent gout .
do not use ganfort eye drops - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of ganforce ( listed in section 6 ) - for respiratory problems such as asthma , severe chronic obstructive bronchitis , or severe lung disease which causes wheeziness or difficulty in breathing , particularly if after long - standing cough - to - heart problems such low heart rate , heart block or heart failure warnings and precautions before using this medicine , tell your doctor if : you have or have had coronary heart disease ( symptoms can include chest pain , wheezing , difficulty in sleeping , breathing difficulties or long  standing cough you have heart problems ( such as low heart speed , shortness of breath , cough with or without pain
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended treatment is one bottle in each eye . use in adults : take the bottle at the same time each day , for example , one in the neck . 5 . wash your hands . do not touch the area where you have ganford . your doctor will show you how to use it . if your medicine is not working , please read the section " instructions for use " at the end of this leaflet . 1 . before using ganforcet , wash your hand . tilt your head back and look at the ceiling . 2 . pull down your lower eyelid until there is a small pocket . 3 . gently squeeze the bottle to release the medicine into your eye , so that it can be easily opened . 4 . close
like all medicines , ganfort can cause side effects , although not everybody gets them . you can usually carry on taking the drops , even if you are not sure . the following side effects have been reported with ganford ( multi - dose or single - dosage ): very common side effects ( may affect more than 1 in 10 people ) - the eye redness . common side effect ( may effect up to 1 in 9 people ), 100 - a feeling of the eye burning , itching , pulling , irritation of the conjunctiva ( the transparent front part of the eyes ), sensitivity to light , eye pain , sticky eyes , dry eyes - feeling of something in the eye , small break in the vision , blurred vision . reporting of side effects 25 if your child gets any side effects talk to your doctor or pharmacist . this
keep out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . use immediately or store in the original package in order to protect from light . eye infections should be treated within 4 months after first opening . discard any unused solution completely . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost , 0 . 3 mg / ml solution for injection , in a vial containing timolol . each bottle contains 5 mbq of titmololl maleate at a concentration of 6 . 8 mg . -the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate . what g ganforce looks like and contents of the pack ganft is a clear , colourless to slightly yellow eye drop ( opalescent ). ganfast is supplied in sachets ( s ) of a plastic bottle . the bottles contain 1 , 3 or 4 single -
gefitinib mylan contains the active substance gefitineb which blocks a protein called ' epidermal growth factor receptor ' ( egfr ). this protein is involved in the growth and spread of cancer cells . gefiteinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan - if you are allergic to gefit inib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking gefiteinib melan : - have any other lung problems . some lung problems may get worse during treatment with gefitINib Mylan . talk to you doctor if this applies to you . - you have ever had problems with your liver . your doctor may want to change the dose of gefitib iniban mylan ( see section " gefitnib " below ). children and adolescents this medicine is not recommended for patients aged under 18 years . other medicines and gefitInib tell your doctor , pharmacist or nurse if they are taking , have recently taken or might take any other medicines . tell your pharmacist or doctor 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one 250 mg tablet per day . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . you can take the tablet with or without food . if necessary , you may take an additional 250 mg dose if your doctor recommends it . take the tablets at about the same time each day , preferably at the same times every day ; - preferably on an empty stomach . alternatively , the tablet may be divided into 2 equal doses , leaving approximately 1 hour between each dose . drink the mixture straight away . this will make sure that you have drunk all of gefitinib mylan . it is important that you do not have trouble swallowing the tablets ,
like all medicines , this medicine can cause side effects , although not everybody gets them . talk to a doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction ( characterised by symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives / nettle rash , or difficulty breathing ). serious breathlessness ( sudden worsening breathlessness accompanied by a cough or fever ): this may mean that you have an inflammation of the lungs called ' interstitial lung disease '. this may affect up to 1 in 100 people who have taken gefitinib . severe skin reactions which may spread across the body , have been reported commonly ( may affect more than 1 in 10 people ). they may also include reddening , raised red or purple patches on the skin 
what gefitinib mylan contains - the active substance is gefiteinib . each film - coated tablet contains 250 mg of gefitineib ( as besilate ). - other ingredients are : lactose monohydrate , microcrystalline cellulose ( e460 ), crospovidone ( type a ), povidone( k30 ), sodium laurilsulfate , magnesium stearate , polyvinyl alcohol , macrogol 4000 , titanium dioxide (  e171 ), red iron oxide ( ileo ) and yellow iron oxide , all in the tablet coating . what geFITini B mylan looks like and contents of the pack gefitib melan tablets are pink , oval , biconvex film . they are 11 . 1 mm x 5 
reblozyl contains the active substance luspatercept and is used to treat myelodysplastic syndromes ( mds ). myelaodys plastic syndromes [ ms ] are many different blood and bone marrow disorders in which certain types of red blood cells become abnormal . signs and symptoms associated with a low red blood cell count ( anaemia ) are red bloodcell transfusions . reglazyl is used : to treat anaemic patients with mcs who need red blood blood cell transfusion , as well as erythropoietin therapies . to treat beta - thalassaemia ( b ): thylassaem is a blood problem caused by passed down through genes by a genetic process . it is caused by the way the cells work .
do not take reblozyl - if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) -if you : - are pregnant or planning to become pregnant ( see section " pregnancy and breast - feeding "). warnings and precautions talk to your doctor or pharmacist before taking this medicine - have thalassaemia or have had your spleen removed - had a blood clot - were on hormone replacement therapy - or have been advised to take preventive measures - especially when starting medicines to prevent a new blood clumping of a previous blood coagulation - suffer from high blood pressure . reglazyl should not be used to treat high blood tension . your doctor will advise you how to take a copy of the medicine . you should have your blood pressure checked regularly while taking
always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your doctor will carry out blood tests to check whether you are being given reblozyl . reglazyl is given as an injection under the skin . it is given to you by your doctor or nurse . how much is given your doctor may decide how much re Blozyl you need and how often . the injections will be given at a dose of 1 . 1 mg per kilogram of body weight . this dose will be calculated according to your blood pressure . to calculate the correct dose you will need to take . when rebzyl has to be given to your child for the treatment of myelodysplastic syndromes , the maximum single dose is 1 , 75 mg per kg of body weigh . in beta - thalassaemia the maximum simple
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , especially if only on one side of the body , blurred vision and / or symptoms of a stroke caused by blood clots swelling of the area around the eyes , face / lips , mouth , tongue or throat allergic reactions such as rashes and swelling of one part of the skin or the entire body . common side effects may include : swelling of any part of your body ; difficulty in moving or speaking sudden difficulty in speaking ; dizzien ; loss of equilibrium and coordination sudden changes in the way things taste ; nuttyness or weakness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl can be stored at room temperature ( up to 25 ) for up to 24 hours . from a microbiological point of view , the product should be used immediately . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains the active substance is luspatercept . each vial contains 25 mg or 75 mg of luspatiercept. after reconstitution , each ml of solution contains 50 mg of the active ingredient luspattercept ; the other excipients are citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ) and sodium hydroxide ( for solution for h adjustment only ). what reablozyn looks like and contents of the pack reglazyl is a white to off - white powder . reblezyl 25 mg and 75 mg lusparce is supplied in glass vials as single - use powder , in a vial . one pack contains one vial of powder ; one vially of rebzyl has been designed
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tivolinib works by slowing down the growth of the cancer and slowing the growth and spread of cancer cells , and opening new blood vessels . fotiva is used in adults with advanced kidney cancer who have not previously responded to other treatments , such as alpha or interleukin - 2 , but whose disease has not responded to the other treatments it is used for .
do not take fotivda - if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). - when taking st . john ' s wort ( hypericum perforatum ) - as a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking fotiva : - high blood pressure . fotivdas can raise your blood pressure so that your doctor can control your blood temperature more effectively . your doctor may prescribe a medicine , or you can take foivida to treat your blood tension . it is important that you also read the package leaflet for this medicine before you start taking foividas . this is to make sure that you have the correct dose . when to start taking a medicinal product for high blood tension
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg for every kg of body weight ( 21 mg ). you will take one capsule every day for 7 days . take 1 capsule each day . after this , you may take capsules for 4 days , at the same time each day ( at the usual time ). do not take more than one capsule each night . do not change the dose unless your doctor tells you to . if your doctor thinks you may have unacceptable side effects , or if severe side effects occur , your doctor may decide to stop fotiva therapy . for example , if the recommended daily dose of ftivdda for adults is 890 mg ( 21 g ) per day ( 7 g per day ) for 1 day
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure : this is a common side effect that may affect up to 2 in 10 people . tell your doctor immediately high blood tension : if you get symptoms such as severe headaches , blurred vision , shortness of breath , changes in your mental state or feeling anxious , confused or disorientated . your doctor will monitor your blood pressure while you are taking fotivda . high blood : it can be hard to tell whether it is affecting your blood or if it is not . a medicine to treat your high blood blood pressure may not be controlled well enough when you take fotiva , but it can make some changes in it . it is important to talk to your doctor if there is anything you can take to reduce the risk of side effects from taking foivid
what fotivda contains each hard capsule of fotiva 890 mg contains tivozanib . each capsule contains  tivonib hydrochloride monohydrate , equivalent to 890 milligrams of tivokaib ( as mesilate ).  the other ingredients are mannitol , magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( k29 / 32 ), yellow iron oxide (  321 ), propylene glycol ( a substance used to create strong ammonia solution ), titanium dioxide [ e 171 ], tartrazine aluminium lake ( ph - 171 [ pfizer ]), shellac , propyen glycol - 4 ( containing strong ammona solution in the form of in
stribild contains two active substances : elvitegravir , an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the effects of eelvisitabine , which is an antiregulatory medicine known alsinamec - a nucleoside reverse transcriptaser inhibitor ( nrti ) and tenofovir disoproxil , another antirétroviral medication known as a nuclear nucleic oxide reverse transcriptatasasse inhibition ( ndrtis ). sTRIbild is available as : as - as ' single tablet regimen ' for the treatment of human immunodeficiency virus ( hiv ) infection . strebild is not a cure for hiv
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , or tenofovir or tenofovar disoproxil , any of the other ingredients of this medicine ( listed in section 6 ) warnings and precautions talk to your doctor before taking sTRIbild . before starting treatment with any medicine containing ten ofovir disoproproxil your doctor will monitor your kidney function while taking these medicines . if the doctor determines that stricbild is appropriate for you , tell your doctor . do not give alfuzosin ( used to treat an enlarged prostate gland ) amiodarone , quinidine ( used for irregular heartbeats ) 47 dabigatran ( used in the treatment of blood clots ). carba
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : adults : one tablet each day by mouth , with or without food . adolescents aged 12 to less than 18 years : a daily dose of 35 mg must be taken twice daily by mouth ( one tablet in the morning and one tablet by mouth in the evening ). your doctor will tell you the dose to take . depending on how you respond to your medicine , your doctor may change the dose and adjust the dose . your doctor might also prescribe medicines called oral supplements ( antacids ) or laxatives containing minerals ( such as magnesium , aluminium , calcium , iron , zinc ) for up to 4 weeks ( see section 4 ). if this happens , stop taking stribild and tell you to
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood cholesterol sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether some of the unwanted effects are caused by stribild or by the hivi disease itself . however , some undesirable effects have been reported with sTRIbild . the hivie disease itself is an extremely serious side effect . report any side effects immediately to the doctor . lactic acidosis ( excess lactic acids in the blood ) is a common side effect of some hiv medications . it is more likely to occur during treatment with a strebild
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each sTRIbild film - coated tablet contains 150 mg of eelvisitegravar , 150 mg cobicISTat / 200 mg emmtricit abine / 245 mg tenovir désoproxile / 300 mg / ten ofovir diproxil fumarate / 36 mg , respectively . the other ingredients are croscarmellose sodium , and hydroxypropyl cellulose , lactose monohydrate , magnesium stearate ( e470b ). what steiger looks like and contents of the pack strebild is a white , round , biconvex ,
zyprexa contains the active substance olanzapine . zy prexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , with symptoms of excitement or euphoria . using zypréxa has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to ozanzapinе treatment .
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a wide swollen face , or swelln lips or shortness of breath . if this has happened to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before taking zy prexa and if any of your medical conditions indicate that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). take special care with zypréxa ask your doctor for advice if these apply to you as soon as possible . some patients with dementia have experienced serious side effects . medicines like these have been associated with unusual movements mainly of the face or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how many zyprexa tablets to take and how long you should continue to take them . the daily dose of zy prexa is between 5 mg and 20 mg . consult your doctor if your symptoms return but do not stop taking zypréxa unless your doctor tells you to . you should take your zypa tablets once a day following the advice of your doctor and take your tablets at the same time each day . it does not matter whether you take them with or without food . zyPrexa coated tablets are for oral use . swallow the zypresa tablets whole with water . do not chew , crush or break the tablets as they may have been crushed . patients taking zeprexа have experienced the following symptoms
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect more than 1 in 100 people ), especially in the legs ( symptoms include swelling , pain and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if any of these symptoms occur , contact your doctor or seek medical advice immediately .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle label after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . zyprexa should be administered to you within six hours of its preparation . you should return the bottle with some water . check with your pharmacist if you notice any change in the appearance of the tablets . these measures will help to protect the environment .
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains either 2 . 5 mg , 5 mg or 7 . 5, or 10 mg . the other ingredients are : - tablet core : shellac , maize starch , talc . - film - coating : lactose monohydrate , hoechst elbasvir , crohn ' s pod , microcrystalline cellulose , magnesium stearate .- tablet coating - hypromellose , titanium dioxide , and carnauba wax . what kyprexа looks like and contents of your zypresa tablet pack : 2 , 3 . 4 mg / 5 mg ( corresponding to 7 , 7  . 7 mg ) or 10 %
what prolia is prolisia contains denosumab , a protein ( monoclonal antibody ) that attaches to another protein . osteoporosis can be a life - threatening condition if treatment with proloa makes bone stronger . it helps to keep the bone healthy . oestrogen is a hormone produced naturally by the body , which is needed for bones to work properly . when the menopause comes on, oesterogen level drops , and the bones become thin and fragile . this can result in osteopororosus . people with osteoposserosis may also develop if they are treated with testosterone or glucocorticoids , but osteoponomics is not a cure for symptoms .
do not use prolia - if you have low calcium levels in the blood ( hypocalcaemia ). - are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using proloa . talk to you doctor before using any of your medicines . do not take prolions if any of these apply to you . if your doctor thinks you may be at risk of developing a skin infection . tell your doctor straight away if it occurs . symptoms include a swollen , red area of skin usually affecting one leg , which feels hot or tender ( cellulitis ). symptoms include fever . these symptoms may be due to an allergy to latex . the needle cover on the pre - filled syringe contains a
always use prolia exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one pre - filled syringe of 60 mg ( 4 injections ) given 6 weeks apart as a single injection under the skin ( subcutaneous ). it can be injected into the thighs , abdomen or upper arm . where to inject prolisa the doctor or nurse will have put stickers on the sachets , calcium and vitamin d supplements to help you remember to inject it . if your doctor decides to keep using prola for as long as your treatment with proloa is safe , it is important that you keep using the pre  six / snester . do not try to inject yourself if it is not clear and colourless or if there
like all medicines , this medicine can cause side effects , although not everybody gets them . prolia may cause skin infections ( cellulitis ). tell your doctor immediately if you develop any of these symptoms while being treated with proloa : - if your doctor notices that you have swollen , red area of skin on your leg or feels hot and tender , which may be symptoms of fever when being treated at the hospital , - when you have pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw / discharge , feeling of numbness or a feeling of warmth in the hand , or loosening of a tooth . these may be signs of bone damage in the hands and feet . as with all medicines the side effects listed below have been observed with prolaminium : common ( may affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . before using your pre - filled syringe you may store it below 25 for a single period of up to three months . at the end of this period the injection must be used within 25 days or disposed of . you must use within 30 days of first use . discard this medicine if not used within this period . it is recommended that you record the date when prolia is first removed from the refrigerator and the date after which it should be discarded . any unused product should be returned to the pharmacy or bottle .
what prolia contains - the active substance is denosumab . 1 ml solution for injection contains 60 mg of denosomab ( 60 mg / mL ). - other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prologia looks like and contents of the pack proloa is a clear , colourless to slightly yellow solution . it is supplied in a ready - to - use pre - filled syringe with a needle guard .
ambirix is a vaccine used in infants , children and adolescents from 1 year up to and including 15 years to prevent two diseases : hepatitis a and hepatis b . infection with the heptis al virus can cause the liver to become swollen and inflamed by the virus . the virus can be seen in almost any infected person , but the virus is not known to be present in faeces , serum or saliva . symptoms can occur from 3 to 6 weeks after infection . you may feel sick , have a fever , aches and pains and may be very severe or life - threatening . ambirx is for use in adults , adolescents , and children aged 1 year to less than 15 years . this is because in this age group , you may not be able to fight two diseases
do not receive ambirix if you are allergic to ambirx or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if this has happened to you , tell your doctor immediately . an allergic response has been seen with any vaccine against hepatitis a or hepatis b diseases . you have a severe infection with a high temperature ( over 38 ). if the vaccine does not work well enough , or you have another infection such as a cold should not be a problem , but talk to your doctor first . warnings and precautions talk to you doctor , pharmacist or nurse before you receive amburix . ambirice will not protect against a type of hep a and b infection that has been within
your doctor or nurse will give you ambirix as an injection into a muscle , usually in the upper arm . ambirx is given into  a vein . the injection will be given into the thigh muscle . you will receive a total of two injections . if you miss one or two of the injections within 12 months , you will be told when to have the second injection . at least six months after the first injection , the second injecting will be in between 6 and 12 months after your first injection and will be discussed with you . your doctor will decide whether you need extra doses or future booster dosing . up to two more injections may be needed . it is recommended that you do not miss a scheduled dose . when two injection sites are given , it is important that you follow the instructions from your doctor , pharmacist or nurse so that your doctor can decide when
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing ; a sudden drop in blood pressure , and loss of consciousness . other side effects include those that have been reported during clinical trials with ambirix : common ( may affect up to 1 in 10 people ) headache loss of appetite feeling tired or irritable pain in hands or feet , dizziness , confusion or disorientation . uncommon ( may effect up to1 in 100 people ). you may feel dizzy or faint . you may also feel dizzier or more easily fatigued . side
what ambirix contains 26 the active substances are : hepatitis a virus ( inactivated ) 1 , 72 x 720 ( elisa units ) hepatis b surface antigen , 20 micrograms / ml . the other ingredients are ; human diploid ( mrc - 4 ) cells ; aluminium hydroxide , hydrated 0 . 05 milligrams al3 + ( produced in yeast cells of saccharomyces cerevisiae ) and aluminium phosphate 0. 4 millilitres al3. the other ingredient is sodium chloride . what ambilix looks like and contents of the pack suspension for injection ( injection ) in a pre - filled syringe . ambirx is a white , slightly milky liquid .
bexsero is a meningococcal group b vaccine . bexxserso is given to protect against the bacteria neisseria meningeritidis group  B . you will be given bex serro in the second week of your 2nd week , to prevent disease caused by the naeisseris meningitidic group a bacteria . these bacteria cause infections in the form of meningitsis ( inflammation of the covering of the brain and spinal cord ) and sepsis ( blood poisoning ). when a person is given the vaccine , the immune system ( the body ' s natural defences ) will produce its own protection ( antibodies ) against the disease .
you should not receive bexsero if you are allergic to a substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before receiving bexSero and if any of these apply to you , tell your doctor , pharmacist or nurse . you have a severe infection with a high temperature ( over 38 ). if this applies to you then vaccination will be postponed until you have recovered . a minor infection , such as a cold , should not be a problem , but talk to you first . your doctor will postponing the vaccination until you know . have haemophilia or any other problem that may prevent your blood from clotting properly , for example if your doctor thinks you may be given blood thinners ( anticoagulants ), or if treatment has
bexsero is given as an injection of 5 micrograms into a muscle of the upper thigh or upper arm . the number of injections you will receive is based on your age and body weight . your doctor , pharmacist or nurse will calculate the dose you will need . from 2 to 5 years of age , you will have three injections of the vaccine . you may receive an additional injection ( booster ) after the first injection . it is important that you follow this advice carefully . if you miss an appointment , make another appointment as soon as possible . please speak to your doctor about when you should have the first dose of bex serro . however , if it is within 1 month of the last dose , the interval between injections should be kept at 2 months and be adjusted accordingly . this may be given as a booster . doses of 12
like all vaccines , this vaccine can cause side effects , although not everybody gets them . when bexsero is given to your or your child , the following side effects may occur : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the inject site ; swelling of the flesh at the site of injection ; hardness at or below the skin on the injection spot . common ( might affect up to 1 in 100 people ). not known ( frequency cannot be estimated from the available data ) : hardness of skin at or near the injection place . side effects reported with this vaccine in children and adolescents : adults and children aged 1 to 10 years include : fever ; loss of appetite . not known : frequency cannot vary from the child ' s body temperature . reporting of side effects 25 if
what bexsero contains the active substance is recombinant neisseria meningitidis group b nhba fusion protein . 1 , 2 or 3 ml contains 50 mg reconstituted nеisseriia meringitididis group group c nada protein , 1 mmol ,2 mL or 3ml containing 50 mg of recominant noreisserian meningidia maningititidas group a fhbp fusion proteins . 2 , 3 - 50 mg concentrate concentrates rerecombinated nneisseisserida meningeritidudis - group d fbp protein - 1 mpa . 3 remd - 3 50 mg protein remanufact
nitisinone mdk contains the active substance nilinione . this medicine is used to treat adults with a rare disease called hereditary tyrosinemia type 1 in adults , adolescents and children ( in any age range ). in this disease your body is unable to completely break down the amino acid tanyrosine ( amino acids are building blocks of our proteins ), forming harmful substances . the harmful substances are accumulated in your body . nitsinone is one of the many substances in this medicine , causing tyingrosine to build up in the body , leading to low tychrosine and phenylalanine ( another amino acid also ) content .
do not take nitisinone mdk if you are allergic to niitisINone or any of the other ingredients of this medicine ( listed in section 6 ). do not breast - feed while taking this medicine , and tell your doctor if there is anything you do not understand . pregnancy and breast  - feeding do not use nitsinone madk during pregnancy unless your doctor has told you to . do not stop taking natisinine mndk unless you have been carefully trained by your doctor to avoid contact with the eyes . warnings and precautions talk to your doctor before taking a dose of nitzisinon mk . if your doctor thinks you may have red eyes or are planning to stop nisino treatment , consult your doctor immediately for an eye examination . eye problems may occur more often in patients
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . treatment with this medicine should be started and supervised by a doctor experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 mg per kg of body weight once daily . the recommended daily dose is 20 mg per kilogram of bodyweight once daily ( see table below ). your doctor will work out the right dose for you based on your child ' s weight . this patient population is calculated by the doctor using the following formula : patients who are unable to swallow the capsules and who are not able to swallow them . alternatively , they may take the capsule with a small amount of water or formula diet just before or after taking nitisinone mdk . if this happens
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . nitisinone mdk can be stored for up to 2 weeks at a temperature not above 25 . keep the blister in the outer carton in order to protect from light .
what nitisinone mdk contains - the active substance is niitisine . nitsinone one mk 2 mg capsules contains 2 mg natisinine - nităisinon mcg - 1 . 5 mg capsule : each capsule contains 5 mg nettitisINone . the capsules of nitzisinonce mmdkin 10 mg capsule ( each capsule has 10 mg / ml of nettisino ). - other ingredients : capsule content : gelatin , titanium dioxide ( e171 ), black iron oxide ( ilead ), shellac glaze what a capsule looks like and contents of the pack nitchisinONE mndk capsules are hard gelatin capsules with " nITisin1 " printed on one side
the name of the medicine is docetaxel accord . docetaxil is a substance derived from the needles of yew trees . didcetaxell belongs to the group of anti - cancer medicines called taxoids .. doceaxel acord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer . gastric cancer or head and neck cancer : - for the diagnosis of advanced breast cancer, docetal accord could be administered either alone or in combination with doxorubicin , or trastuzumab , and capecitabine . - für the treatment or prevention of early breast cancer or lymphoma , in adult patients with lymphoblastomum .
docetaxel accord should not be used : - if you are allergic ( hypersensitive ) to docetaxil or any of the other ingredients of docetastel accord ( listed in section 6 ). - because the number of white blood cells is too low . - as a precautionary measure , your doctor will check that you have enough blood cells and sufficient liver function to receive docetal accord . before each treatment with docetaxiall accord, you will have blood tests to check that your liver is working properly . warnings and precautions before each injection of doceaxel agreement , you may not be given the medicine if : you have been told that you do not have white blood cell disturbances , which may cause fever or infections . tell your doctor immediately if your condition is not being controlled . you have abdominal pain or tenderness , diarrhoe
docetaxel accord will be administered to you by a healthcare professional . usual dose the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m2 ) and will determine the dose you should receive . method and route of administration docetaxil accord is given by infusion into one of your veins ( intravenous use ). the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . the dose may vary depending on your blood tests , your general conditions and your response to docetal accord . in particular , please inform your doctor in case of diarrhoea , sores in the mouth , feeling of numbness or pins and needles , fever and give her / him results of your blood
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord alone are : decrease in the number of red blood cells or white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . in most cases the severity of adverse events of docotaxel may be increased . docetaxil accord may be given in combination with other chemotherapeutic agents . during the infusion at the hospital the following allergic reactions are reported : very common ( may affect more than 1 in 10 people ): flushing , redness , burning and rash . common ( might affect up to 1 in every 10 people in): congestion in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of the vial after exp . the expiration date refers to the last day of that month . store below 25 . keep the vially in the outer container in order to protect from light . after dilution , the medicine should be administered immediately and not stored in the refrigerator . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 6 hours below 25 for the first use . when infusion - related storage times are the u / v controlled controlled by the dl , and the infusion solution should be used immediately after preparation . in / outgoing non - pvc bags , once removed from the refrigerator and allowed to
what docetaxel accord contains - the active substance is docetaxil . each ml of concentrate for solution for infusion contains 20 mg of docetaaxel - 1 mL concentrate contains 20 g of doceaxel and 4 m / m3 concentrate contains 80 mg of doncetaxell . one 8 mlitre vial concentrate contains 160 mg of didcetaxe - -the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 ) and citric acid anhydrously . what docetaxel accord looks like and contents of the pack docettaxeel acord concentrate for concentrate for infuse - this medicine is a clear pale yellow to brownish - yellow solution . it is supplied in glass vials . the vial contains : polysorbates 80 mbq , water for
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the brain . your doctor has prescribed this medicine because you are more impulsive or hyperactive than usual . you should have been trained by your doctor before taking this medicine . it is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately controlled with current stimulant medication . current medication does not reduce or prevent adhd symptoms . the medicine should be administered in combination with a treatment programme called psychological therapy , educational therapy and social therapy . intunev has been shown to improve the ability of people to control adhd and to reduce the risk of adhd in adults .
do not take intuniv : - if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine :- - patients with low or high blood pressure . - people with heart problems . tell your doctor before taking intunev if any of these apply to you . heart problems may occur . you should tell your physician immediately if this applies to you and do not follow the advice given . some patients have fainted recently after taking infusion , or have had thoughts or feelings of suicide . please tell your employer if your doctor tells you to stop taking inunivi . any other psychiatric conditions can develop withdrawal symptoms . increased heart rate or high heart pressure can occur when taking this medicinal . your
your treatment should be initiated under the supervision of a doctor experienced in the treatment of geriatric adolescents with adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor if you are not sure . your treatment will be initiated in a hospital or clinic . the recommended starting dose is 1 tablet per kilogram of bodyweight . after the first week of treatment , the usual dose is 0 . 05 mg per kilogram ( kg ) of body weight . starting treatment once every 1 week , your doctor may increase the dose to 0. 12 mg per kg of bodygewicht . during the first month of treatment ( 1 to 7 days ), your doctor will decide if and when you should stop using intuniv . it is recommended that you take intunev for as long as your physician prescribes it for you , as
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , do not stop taking your medicine and talk to your doctor . serious side effects tell your doctor or pharmacist straight away if any of the following side effects occur : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of conciousness ( syncope ), which is a serious withdrawal side effect . high blood pressure , which may cause symptoms such as headaches , being confused , nervousness , agitation , or tremors ( hypertensive encephalopathy ). the following other side effects have also been reported : common side effects ( may affect up to 1 in 10 people ): diarrhoea , stomach pain , vomiting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . keep the tablets in the blister pack in order to protect from moisture .
what intuniv contains 1 - the active substance is guanfacine hydrochloride . 1 mg of guantunfacina per 2 ml solution for injection contains guanifac hydroch chloride corresponding to 2 mg of the active ingredient , guangfacan . 3 mg of solution for guinfaace hydrochchlorides corresponding à 3 mg / mL of GUanf acine . 4 mg of pure guansfacate hydrochchromide resulting in 4 mg guANface . - intunev contains hypromellose 2208 ( e464 ), methacrylic acid - ethyl acrylate copolymer , lactose monohydrate , povidone ( k25 ), 
ecalta contains the active substance anidulafungin . it is used to treat adults ( aged 1 to 18 years ) with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis when the infection is spread by fungal cells called candida , which are called echinocandins . these medicines help to control serious fungal infections caused by the formation of fung cell walls . eCALta is used when fungal cell walls become damaged or do not work properly . the active ingredient in ekalta binds to the dna of fungen , including ecg - a - fungal - colony stimulating factor ( egf - 1 ) and stimulates the growth of fungelatinous cells . some fungal cultures have incomplete or defective cell walls
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , or caspofungin acid , any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or nurse before using eCALta and during treatment : - check with your doctor , pharmacist or nurse if : you have problems with your liver function you have liver problems at the start of your treatment . you will be given anaesthetics during your treatment with echelta ( see section 4 ). during treatment with the ecta you may experience an allergic reaction which may include itching , wheezing , and blotchy skin ( known as an infusionrelated reaction ) which may appear as a rash , hives , it
the treatment will be started by a doctor who is experienced in the care of patients with kidney disease . the recommended dose is 200 mg twice a day ( a total of 100 mg per kg of body weight ) given once a week . use in children and adolescents ( aged 1 year to 18 years ) the recommended dosage is 3 . 0 mg twice daily . your doctor will decide the dose of 200 mg and 1 . 5 mg twice weekly based on the patient ' s weight . how ecalta is given eCALta will be given to you in a slow infusion ( s ) through a drip into a vein ( intravenously ) over a period of 1 , 5 minutes . each 3 hour period will be repeated if necessary . depending on the loading dose , the patient may vary depending on how much ecalcta you are
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking ecalta and tell your doctor immediately if you notice any of the following serious side effects you may need urgent medical attention : potentially life - threatening allergic reactions such as difficulty breathing , wheezing or an existing rash . eCALta may cause serious side impacts including convulsion ( seizure ), flushing , rash ( pruritis ), itching , hot flush , or hives , sudden contraction of the muscles , coughing / difficulty of breathing other side effects include : very common side effects ( may affect more than 1 in 10 people ): convulsive behaviour ( seizure or convulsed state ), rash or rash in elderly patients ( elderly ), diarrhoea , nausea 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . if the reconstituted solution is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user . however , the infusion solution can be stored at room temperature ( up to 25 ) for up to 48 hours , or for upto 48 hours at roomtemperatur ( 15 - 25 ).
what ecalta contains - the active substance is anidulafungin . one vial of powder contains 100 mg of anidulatefungin ( as monohydrate ). - other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid . what a echelta looks like and contents of the pack eCALta is presented as a powder for concentrate for solution for infusion . the powder is white to off - white . pack size of 1 vial containing 100 mg concentrate for concentrate .
adynovi contains the active substance rurioctocog alfa pegol and pegylated human coagulation factor viii . factor ixi is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , lack of factor  vii is not a problem . aadyingnovi is used for the treatment and prevention of bleeding in adults , adolescents and children aged 12 years and above with haermophilica b , an inherited bleeding disorder caused by lack offactor viiis .
do not use adynovi if you are allergic to rurioctocog alfa pegol , octtocogg alf a or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor before using aynovide . warnings and precautions talk to your doctor or pharmacist before using this medicine : if your child is allergic to any of these ingredients , talk to their doctor before you are given aadonovi as they may increase the risk of developing an anaphylactic reaction ( a severe , sudden allergic reaction ) to adenovi ( see " allergic reactions " in section 4 ). early signs of allergic reactions may include rash ( up to 95 ), hives , wheals , generalised itching , swelling of lips and
treatment with adynovi will be started by a doctor who is experienced in the care of patients with haemophilia a . always use adeynovide exactly as your doctor has told you . check with your doctor if you are not sure . treatment of bleeding your doctor will determine the dose of aadyingnovi you should receive . usually , the replacement therapy with kadyni is a life - long treatment . your doctor should continue to use this medicine until you have reached the recommended dose . prevention of bleeding the usual dose of the usual starting dose of an aynovin is 40 to 50 iu per kg body weight , given every 2 weeks . to prevent bleeding the dose or duration of  10 - 10 minutes should be done . the dose recommended for adults is based on your body weight and the factor vii
like all medicines , this medicine can cause side effects , although not everybody gets them . if severe , sudden allergic reactions ( anaphylactic ) occur , the injection must be stopped immediately . you must contact your doctor immediately if you have any of the following early symptoms of allergic reactions : - rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , cough , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . severe symptoms , including difficulty in breath and fainting , require prompt emergency treatment . patients who have received previous treatment with adynovi may experience similar symptoms . these reactions are usually mild to moderate and do not last for a long time . however , patients who are unable to sleep and who are unwell may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . after first opening , the powder vial may be stored at room temperature ( up to 30 ) for a single period not exceeding 3 months . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 , or 2000 iu rurileocta pego . the solvent vial is then diluted in 5 ml sterilised water for injections . ingredients : mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrate and tris ( hydroxymethyl ) amenomethane , polysorbate 80 and sterile water for injecting . what  adeynovis looks like and contents of the pack aadyeri is
rekovelle contains follitropin delta , a feollicle stimulating hormone ( fsh ), which belongs to the family of hormones called gonadotropins . gonadotrophins are involved in the development of female infertility in women in need of assisted reproduction programmes . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection : the ovaries produce many egg sacs which are then released into the womb .
do not use rekovelle if your fertility problems are not well controlled . - if you are allergic to follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) - the effect of recovelle on your fertility is not known - this medicine may not be suitable for you . warnings and precautions talk to your doctor before using revelle : - you have a tumour of the uterus ( the ovaries that contain the breasts , pituitary gland or hypothalamus ) or have enlarged oocytes - your doctor may want to check your ovulation status - these may be signs of cysts on your  Ovaries ( also known as polycystic ovarian disease ). - bleeding from the vagina after an early menopause - or malformations of
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will tell you how much rekovelle you should use and for how long . the recovelle dose will be calculated for you during your first treatment cycle . it will be injected by a doctor who is experienced in the use of anti - millerian hormone ( hcg ). if your ovaries have been stimulated by stimulation with gonadotropins , the dose will vary depending on your body weight . a blood sample will be taken in the last 12 months of treatment to help you remember to use it . this is to measure your body weigh before you start treatment and to measure how well the medicine is working . how often you should have treatment if the dose is needed , your body size will be measured at the start of treatment . you
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects due to the high levels of hormones involved in infertility have been reported in women taking this medicine . they may be due to a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms may include pain or discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain , and difficulty breathing . if you notice any of these symptoms you should immediately contact your doctor . another side effect may occur with rekovelle . common ( may affect up to 1 in 10 people ): headache , or nausea ( ovulation syndrome is an uncommon occurrence in women ) ovary hypersmulation syndrome may occur in men . it can also occur in women when the follicle
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution the solution is stable for up to 25 days when stored at a temperature below 25 . from a microbiological point of view , the product should be used immediately . if not used immediately the product is to be used within 3 hours . once removed from the refrigerator it must be used or discarded . for a single period of up to 28 days from the date of the first use , it must not be longer than 25 days at room temperature . any unused solution must be discarded after the first administration . medicines should not be disposed of via wastewater or household waste . ask your
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 micrograms of flollitropIN delta in 0 . 6 millilitre of solution or 0. 36 milliliter of solution corresponding to 33 . 3 mg of  FollitropIn delta in each millimetre of solution. the other ingredients are : phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrate and concentrated phosphoric acid , water for injections . what retinol looks like and contents of the pack rekorelle is a clear and colourless solution for injection in a single use cartridge . pack size of 1 cartridge and 3 pen injection needles 
the active substances of revinty ellipta are fluticasone furoate and vilanterol . two different active substances in revinting elliрta : fluticasesone furóate 92 mg and vanterol 22 mg : one ellipple contains fluticatone furoaieate 184 mg and also contains vilantérol 22 mg and more : two ellipases : 92 / 22 mm : each ellipagate is used for the treatment of chronic obstructive pulmonary disease ( copd ) and asthma in adults and adolescents 12 years and over . the 184 / 21 mg tablet is used to treat asthma in adult patients who weigh 12 kg or more . each 184g / 20 mg tablet contains 22 mg of the active ingredients in the treatment and for copd the other ingredients in reven
do not use revinty ellipta : if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not take ellippa and tell your doctor immediately . warnings and precautions talk to your doctor before using ellipinta do not try to use ellipita if any of these apply to you and tell them you are not sure . talk to you doctor before you use a pen for any reason . this is because ellipata has not been tested in patients with liver disease . it is possible that some of the side effects could be serious . if your doctor determines that you have moderate or severe liver disease the lower strength of revinny elipta is 92 / 22 ellipas . tell
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , nurse or pharmacist if you are not sure . how much to use asthma the recommended dose to treat asthma is one inhalation ( 280 micrograms of fluticasone furoate and 22 microgram of vilanterol ) once daily . if severe asthma occurs , your doctor may need to increase your dose . the higher strength inhaler ( 380 microgram / ml fluticasesone furorate and 20 microgram ( 480 microgram fluticassée and 22micrograms vilantérol ) is used twice daily , once daily for copd . when used for copD the recommended dosage for copde is one puff ( 850 microgram inhale fluticason furoates and 22 mg vilantesrol ). how to use revinty
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you get any of the following symptoms after taking ellipata stop using this medicine and tell your doctor immediately : skin rash ( hives ) or redness swelling , sometimes of the face or mouth ( angioedema ). becoming very wheezy , coughing or having difficulty in breathing , feeling weak or light headed , or having fits ( anaemia ). tell your anaesthetist if your condition gets worse or gets worse after using this medicinal product . your doctor may decide to keep you under closer observation or change your dose of revinty ellippa and tell you to stop using it . not known ( frequency cannot be estimated from the available data
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . 92 micrograms each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 92 mg fluticasesone furonate and 22 mg vilantéro ( as trifenatate ). 184 microgram ( the dosage leaving the stomach ) each single dose provides : 184 mg fluticsone furnaceoate AND 22 mg ( the equivalent of vilantesone ( as Trifenaboate ). the other ingredients are lactose monohydrate ( see section 2 ) and magnesium stearate . what revINty looks like and contents of the pack the ellipsy device is a light grey inhaler with a yellow mouthpiece cover and a dose counter . it is packaged in a pouch 
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and emtricitabine , another nucleolar side reverse transcriptataser inhibitor ( not nrrtis )) and the other active substances : dosing tenofovir , also known as a nucleopeniasе reverse transcriptor ( trt ). these active substances are also known to be antiretroviral medicines that work by preventing the activity of an enzyme ( reverse transcript ast ) that is essential for the virus to multiply . atripLA is a treatment for human immuno deficiencies virus ( hov - 1 ) infections in adults
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . take the number of tablets following your doctor ' s instructions . the dose is one tablet by mouth once daily . swallow the tablet whole with a glass of water . you can take atripla with or without food . do not take atrapla on an empty stomach . alternatively , take the tablets at about the same time each day ( for example , one day in the morning and one day at the same times every day ). do not split , crush or chew the tablet . if possible , you may experience some side effects ( e .g . dizziness , drowsiness ) while taking atriplap . your doctor will tell you how long you should keep taking atrippingla . when taking atraplap , your doctor
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of blood fats sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . possible serious side effects some patients have had lactic acidosis ( excess lactic acids in the blood ). this is rare ( may affect up to 1 in 1 , 000 people ) but serious side effect that can be fatal . the following side effects can be signs of lactic Acidoss : deep rapid breathing , drowsiness feeling sick ( nausea ), being sick ( vomiting ), stomach pain . if you think you may have lactic acidosis , contact your doctor immediately .
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atripLA film - coated tablet contains 600 mg of eef Avirenz ; 200 mg of it ; and 245 mg of its equivalent tenovir désoproxils ( as fumarate ). the other ingredients are croscarmellose sodium , the active ingredients are holocaust , magnesium stearate ( e572 ), microcrystalline cellulose and sodium laurilsulfate (  see section 2 " atriplap contains sodium "). the tablet film coating contains iron oxide black ( i . e ., iron oxide red ( a ) and iron oxide yellow ( b ).
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin , which stimulate the natural gonadotropin releasing hormone ( gnrh ). gndrh regulates and prevents release of gonadotropics , including follicle stimulating hormone ( fos ). gonadophagins are necessary for the growth and development of f - flollicles in the ovaries . ffolliculars are small round sacs that contain the egg cells . they are thought to be related to the floppy nature of the egg and so to stimulate the production of the mature egg cells in the mother ' s womb . orgalugatran is used in combination with assisted reproduction techniques ( such as in vitro fertilisation ( ivf ) and other methods .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - you are hypersensitive to gonadotrophin releasing hormone ( gnrh ) or a gngrh analogue . - your doctor may want to adjust your dose . warnings and precautions talk to your doctor , pharmacist or nurse before using orgaluntran allergic reactions if your dose is too low . you have an active allergic condition . your doctor will discuss this with you . in this case , you will require additional monitoring during treatment . allergic reactions may occur in people who have allergic reactions such as generalised or hives ( urticaria ), swelling of the face , lips tongue and / or throat , with difficulty in breathing or swallowing ( angioedema or an
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will decide the correct dose of orgalutran based on your body ' s body weight , and will explain the treatment in detail . women of childbearing age should use the preparation before they are born , as they should during assisted reproduction techniques , in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), or corifollitropin . on day 2 or 3 of each cycle , orgalugatran is injected under the skin ( subcutaneously ) on days 5 or 6 of each course . the preparations are made up in the laboratory and are given in controlled and validated aseptic conditions . different injection sites are available for daily treatment . depending on the type of
like all medicines , this medicine can cause side effects , although not everybody gets them . if you get a side effect , talk to your doctor , pharmacist or nurse . very common ( may affect more than 1 in 10 people ) local skin reactions , including redness and swelling . the local reaction usually disappears after 4 weeks . uncommon ( may effect up to 1 in 100 people ), headache nausea , malaise very rare ( may impact up to1 in 10 , 000 people , and may affect up to one in 10 000 people) allergic reactions : rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue ,and / or throat , which may cause difficulty in breathing or swallowing ( dyspepsia ), swelling of mouth , hands , feet , ankles , or feet ( angio
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . syringes should be stored in the original package to protect from light . clear , particle - free solutions should be used immediately after dilution .
what orgalutran contains - the active substance is ganirelix , diluted in 0 . 5 ml of acetic acid . -- the other ingredients are mannitol and water for injections . to adjust the ph , there are two different strengths of sodium hydroxide and acettic acid ( e524 ). what or galutran looks like and contents of the pack orgalurtran is a clear and colourless aqueous solution . the solution is clear to slightly opalescent and is used for subcutaneous administration . only the needle is cut from the stem of the needle . it is made of dry natural rubber / latex which may have been dissolved in the solvent . orgalugatran is available in packs containing 1 or 5 vials , each containing one vial .
what blitzima is bblitzIMa contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to the surface of a kind of white blood cell called " b - lymphocyte ". when ritsimaab sticks to this cell , the cell dies . what brilitzimа is used for billetima may be used for the treatment of several different conditions in adults . your doctor may prescribe bblastima for the following conditions : a ) non - hodgkin ' s lymphoma this is the disease of the lymph tissue ( part of the immune system ) that affects a certain type of whiteblood cell called b- lymphoocytes ; your doctor will prescribe  Blitzim , together with
do not take blitzima if you are allergic to rituximab , other proteins which are like ritzimabe , or any of the other ingredients of this medicine ( listed in section 6 ) if your doctor has told you that you have a severe active infection at the moment if this is because you have such a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before taking bblitzIMa : if the medicine is not working if : you have severe heart failure or severe uncontrolled heart disease , including granulomatosis , polyangiitis / microscopic polyangitis or pemphigus vulgaris . billetima may increase the risk of getting a hepatitis infection . it is important to make sure that you are checked for 
blitzima will be given to you by a doctor or nurse who is experienced in the use of this treatment . they will watch you closely while you are being given this medicine . this is in case you get any side effects . you will always be given bitzima as a drip ( intravenous infusion ). medicines given before each bblitzIMa administration before you are given a dose , you will be told by your doctor or hospital pharmacist if you are using blitima . your doctor may prescribe other medicines ( pre - medication ) to prevent or reduce possible side effects from your treatment , if necessary . if your doctor determines that you are at increased risk for non - hodgkin ' s lymphoma if the recommended dose is 4 mg . repeated treatment courses with billetima are possible . when you
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate but some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during or within the first 24 hours of the infusion you may develop fever , chills and shivering . less frequently , you may experience pain at the inffusion site , blisters , itching , sickness ( nausea ), tiredness , headache , breathing difficulties , blood pressure raised , wheezing , cough , fever and chills . not known : frequency cannot be estimated from the available data . some side effects may be severe and may require medical attention . tell your doctor if you experience any of these . common : may affect up to 1 in 10 people blisters and itching at the site of the injection
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light .
what blitzima contains the active ingredient in blituxima is called rituximabolic acid . the 10 ml vial contains 100 mg of ritsimab ( 10 mg / mL ). the 50 mml throughl contains 500 mg of of  Rituximiab (+ 10 mg/ mpa ). other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what brilitzimа looks like and contents of the pack bblitzIMa is a clear , colourless solution for infusion , supplied in glass vials containing 2 m , 50 x 1 mmol , glass vially .
roactemra contains the active substance tocilizumab , a so - called monoclonal antibody - 6 ( mabs ). this unique type of protein is found in many parts of the body and causes the inflammation in your body . rroaktemrea is used to treat symptoms such as pain and swelling in your joints . by doing so , it reduces the damage to the cartilage which forms the bone and cartilage in your joint after the disease has been caused by it . in adults , the use of r oact ema is indicated for the treatment of adult patients with moderate to severe active rheumatoid arthritis , an autoimmune disease , when previous therapies have not worked well enough or have not helped . the use in children and adolescents raactememrа can be used alone or
you must not be given roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). you have an active , severe infection that your doctor thinks is important . warnings and precautions talk to your doctor or nurse before you are given a dose of raactememrre . if any of these apply to you , tell the doctor or nurses giving you the infusion immediately . you may experience allergic reactions such as chest tightness , wheezing , extreme dizziness or light - headedness . swelling of the lips or skin rash during or after the infustion of the medicine . infection if your doctor suspects you have infections , contact your doctor immediately if : you feel unwell . the use of a racteema
roactemra will be given to you by a doctor or nurse , as an injection into a vein , by authorised healthcare professional or a nurse . your doctor or healthcare professional will supervise the intravenous infusion and will supervise your entire treatment . raacteemrana is given every 8 hours for 4 weeks . after 8 hours , ronactememrra is administered every 4 hours as a drip in the vein ( intraveous infusion ) over 2 hours . you will be supervised while being given rroactuema : once every 12 hours : 30 to 8 hours dose based on your body weight . the recommended dose of r oactamrre is given twice a day for up to 2 weeks as : through a drop in the blood stream ( intravenously infusion
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects may happen with raactememr : very common side effects ( may affect more than 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness ; rash , itching , or hives ; swelling of the lips , tongue or face ; serious infections , such as fever and chills , especially in the mouth and / or throat . uncommon side effects in children and adolescents : reporting of side effects 25 if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side
keep this medicine out of the sight and reach of children . do not use roactemra after the expiry date which is stated on the carton and label after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). keep the vial in the outer carton in order to protect from light . this medicine does not require any special temperature storage conditions . if you notice any change in the appearance of the tablets , please inform your healthcare professional that you are using rroaktemrarera .
what roactemra contains the active substance is tocilizumab . each vial contains either : 4 mg or 80 mg tocilizamab in 20 ml , or 10 mg / mL as a single - use vial . after reconstitution each mliter contains 200 mg toccizumabe ( 20 mg , 20 mg or 400 mg tochizumabat in 20 mg concentrate ). the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphata dihydrate and water for injections . what if you think you have been given too much raactemira , tell your doctor or nurse . how rroaktemrana is a concentrate for solution for infusion . r oact mrr
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it relaxes the muscles in the walls of the small air passages in the lungs . onbraz breezehaler is used to make breathing easier for adult patients who have breathing difficulties due to : a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten . this makes breathing difficult . when this medicine is used , it relax these muscles in your lungs and makes it easier for air to get in and out of the pulmonary airways to get into the  lung .
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using onbreezhalers if any of these applies to you . if your doctor thinks you may have asthma ( in this case you must not use this medicine ). talk to you doctor before using Onbrez
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is to inhale the content of one capsule each day . you only need to inhake once a day because the effect of the 150 microgram capsule lasts for at least one hour . your doctor may decide to increase your dose to 300 micrograms depending on how you respond to the treatment . always use your inhaler exactly as described in this leaflet and follow the instructions at the end of this leaflets . for 24 hours use onbrez breezhaler as an inhalation and capsules ( in blisters ) contain the medicine as inhalations powder . use the onbezhalers inhalers provided in this pack . in this package , you will find an inhaled dose of the medicine only for the capsule
what onbrez breezhaler contains - each onbre breezehaler 150 microgram capsule contains 150 microgramm indacaterol as indocaterol maleate . the other ingredients include lactose and the capsule is made of gelatin . - every onbriez breEZhaler 300 microgram hard capsule contains 300 microgramms inddacatrol as and indabacaterol femaleate , lacto and the cap is made from gelatin ( e420 ). what onbreezhaled looks like and contents of the pack onbezhalers inhaler is a white powder in a blister . each onbrezhaler delivers 150 microlitres of content as a single inhalation and each capsule is white . onbraz brezhahaler 250 micrograms hard capsules contain 300 microlitre ( 900 micro
clopidogrel hcs contains clodogrell and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood cluts forming ( a process called thrombosis ). clopdogral hecs is taken by adults to prevent blood globulosis ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed cloclopidegrel
do not take clopidogrel hcs if you are allergic to clopizil or any of the other ingredients of this medicine ( listed in section 6 ). if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if your doctor thinks this is too strong or not strong enough , tell your doctor . have severe liver disease . do not taking clodogrell hCSs : if any of these apply to you . warnings and precautions  before you take , or while you are taking , clodidogreil hs , you should tell your healthcare professional if : you have a risk of bleeding such amedical condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you have been told by your doctor that you have had
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if your doctor has decided that you should take clopigrel hacs , but if the patient is having severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogral hecs ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one75 mg tablet , three times a day , taken or divided . you
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if not treated , confusion ( see section 2 ' take special care with clopidogrel hcs '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the first signs of an allergic reaction . the most common side effects reported with clumping together with glibenclamide ( thrombocytopenia ). if any
what clopidogrel hcs contains the active substance is clopizigrel which is contained in the tablet core . each film - coated tablet contains 75 mg of clodogrell ( as hydrochloride ). the other ingredients are ( see section 2 ' clodegrel hics contain hydrogenated castor oil '): tablet core: microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castingor oil tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide [ e172 ], talc and macrogol 3000 . what ' cool things to look like and contents of the pack the film  - covered tablets are light pink , capsule - 
fetcroja contains cefiderocol , which is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics help the body to fight bacteria that cause infections . f et Croja is used to treat infections caused by bacteria when other antibiotics are not suitable .
do not take fetcroja - if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). - are allergicto other antibiotics such as cephalosporins . - have had a severe allergic reaction to certain antibiotics ( e . excipients , penicillins and carbapenems ). warnings and precautions severe skin peeling , swelling of the hands , face , feet , lips , tongue or throat , difficulty swallowing or breathing . you should not take the tablets , as there is insufficient experience of ftcrojo . have had any allergic reaction with other antibiotic medicines . tell your doctor or pharmacist if any of these apply to you . warningsand precautions talk to your doctor before taking f et Croja : 
this medicine will be given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it will take about 3 hours and may take 2 hours . your doctor will decide how many days of fetcroja treatment are needed . before infection , the doctor will check the severity of your infection and any pain you might experience during the ftcrojan infusion . this will take place in a separate hospital or clinic . patients with kidney problems if you have kidney problems then your doctor may decide to reduce your dose of  Fet Croja . the doctor may also decide to increase your dose if a higher dose is needed , depending on how serious your condition is . if your doctor thinks that your dose is too high , talk to your doctor or pharmacist . you may need to be treated with fеtcroj for as long as
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : severe allergic reaction - this may include sudden swelling of your lips , face , throat or tongue , as well as a severe rash or other severe skin reactions , including difficulty swallowing and breathing . this reaction may also include diarrhoea and stools that may contain blood or mucus . your doctor may decide to stop treatment and to give you medicines to slow bowel movement . tell your dentist straight away or go to the nearest hospital if it happens . other side effects include : very common side effects ( may affect more than 1 in 10 people ): - feeling sick ( nausea ) - vomiting - nausea - difficulty swallows or breathing - 
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of cefividerol . the other ingredients are sucrose , sodium chloride , and sodium hydroxide . what fertcroje looks like and contents of the pack fеtcroj is a white to off - white powder for concentrate for solution for infusion supplied in a glass vial containing 10 ml , which is packed in sachets .
depocyte is used to treat lymphomatous meningitis . lymphomatolus meningitsis is a condition in which tumour cells form in the membranes of the brain and spinal cord . depcyto works by inhibiting the growth of lymphoma tumour cells .
do not take depocyte : - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). - when you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with dep cell . you may experience symptoms related to the nervous system ( convulsions , pain , numbness , or tingling ), blindness / visual disturbances . if these symptoms occur , stop taking any depamethasone tablets and tell your doctor immediately . your doctor may decide to reduce the dose , temporarily or permanently , to reduce your unwanted effects . talk to your doctor if your side effects get worse or if they worsen or get worse . it is very important that you tell your caregiver that you are taking depcyto and ask your doctor for
there are strict laws on the use , handling and disposal of depocyte . it will only be used in special controlled areas where the medicine is known and should only be handled and given to you by people who are trained and qualified to use it safely . these persons will take special care for the safe use of depecocyte and will keep you informed of their actions . the storage details are as follows : for cancer - causing substances , such as lumber sac , depcyto is to be used by the health care professional . dep cell - related injections are to be performed by a healthcare professional , at the appropriate time . use in children and adolescents the following information is intended for the healthcare professional to ensure that adequate storage and appropriate storage conditions are followed : 1 . 5 ml water for injections in a vial ( 0 . 25 mL ) de
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss the possible side effects with you and will explain the potential risks and benefits of your treatment . the frequency of possible side events listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common (affects 1 to 10 users in 100 ) uncommon ( affect 1 to10 users in 1 , 000 ) rare ( affect only 1 to 5 users in 10 000 ). very rare (affects less than 1 to 0 . 5 users per 10 , very rare ) adverse events reported with depocyte in combination with other chemotherapeutic agents very common reported events ( affect more than1 user in 100 000 ), not known ( frequency cannot be estimated from the available data ): nausea vomiting weakness confusion fever headaches diarrhoea stomach upsets ( including nausea and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . depocyte can be kept at room temperature ( up to 25 ) for no longer than 4 weeks before use . keep the container tightly closed in order to protect from light . this medicine should not be used if you notice severe discolouration , a changed appearance or a defective container . once removed from the refrigerator , dep cell should be used within 3 - 6 weeks . it should not been used , but if the medicine is not used within 4 weeks , it should be discarded . another treatment of depcell is recommended . cytarabine should not always
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cychtarabin . one vial of 5 mL solution contains 50 mg / m2 of cyingtarabe . - other ingredients are : cholesterol , trioein , dioleoylphosphatidylcholine , dipalmitoylaphosphatidielglycerol , sodium chloride , water for injections . what depeocyte looks like and contents of the pack depcyto is a solution for injection and is supplied in 5 g of solution . it is supplied as a single injection in a multipack containing one vially .
what bemrist breezhaler is bem breezeezhalers contains two active substances called indacaterol and mometasone furoate . indabacaterol belongs to a group of medicines called bronchodilators . it relaxes the muscles of the small airways in the lungs . this helps to open the airways and makes it easier for air to get in and out of the . when it is taken regularly , it helps to keep the small lungs open . momeason furoates belongs to one of a groups of medicines known as corticosteroids ( or steroids ). corticostosterides reduce the swelling and irritation ( inflammation ) in the small Airways inthe lungs and so gradually ease breathing problems . corticotropoids also help to prevent attacks of asthma . what bemarrist
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor . if there is anything you do not understand , ask your doctor to explain . are allergic ? have heart problems , including an irregular or fast heartbeat . have thyroid gland problems . suffer from diabetes or high blood sugar . or have ever had seizures . you may be told that you have a low level of potassium in your blood . do not take bemmrrist brezhalers if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using this medicine . warnings and precautions talk to you doctor or nurse before using bemreist
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much bemrist breezhaler to inhale the usual dose is to inhalate the content of one capsule each day . you only need to use the medicine once a day , so you only use the dose once . do not use more than your doctor tells you to use . your doctor will prescribe the dose that is right for you , depending on your asthma and how your symptoms are controlled . use bemmrrist brezhalers at the same time each day and night . this will help to control your symptoms throughout the day andnight . it will also help you to remember to use it . - bem breezehaler is for inhalation use , which is for use at the right time of the
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects could be serious common ( may affect up to 1 in 10 people ) difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( may effect up to1 in 100 people !) swelling mainly of the mouth , tongue - lips - face and throat ( signs indicate angioedema ). other side effects include : very common ( might affect more than 1 in every 10 people people ). difficulty swallowing and / or breathing may be caused by swelling ofthe tongue / lips / face / throat ( possible signs of angio edemata ) other side effect that may occur while taking bemrist breezhaler ( signs include breathlessness and cough 
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after " exp ". the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store the capsules in the original blister in order to protect from light and moisture .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . each bemmrister breezehaler 125 micrograms / 62 . 5 microgram inhaler delivers 173 microgram ( mg ) of inddacatrol aate ( equivalent to 150 microgram of indeacaterolul ) plus 80 microgram( ml ) momeason furoates . the delivered dose ( the dose that leaves the mouthpiece of the inhalers ) is equivalent to 125microgram of idacetate and 62. 5micrograms of momeatasine furoat . bemreist  Breezhalers also contains 125 macrograms ( equivalent equivalent to 12 . 7 microgram )
zyllt contains the active substance clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). zylt is used to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , with an increased risk of atherathrombotic events ( such as stroke , heart attack , or death ). you have been prescribed zyllingt to help prevent blood
do not take zyllt - if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). -if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - in case you have severe liver disease . do not taking zylt if any of these apply to you . warnings and precautions if this applies to you or your child , tell your doctor before taking yllt and tell your healthcare provider if : you have an increased risk of bleeding such if your current medical condition puts you at risk of internal bleeding ( such as an stomach ulcer ). you have ever had a blood disorder that makes you prone to internal bleeding , such as bleeding inside any tissues , organs or joints of your body . this is called ' long q
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if your doctor has recommended that you take zylt for several days , you should take a tablet of 75 mg once at the start of treatment . then , the recommended dosage is one 7 - day tablet of 150 mg once daily ( 4 tablets of  60 mg ) once at bedtime . you should swallow the tablet whole . do not chew , break or crush the tablet . contact your doctor immediately , or go to the nearest hospital emergency department because of the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if not treated , confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the signs of an allergic reaction . the following side effects have been reported with zyllt mainly mild to moderate . they mostly occur during treatment . very common side effects ( may affect more than 1 in 10 people )
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clodogrell ( as hydrogen sulphate ). -the other ingredients are : lactose ( see section 2 under ' zyllingt contains lactoses '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( i171 ), red iron oxide ( EDGE ), talc and propylene glycol in the film . what kyllt looks like and contents of the pack the film- coated tablets are pink , round and slightly convex . boxes of 7 , 14 , 28 , 30 and 50 tablets are available . not
what lamivudine teva is lamivine the active substance in lamivane is lamevudines . what lamemiviludinе tva is used for lamuzine to treat long term ( chronic ) hepatitis b infection in adults . lamizine est a type of medicine that suppresses the hepatis - b virus and belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis). heptis ( b ) is a virus that infects the liver , causes long term( chronic ] infection , which can lead to liver damage ). lamijine can also be used in adults who have compensated liver disease during treatment with lamigane it reduces the amount
do not take lamivudine teva if you are allergic to lamivine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor or pharmacist before taking lamivaudinne toeva . taking lamevudines t Eva with other similar medicines may cause serious side effects , especially if they are taken in combination with other medicines . tell your doctor if this applies to you . you have ever had liver disease other than hepatitis c . if vous are seriously overweight ( especially : if your doctor considers you need extra check - ups ). you may need extra checks if necessary to take your medication . see section 4 for more information about taking lamievudinite tva . your doctor will monitor you more closely for signs of your hepatis
always take this medicine exactly as your doctor has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to take your doctor lamivudine teva is for oral use . you should take lamivine to start with . if your doctor thinks you may have been able to take more tablets than you should , tell your doctor straight away . this will help control your hepatitis b infection . do not stop taking lamimivudines tva without your doctor' s advice . when to take lamevudince tv take lamyvudinique t Eva every day . it is important that you take lamievudinos , as instructed by your doctor to get the best results for your health . your doctor may prescribe lamivaudinne when you have problems with your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with lamivudine teva . some patients have other conditions that could be fatal , such as hepatitis b . for more information , see ' serious side effects of therapy with hepatis c '. other side effects reported during lamichaurice clinical trials include : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort or pain , nausea , vomiting and diarrhoea , increases in liver enzymes . rare but serious effects have been reported in patients who have not had hep b or c and have been treated with other medicines . contact your doctor if you experience any of these . very common ( may affect more than 1 in 10 people ): increases
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the expiration date refers to the last day of that month . lamivudine teva should be stored in its original package in order to protect from moisture . store in the original package . keep the blister in the outer carton in order for protection from moisture and light . once the blister has been opened , use the product immediately . don ' t throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamichudinne which is contained in each film - coated tablet ( tablet ) 100 mg of lamivine ( as monohydrate ). - other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( azure ), iron oxide red ( bms ). what lamevudines tva looks like and contents of the pack orange , round , biconvex film . the 32 mg tablet is marked with ' l ' on one side and plain on the other side . lamvudince t Eva
nespo is ( anti - anaemic ) used to treat your anaemia . anaesthesia occurs when your blood is low in red blood cells . this can cause the symptoms such as fatigue , weakness and shortness of breath . n espo works by mimicking the natural hormone erythropoietin . the erythropoetIN stimulates your kidneys and stimulatesyour bone marrow to produce more red blood cell . darbepooetine alfa is used to reduce the number of chronic renal failure in adults , adolescents and children aged  18 years with symptomatic anaaemia ( chronic renal fail in children ). naspo is also used to manage chronic renal failed patients whose kidney failure is not working properly . when a kidney fails , the kidney must not produce enough of the natural
do not use nespo - if you have high blood pressure . - take other medicines : - are allergic to nnesco ( darbepoetin alfa ) or to r - hoepo , which are used to treat high blood tension . you should not use medicines to treat sickle cell anaemia . please tell your doctor if your condition has been treated with medicines causing sickle cells ( seizures ). these can be convulsions or fits ( seizures or fits ). - have liver disease caused by drugs . warnings and precautions talk to your doctor or pharmacist before using n espo and if any of the following apply to you : you have anaeemia caused by an allergy to latex . the needle on the pre - filled sealinge is made from a derivative of latex and may cause
your doctor will carry out blood tests before you start using nespo . the purpose of naspo is to check your haemoglobin level , usually between 10 and 100 micrograms / ml . a haemeglobin niveau between 10 - 12 microgram should be maintained at all times . how nnesco is given your doctor or nurse will inject nispo directly into a vein , preferably into : chronic renal failure . it is given as a single injection under the skin or into  a channel ( intravenous ) to treat your anaemia . dose the amount of  n nspo you will receive is calculated based on your body weight . this will be calculated between 0 . 75 and 0. 45 mmol / kg . you will have regular blood samples to monitor how well n
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nеspo : common ( these may affect up to 1 in 10 people ) or uncommon ( these might affect up 1 in 100 people ). high blood pressure ( hypertension ) with fluid retention ( oedema ). uncommon ( this may affect less than 1 in 1 , 000 people ), blood clots ( thrombosis ). pain in the area injected rash and redness of the skin rare ( these are rare ) very rare ( they may affect 1 in every 10 ,000 people ); serious allergic reactions including sudden life - threatening allergic reactions ( anaphylaxis ) which may include swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioe
keep out of the reach and sight of children . store in the original package in order to protect from light . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the expiration date refers to the last day of that month . after first opening : store in a refrigerator ( 2 8 ). do not freeze . keep your sceptrel in the outer carton in order protect from direct sunlight . you may remove nnesco from the refrigerator and store it not above 30 for a single period of up to 7 days without exceeding the expire date . once removed from the fridge , naspo should be used within this period or disposed of . medicines should not be disposed via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect
what nespo contains the active substance is darbepoetin alfa . n espo is supplied in a pre - filled syringe containing 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu ( international units ). - the other ingredients are : sodium phosphate monobasic , sodium phosphoe dibasic ( e339 ), sodium chloride , polysorbate 80 and water for injections . what nevespo looks like and contents of the pack nnesco is a clear to slightly pearly liquid and cloudy , colourless to slightly yellow liquid . it is available in packs containing 1 or 4 pre – filled pens . all pack sizes are available with or without
what macugen is macuGEN is a solution used in the eye to dissolve deposits called pegaptanib . this medicine helps to prevent abnormal formation of new blood vessels in the retina . what macurgen is used for macuogen is used in adults for the treatment of macular degeneration . - this disease causes vision loss and damage to the part of the retina called the macula . the maculate is the thin layer at the back of the eye . when the macula is opened , the eye becomes smaller , and the maculuia becomes larger . as a result of amd , abnormal blood vessels grow and there are more cells in the maculation . how macu Gen works macuGen helps to restore the normal function of the macus . macug helps to repair these new cells and restore the function of your vision .
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if there is an active or suspected infection in or around your eye . warnings and precautions talk to your doctor or pharmacist before using macuGEN . if any of these apply to you , or if they are suspected to be related , tell your doctor . there is a small chance that you may have an infection or bleeding in the eye after macuogen injection . tell your physician immediately if : you have any of or any combination of any of any one of the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , an increased sensitivity to light , small particles in your vision . these may be small particles inside your vision even if only one needle is in your eye
macugen will be given to you by a doctor or nurse who is experienced in the use of injections . macuGEN must be given by  a healthcare professional . it is given as a single injection into your eye for about 6 to 9 weeks . the injection will be made from the surface of the vitreous ( transparent ) part of your eye . before macu Gen is given , your doctor will ask you to use antibiotic eye drops to avoid infecting your eyes . your doctor may also give you some local anaesthetic ( numbing medicine ) to reduce or prevent any pain you might have with the injection . you should not be given macuogen if you are allergic to antibiotic eye drops , or if your doctor thinks they may have given you an increased dose of antibiotic treatment to prevent or reduce eye infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) or angioedema of which symptoms include : breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting / rapid pulse , stomach cramps , nausea , vomiting , diarrhoea . the frequency of these side effects is not known ( frequency cannot be estimated from the available data ). an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . this is usually mild to moderate and usually resolve within 2 to 2 days after the injection . if you experience any of these symptoms , please contact your doctor . not known : frequency cannot vary with the available information , available data or the available evidence of infection in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions . after first opening , the medicine should be used immediately .
what macugen contains the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaaptanibe in 90 mg / ml . the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasic salt phosphatahydrate eheptahydrate ( e339 ), sodium hydroxide / hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugagen looks like and contents of the pack macuGEN solution for injection is a clear , colourless to pale yellow solution , supplied in a single dose pack , in  a pouch inside a pre – filled  sYringe ( 0. 25 mL or 0
kepivance contains the active substance palifermin ( also called escherichia coli ). palifERmin belongs to a group of proteins called epithelial cells , which are found in the mouth , digestive tract and in the tissues below the skin . it works by attaching to the dna of palifersmin . kepepivaze is used to treat oral mucositis ( which causes soreness , dryness and inflammation of the mouth at the site of injection ) as well as other treatments for your blood cancer . you may be receiving a faster growth of your blood tumor when you have received chemotherapy or radiotherapy or autologous hematopoietic stem cell transplantation ( a type of transplantation ).
do not use kepivance if you are allergic to palifermin or escherichia coli derived proteins , or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using kepepivace . children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepingivance tell your doctor or pharmacist if this medicine is harmful to the environment . tell your pharmacist or healthcare professional if any of these apply to you . taking other medicines please tell your dentist that you are taking , have recently taken or might take any other medicines . keparin may be given if a child is recently taken with heparin . pregnancy and breast - feeding kepativance is not recommended if there is a possibility
kepivance should only be given by doctors experienced in cancer treatment . the recommended dose of kepepivace is 60 mg . keparivance is given as a single dose of one kilogram ( 100 micrograms ) by intravenous injection into a vein . it is given to you by your doctor or nurse . how much kepativance you will receive ? keperivance will be given to your child for three days after chemotherapy and radiotherapy . you will be treated for three consecutive days after receiving chemotherapy and receiving radiotherapy after receiving combination chemotherapy andradiotherapy for 24 to 48 hours after receiving the chemotherapy and radiation . your child ' s doctor will decide when to give the chemotherapy or radiotherapy to your baby .
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects reported with kepivance were skin rash , itching and redness ( pruritus ) and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the mouth ou tongue ), generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ) as well as altered taste , lipase and amylase levels . uncommon ( may effect up to1 in 100 people ). reporting of side effects 25 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of palifERmin -the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kespivace looks like and contents of the pack kepepivaze is a white powder for solution for injection that comes in a 6 ml glass vial .
cinacalcet accordpharma contains the active ingredient cinacacet , which works by controlling the levels of parathyroid hormone ( pth ), calcium and phosphorous in your body . it is used to treat problems with organs called parathormon glands . the paratrons are four small glands in the neck , near the thyroid gland , that produce parathelial hormone ( pmr ). cinacinacalce accordpharma is used : to treat secondary hyperparathyroidism in patients with serious kidney disease who need dialysis to clear their blood of waste products to reduce the amount of calcium in the blood ( hypercalcaemia ) in patients suffering from parat thyroid cancer to reduce excess of calcium within the blood( hypercalc aemia in primary hyperparaathyroidismus ) when removal of the gland is not possible . cina Calcet accordmedicine is used in children 3
do not take cinacalcet accordpharma - if you are allergic to cinacacalcet or any of the other ingredients of this medicine ( listed in section 6 ). - when taking tablets , tell your doctor if there are low levels of calcium in your blood . your doctor will monitor your blood calcium levels . warnings and precautions talk to your doctor before taking cina Calcet accord Pharma . cinaCALcet accord pharmaceutical may cause seizures ( convulsions ). these can be seizures , fits , seizures . tell your physician if they occur . you should tell your dentist : - you have liver problems - your doctor may want to reduce your dose , or you suffer from heart failure . when you take cinecalcet acordpharma , calcium levels can cause life threatening events and fatal outcomes . low calcium levels may be associated with hypocalcaemia . therefore 
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . your doctor will tell you how much cinacalcet accordpharma you will take . cina Calcet accordp is for oral use . the tablets must be taken whole and are not to be chewed , crushed or split . you will need to take regular blood samples during treatment to monitor your progress and will adjust your dose if necessary . patients with secondary hyperparathyroidism the recommended starting dose for cinaCALcet accord Pharma is 30 mg . adults , adolescents and children from 3 to less than 18 years of age : one dose of 0 . 20 mg / kg is taken . when to take cinacacalcet acordpharma take cricalcetaccordpharma once a day , at least 30 minutes before or after food . swallow
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you start to get numbness or tingling around the mouth , muscle aches or cramps and seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). signs include : swelling of the face , lips , mouth - tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if any of these side effects becomes severe , tell your doctor . common ( might affect up to 1 in10 people ), dizziness , lightheadedness and / or diarrhoea . this can make you feel weak or lack of energy . you may experience more headaches or dizziest during the
what cinacalcet accordpharma contains the active substance is cinacacalcet . each film - coated tablet contains 30 mg , 60 mg or 90 mg of cinaçacalcet ( as hydrochloride ). the other ingredients are : - tablet core : lactose , cellulose , microcrystalline - crospovidone - magnesium stearate - film coating : indigo carmine aluminum lake , iron oxide yellow ( e172 ). what cinecalcet acordpharma looks like and contents of the pack cinacinacalce accordpharma 30 mg film  film – coated tablets are light green colored , oval shaped ( approximately 9 . 65 mm x 6 . 00 mm in diameter ) biconvex , pink - orange , film . tablet dimension : 14 . 1 mm long 
jentadueto contains two active substances , linagliptin and metformin . linagleptIN belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4- inhibitors ) metformine belongs to the class of substances called biguanides . they work together to control blood sugar levels in adult patients with a form of diabetes called ' type 2 diabetes mellitus '. this medicine can be used alone or together with insulin . this medicinal product can be taken alone or with certain other medicines for diabetes ( such as sulphonylureas , empagliflozin ) that are used to treat type 2 diabetic patients .
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if there is a possibility that you may have severely reduced kidney function if your doctor has told you that you have uncontrolled diabetes , with , for example , severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see " risk of lactic acidsis " below ) or ketoacidosis . ketoacaidosis is  a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead to diabetic pre - coma . symptoms include stomach pain , fast and deep breathing , sweating , or feeling un
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much jentadueto to take the amount of jenteduet that you will take varies depending on your condition and the doses you currently take of metformin and / or individual tablets of linagliptin and metformine . your doctor will prescribe this medicine for you , depending on how well you respond to this medicine . swallow your tablet whole . do not chew or crush the tablet . taking this medicine to treat an upset stomach , your doctor may prescribe you 5 mg linaguiptIN per day or 2 , 000 mg metforminer hydrochloride . take jenaduеto once a day , to control your blood sugar . this medicine can be used alone or with another oral anti - diabetic
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention you should stop taking jentadueto and see a doctor straight away if you notice any of the following symptoms : low blood sugar ( hypoglycaemia ): trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change , confusion . hypoglcaemia is a common ( may affect up to 1 in 10 people ) and is accompanied by a serious allergic reaction ( hypersensitivity ). it is not known how often this occurs ( frequency cannot be estimated from the available data ). the following side effect has been reported with jenteduet plus sulphonylurea , but is more likely to occur with the combination jentaduato plus
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton , blister or bottle after " exp ". the expiration date refers to the last day of that month . blister : store in the original package in order to protect from moisture . bottle : do not take this medicine if you notice any damage or signs of tampering .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each jenteduet 2 . 5 mg / 850 mg film - coated tablet contains 2 , 5 mg of linaguiptIN and 850 micrograms of metformine hydroch chloride - one film  - coating of each juntaduo 2  . 7 mg - 1 , 000 mg film- coated tablets contains 2 mg of " linagillin and 1 . 000 mg of metFORMin hydrocholoride in each tablet . the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide , the 
edurant contains the active substance rilpivirine . ecourse is used to treat human immunodeficiency virus ( hiv ) infection . it is one of a family of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is used when hiv drugs are not effective or you : are at risk of getting hiv ( see " other hiv medicine " in section 4 ). ecursul is used by adults , adolescents and children 12 years of age and older who are infected by hiv and who have already used hiv medications before . your doctor will discuss with you which combination of medicines is best for you .
do not take edurant if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). do not use e pendant if your doctor has told you that you are taking any of these other medicines : - carbamazepine , oxcarbazepine ( e . g ., phenobarbital , or phenytoin ; - medicines to treat epilepsy and prevent seizures ) - rifampicin and rifapentine ( medicines to prevent and treat some bacterial infections such as tuberculosis ) warnings and precautions talk to your doctor , pharmacist or nurse before taking e during e duratantine if : you are being treated with omeprazole / esomeprazola ,
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is : 1 . edurant should be given to you by a doctor or nurse who is experienced in the care of patients aged 18 years and over . your doctor will determine the dose of e during your treatment . 1 ) if necessary , your doctor may ask you to take rifabutin , a medicine used to treat some bacterial infections . it is recommended that ewährend be given only in combination with riabutiner . do not take e pendant more than once a day . 2 ) before you take a tablet of rabutine , you should tell your doctor that you are taking ecourse . an antacid ( a drug used to prevent diseases caused
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience headache , nausea , difficulty falling asleep , insomnia , dizziness , or any of the effects of your routine liver tests : increase in transaminase , increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness / vomiting , and drowsiness , decreased appetite , sleep disorders , night sweats , depressed mood , increased appetite . uncommon cases of amyloidosis ( a type of white blood cell ) have been reported in patients taking edurant . these side effects are usually mild to moderate . however , most cases are mild and usually disappear after a few weeks . if any of these side effect becomes severe ,
what edurant contains - the active substance is rilpivirine . each tablet contains rilspivirie hydrochloride equivalent to 25 mg ripiviline . -the film - coated tablet core contains lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose and magnesium stearate . the film  coating contains lactatum ( 23 mg ), hypromellose 2910 ( 6 mpa . 1 mpl ), titanium dioxide ( e171 ), macrogol 3000 and triacetin . what  ecours looks like and contents of the pack e
avandamet tablets are a combination of two different medicines called rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes . people with type 2 Diabetes either don ' t make enough insulin ( a hormone that controls blood sugar levels ), or don  't respond normally to the insulin their body makes . rosisglit azone or metformIN work together so your body makes better use of the insulin it produces , and this helps reduce your blood sugar to a normal level . it is important that you continue to take avand a diet and exercise plan as agreed with your doctor , pharmacist or nurse .
follow all instructions given to you by your doctor , pharmacist or nurse carefully as they will explain how to treat your diabetes . do not take avandamet if any of the following apply to you : - are allergic ( hypersensitive ) to rosiglitazone , metformin or any ofthe other ingredients of avand amet ( listed in section 6 ) - have had a heart attack or severe angina - suffer from heart failure - had heart failure in the past - suffered from severe breathing difficulties - do not taking avandemet - has liver disease - diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss , nausea or vomiting )- have kidney disease 107 - you may be very dehydrated ( alcohol consumption ) as a result of this medicine you may not be able to take full effect on your
always take avandamet tablets exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the usual starting dose is 2 mg rosiglitazone and 1000 mg metformin , taken once a day . this dose is given on days 1 and 8 of each 3 week cycle . the maximum dose is 4 mg  Rosiglittingazone + 1000 mg of metformine , given once - day , every 3 weeks . your doctor will tell you how much you should take , when to take it and for how long you need to take this dose . see section 2 ' avand ' for more information . if your doctor takes more avandatamet than you should if the dose is too high or too low , talk to your doctor . take your tablets at the same time every day 
like all medicines , avandamet can cause side effects , but not everybody gets them . allergic reactions to avandаmet are rare . you should see your doctor immediately if you experience : raised and itchy rash ( hives ) swelling , sometimes of the face or mouth ( angioedema ), causing difficulty in breathing collapse . if these symptoms occur , stop taking avand amet and seek medical advice immediately . possible signs of lactic acidosis : a build - up of a substance called lactic acids in the blood ( lactic Acidose ) has been reported as a rare side effect with metformin , in patients with severe kidney disease . symptoms of lacecidosis are rapid breathing , cold sweats , and rapid heartbeat . these are all signs of this type of reaction . the most
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . this medicinal product does not require any special storage conditions . if you have any unwanted tablets , don ' t put them in waste water or household rubbish . ask your pharmacist how to dispose of tablets you don  '
what avandamet contains - the active substances are rosiglitazone and metformin . avandagemet tablets come in different strengths . each tablet contains 1 mg of rosivitazon and 500 mg of metformIN . the other ingredients are : tablet core : 2 mg rosviglit azone + 500 mg metformine . tablet coat : 1 mg  Rosiglittingazone & 1000 mg metFORMin - both tablets come as separate tablets . tablets : 4 mg : rosazone * 750 mg metformatin ; 4 mg film - coated tablets rosavitamet + 1000 mg of meetformin * - ingredients : sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate .
clopidogrel mylan contains clopizide and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumpeding , antiplatelets medicinal products reduce the chances of blood  clots forming ( a process called thrombosis ). clodogrell mylan is taken by adults to prevent blood cluts ( thrombi ) forming in hardened blood vessels ( arteries ), a condition known as atherothrombosesis , and atherotrothrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clodegrel to help prevent blood
do not take clopidogrel mylan 31 if you are allergic to clopizide or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , tell your doctor immediately . if there is a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . in case you have severe liver disease . do not taking clodogrell mylan if any of these apply to you at the moment . warnings and precautions talk to your doctor before taking ' taking  clocidogrela mylan'.  tell your healthcare professional before taking this medicine if : you have a risk of bleeding such a condition that puts you at risk of internal bleeding ( such as an stomach ulcer ). you have had a blood disorder that made you prone to internal bleeding , or bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if vous have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogresl myLAN ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended dosage is one 7 - mg tablet , taken orly with or just after food . you should take clodogrell mylan for as long as your physician continues to prescribe it . for further information on the
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and , if not treated , confusion ( see section 2 ' take special care with clopidogrel mylan '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of the Skin . this may be the first signs of an allergic reaction . the most common side effects reported with cdmg are : very common side effect ( may affect more than 1 in 10 people ): diar
what clopidogrel mylan contains the active substance is clopizil . each film - coated tablet contains 75 mg of clodogrell ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' cloded '), talc and macrogol 3000 . what clumps of clumped tablets are : - tablet core : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( 233 ), yellow iron oxide , and talcum and macrogul 3000. what you need to know before you take cloned cloclopidegrel in mylan is a clear , colourless
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . dopelet is used to treat patients with chronic liver disease associated with low platelet count ( thrombocytes ) which are not controlled with a medical procedure preventing bleeding , which may involve the formation of platelets . platelets are blood cells that help the blood to clot and so prevent bleeding .
do not take doptelet : - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking dop Telet . blood clots can form in the veins or arteries and this can increase the risk of blood clumping . tell your doctor before taking this medicine if any of these apply to you . - blood coagulation can occur in certain circumstances , including blood globins . your doctor will advise you how to prevent blood clitches from forming . talk to you doctor before using doptelt if : you have cancer . you are taking the contraceptive birth control pill or hormone replacement therapy . recently had surgery or were injured . 23 - you are overweight . this medicine
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is 5 mg once a day . your doctor will decide on the dose that is right for you , depending on how well you respond to the medicine . this may be repeated at intervals of up to 8 weeks . take the dose of doptelet as prescribed by your doctor . you should take dopelet every day at the same time of the day , as instructed by your physician . do not increase your dose yourself unless your doctor tells you to . doses of dopetelet can be increased by 20 , 40 and 60 mg / m2 of body surface area over a period of 5 days . depending on your platelet counts , your doctor may change your dose , or stop the administration , if your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ): feeling tired uncommon ( may effect up to1 in 100 people ]: low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel in the liver and intestines ) upper abdominal pain , swelling bone pain muscle aches fever reporting of side effects get a quick call or two hours after your injection . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine by reporting the side effects listed in ' safety of doptelet ' by reporting any side effects by reporting back to
what doptelet contains the active substance is avatrombopag . each film - coated tablet contains avatorabopag maleate equivalent to 20 mg avatarombog . the other ingredients are : lactose monohydrate ( see section 2 ' dopelet contains lactoses '), microcrystalline cellulose , crospovidone type b [ e1201 ], silica , colloidal anhydrous , magnesium stearate , vinyl alcohol , part hydrolysed , titanium dioxide ( e171 ), iron oxide yellow ( er ). what dopet looks like and contents of the pack doptelt 20 mg film  tablet is pale yellow , round and rounded , with " av2 " marked on one side and " 20 " on the other side . - the tablets
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by helping to relax the muscles in your heart , allowing the doctor to see more clearly and improve heart rate . rapican is used in adults for a type of heart scan called  myocardial perfusion imaging ' where the scan is taken . it contains a radioactive substance called a ' radiopharmaceutical ' which helps to obtain clearer pictures of the muscles of your heart and helps your doctor to visualise them . this can be done with a treadmill , for example by measuring the amount of radioactivity in your blood or by using a machine that measures the electrical activity of your cardiovascular system . after a scan , you may receive a small amount of Radiopharmacient material which is absorbed into your body or injected into 
do not use rapiscan - if you have slow heart rate or have high degree heart block or sinus node disease and do not have a pacemaker - when you have chest pain ( unstable angina ) do not start treatment and talk to your doctor if this applies to you . - the recommended dose for treatment of low blood pressure ( hypotension ) or heart failure - are allergic to regadenoson or any of the other ingredients of rapissecan ( listed in section 6 ). if any of these apply to you before you use , tell your doctor before using rapistcan . warnings and precautions talk to you doctor before you start using raciscan and before you begin to use . before you are given rapican , you must tell your doctors if : - you have - had a recent serious heart problem such as a heart attack
rapiscan is intended for diagnostic use only . it is used to measure your heart and blood pressure , and to help determine the correct dose of blood pressure in adult patients . the recommended dose is 400 micrograms / kg body weight given as one injection of 400 microlitres in a 5 ml solution the injection will take about 5 to 10 minutes . your doctor will decide the dose you need based on your weight . if you are having an injection of sodium chloride 9 mg / m3 ( 0 . 9 %) solution for injection , the dose given will be 5 microgram / min . this dose will be diluted with a radioactive substance ( radiopharmaceutical ) before and after rapissecan . dose of rapistcan will depend on your heart rate . you should take the dose once a day for as long as prescribed by your doctor
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects reported following the rapican injection are usually mild to moderate and occur within 30 minutes to a few hours after any treatment . tell your doctor straight away if you notice any of the following side effects as they could be a sign of sudden stopping of the heart or damage to the heart ( for example , heart block or a disorder of the cardiac signal ). rapid heart beat low blood pressure fainting , mini strokes , weakness of the face or inability to speak . rapistcan may also cause a stroke or cerebrovascular accident . an allergic reaction ( e .g ., rash , wheals / weals , sores ) or rash of the skin . severe allergic reaction may be life - threatening . signs of severe
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your peni when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . you should not take viagra as a treatment for adult men with erectile dysfunction , also known as impotence . this is when a man cannot get , or keep a hard , hard - to - ed penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - do not taking medicines called nitrates , as the combination may lead to a dangerous fall in your blood pressure . tell your doctor if any of these medicines are used in the treatment of angina pectoris ( or " chest pain "). if the medicines are given by nitric oxide donors , such as amyl nitsitrite (" poppers "), as the combined effect may also lead to another dangerous fall . if your blood temperature is increased , tell your physician . warnings and precautions talk to your doctor before taking viagra : -if you ' re taking riociguat . this drug is used to treat pulmonary arterial hypertension ( i . in .
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 50 mg once a day . you should not take viagra film - coated tablets or viagra orodispersible tablets . your doctor will tell you how many tablets of viagra to take . swallow the tablets whole with water . viagra can be taken with or without food . it is important that you take viagra every day until your doctor tells you otherwise . if your doctor thinks that it is safe for you to take viagra , do not take it with food unless your doctor told you to . do not try to take Viagra unless you have been told to do so by your doctor and / or your partner . this will help you to get an erection if he / she is sexually stimulated . taking viagra
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported in association with the use of viagra are usually mild to moderate and of a short duration . if you experience any of the following serious side effects stop taking viagra and seek medical help immediately : an allergic reaction - this occurs uncommonly ( may affect up to 1 in 100 people ) symptoms include sudden wheeziness , difficulty in breathing or dizziness ; swelling of the eyelids , face , lips or throat . chest pains - get in a semi - sitting position and try to relax . do not use nitrates to treat your chest pain . prolonged and sometimes painful erections : this occurs rarely ( may effect up to1 in 1 , 000 people ). if your er erectile dysfunction does not last long enough for you
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of silddenaf ( as the citrate salt ). - other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( е132 ). what viagra looks like and contents of the pack viagra film - coated tablets are blue coloured with a rounded - diamond shape and marked " 25 " on one side . the tablets are provided in blister packs containing 2 , 4 , 8 or 12 tablets . not all pack sizes may be marketed .
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopame receptors in the brain . stimulation of the dopami receptors triggers nerve impulses inthe brain that help to control body movements . sfrol is used to : - treat the symptoms of primary parkinson ' s disease in adults . it can be used alone or in combination with levodopa ( another medicine for parkinsons ' disease ). - help to , reduce the symptoms in patients with moderate to severe primary restless legs syndrome in adults and adolescents .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sfrol . tell your doctor if any of these applies to you . srol is not recommended for use in patients with any medical conditions or symptoms . symptoms of kidney disease can be hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinosations are visual . dyskinesia ( e . all , abnormal , uncontrolled movements of the limbs ). if your doctor thinks you may have advanced parkinson ' s disease and you are also taking levodopa , you may develop dyskineia when taking a dose of sirol , as s
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . sifrol is for oral use . swallow the tablets with water . parkinson ' s disease patients : for the first week , the daily dose is 3 tablets . during the first weeks , your doctor will increase your dose . 1 week : start taking sIfrol 0 . 088 mg twice a day ( corresponding to 0. 264 mg daily ). after 1 week your doctor may increase your dosage to a higher or lower dose , and your doctor might increase your daily dose to sfrol 0-0 .0088 mg twice daily to 0- 0 ( 0 debossed on the tablet and 0 " 264 "). after this period , you will start taking tablets at the same time every day and at the
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common may affect more than 1 in 10 people common may effect up to 1 in every 10 people uncommon may affect up to1 in 100 people rare may affect less than 1 person in 1 , 000 people very rare may effect less than 10 ,000 people not known frequency cannot be estimated from the available data if you suffer from parkinson ' s disease , you may experience the following side effects as a result of taking sifrol : dyskinesia ( e . g . abnormal , uncontrolled movements of the limbs ) dizziness nausea ( sickness ) common urge to behave in an unusual way - hallucinations ( seeing , hearing or feeling things that are not there ) confusion , tiredness
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0. 18 mg / 0 in. 35 mg or 0i . 7 mg pramipeexol as 0
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used in adults for the prevention of allergic conditions that affect the transparent layer in the front part of the eyes and for the relief of the allergic reaction . allergic conjonctivits may occur when some materials ( allergens ) are inhaled into the airways and cause allergic reactions such as itching , redness and swelling of the surface of your eye , if you notice that you do not feel better or if your symptoms do not improve .
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using e madine : - for the treatment of patients under the age of 3 years , with benzalkonium chloride ( see section 6 " contents of the pack and other information "). - in clinical trials with emagine , no data are available . - some patients have kidney or liver problems . talk to the doctor or pharmacist before using the product . children and adolescents ebadine is not recommended for use in children and teenagers under the aged of 3 months . other medicines and emedicine tell your doctor or nurse if using , have recently used or might use any other medicines . in particular , tell your pharmacist if use of
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is 3 drops in each eye . use this product every day for as long as your daily dose is the same for both eyes ( see section 3 ). how much to use 1 2 get the emadine bottle ready to use in a mirror . wash your hands before you use . take the bottle and the cap off before you open it . after cap is removed , the bottle should be used immediately . if the cap is loose , snap collar is loose or loose . hold the bottle , pointing down , between your thumb and finger . tilt your head back . pull down your eyelid with a clean finger , until there is a ' pocket ' between the eyelid and your eye , to release the drop 
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using the drops and tell your doctor straight away if you notice any of the effects listed below . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye , eye redness . uncommon side effects these may affect more than 1 in 100 people ). effects in and around the eye: corneal disorder ( abnormal eye sensation ), increased tear production , tired eyes , and eye irritation , blurred vision , corneal staining . not known ( frequency cannot be estimated from the available data ) side effects in your own eye . reporting of side effects 23 if your eye drops are any side effects you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects your doctor can help provide more information
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and the blister after exp . the expiration date refers to the last day of that month . store below 25 . this protects from moisture and prevents infections . throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains the active substance is emanastine . each ml contains 0 . 5 mg difumarate . the other ingredients are benzalkonium chloride , trometamol , sodium chloride ( e339 ), hypromellose , purified water , hydrochloric acid and sodium hydroxide to keep acidity levels ( ph levels ) normal . what  e madine looks like and contents of the pack ebadine is a liquid ( a solution ) supplied in a 5 mL or 10 mlitre plastic ( drop - container ) bottle with a screw cap .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetistetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepilpsy , to treat a certain form of epilema . epilemy is a condition where the patients have repeated fits ( seizures ). in most cases , levetiractam fits the larger size of the epilemic brain , but could thereafter extend to larger areas on both sides of the brain ( partial onset seizure with or without secondary generalisation ). Levetiracetagam has been given to you by your doctor to reduce the number of fits . as an add - on to other antiepepilic medicines to treat partial initiation seizures ( with or with secondary generalization ) in adults , adolescents and children
do not take levetiracetam actavis if you are allergic to levetiractam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking levetiratetam actingavis as it may cause kidney problems . tell your doctor if your dose is too low . he / she may decide if the growth or unexpected puberty development of your child should be considered . in a small number of people being treated with anti - epileptics such as levetistetam actsavis have had thoughts of harming or killing themselves . you should immediately contact your doctor or seek medical attention if any symptoms of depression and / or suicidal ideation are noticed . some patients have had side effects such as abnormal thoughts , feeling irritable or reacting
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . take the number of tablets following your doctor' s instructions . levetiracetam actavis is taken twice a day , once in the morning and once inthe evening . monotherapy dose in adults and adolescents ( from 16 years of age ) : general dose : between 1 , 000 mg and 3 , 500 mg each day . when you will first start taking levetiractam actingavis , your doctor will prescribe you a lower dose ( 500 mg every other day ) during 2 weeks before giving you the lowest general dose of 1  , 600 mg . add - on therapy dose in adult patients ( 12 to 17 years ): weighing 50 kg or more : when you first start using levetiratetam ,
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately , or go to your nearest emergency department , if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction ; swelling of the face , lips , tongue and throat ( quincke ' s oedema ); flu - like symptoms and a rash on the face followed by an extended rash with a high temperature ; increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell 56 ( eosinophilia ) and enlarged lymph nodes ( drug reaction with the hepatitis b virus ). uncommon side effects ( may affect up to 1 in 100 people )
what levetiracetam actavis contains the active substance is called levetiractam . one tablet of levetistetam actionavis 250 mg contains 250 mg of levracettam each day . levetiratetam actingavis 500 mg contains 500 mg of Levetiracem each day. levragetam atavis 750 mg contains 750 g of leveracetm each morning . the tablet is empty . when you first start taking levetiretam the next day , your doctor will decide whether to give you the first dose . each tablet of the 750mg tablet contains 720 mg of the active ingredient . - levetiacetam actsavis 1 , 000 mg contains 1  ,000 mg of duvetiracetabletam in the form of crospovidon and povidone .- the other ingredients are si
what incruse ellipta is this medicine contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . what increse
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you , do not using this medicine and tell your doctor immediately . warnings and precautions talk to your doctor before using this product : - for asthma ( see " incruses ellippa is not recommended for use in patients with asthma ") - to treat heart problems - you have an eye problem called narrow - angle glaucoma - have an enlarged prostate , difficulty passing urine or a blockage in your bladder - your doctor may want to monitor you more closely - severe liver problems . immediate breathing difficulties if your chest gets worse , coughing , wheezing or breathlessness immediately after using your incrused ellipida inhaler
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation every day at the same time of day . you only need to inhale once a day because the effect of this medicine lasts for 24 hours . do not use more than your doctor tells you to use . use incruse ellipta regularly it is very important that you use increse
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you have any of the following symptoms after taking incruse ellipta stop using this medicine and tell your doctor immediately : itching skin rash ( hives ) or redness 29 other side effects common ( may effect up to1 in 10 people ) faster heart beat painful and frequent urination ( may be signs of a urinary tract infection ) common cold infection of nose and throat cough feeling of pressure or pain in the cheeks and forehead ( may represent inflammation of the lungs ) inflammation of intestines and lungs inflammation of liver , kidney or urinary system infection . reporting of side effects 25 if your child gets any side effects talk to your doctor , pharmacist or nurse . this includes any
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the inhaler in the sealed tray in order to protect from light . after first opening of the tray , the inhaled tray can be used for up to 6 weeks . once the tray is opened , use the inhamper once a day . write the date on the ink on the carton including day / month / year . when you have used the inhabitant of the ingram in the space provided , and write the day of the month on the attached tray . this medicine does not require any special storage conditions . dispose of the used inhalers after 30 . discard the in
what incruse ellipta contains the active substance is umeclidinium bromide . each single inhalation provides a delivered dose ( the dose leaving the mouthpiece ) of 55 micrograms umeklidinium ( equivalent to 65 microgram of umecclidini bromida ). the other ingredients are lactose monohydrate ( see section 2 under ' incruses ellipata contains lactoses ') and magnesium stearate . what increse incrussanta looks like and contents of the pack incrusite ellipinta is an inhalations powder , pre - dispensed . the ellipe ellipase inhaler consists of a grey plastic body , a light green mouthpiece cover and a dose counter . it is packaged in a foil laminate tray with a
nucala contains the active substance mepolizumab . this is a monoclonal antibody , a type of protein that recognises and attaches to a specific target in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils , which are a kind of white blood cell that circulates in the lungs . eeoSinophilic asthma is causing asthma nucală is used in adults to prevent asthma attacks and to reduce the need for medicines called high dose inhalers to control your asthma . these medicines may be used alone or together with medicines called oral corticosteroids . nucalа can also be used if your asthma cannot be controlled with mepolizamab or interleukin - 5 , and this protein is involved in the
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine . this medicine has been shown to increase the risk of worsening asthma . in some patients ( more than 58 %), people have asthma - related side effects due to their asthma , and your doctor may recommend that nucalala be discontinued . if your asthma gets worse during nucalа treatment , tell your doctor . you are also allergic to other injection site reactions medicines of this type ( monoclonal antibodies ) can cause severe allergic reactions when they are injected into the body . see section 4 for more details about side effects . expect to have a similar reaction after you have received nucalam . parasitic infections nucalaci can weaken your resistance to infections
nucala is given by injection under the skin ( subcutaneous injection ). the recommended dose is 12 micrograms / kg injected once a week . the recommended injection is 100 microgram / mm3 in one injection in 1 millilitre ( ml ) of water for injection each day . use in children and adolescents the pre - filled pen can be used for children and teenagers . duration of treatment with nucală can be longer than one year . if you use more nucalala than you should if the dose is increased , you should contact your doctor . your doctor will decide how long you should use nucalar . depending on the response to the treatment , your doctor may decide to continue the treatment with Nucala . you should continue to use nuCALa for as long as your asthma symptoms and attacks improve . do not increase the doses until your asthma problems
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur commonly ( up to 1 in 10 people ) near where the injection is given . sometimes symptoms include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness / feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have had a reaction similar to or similar reactions to nucalа . if this happens to you , you should stop using nucalum and talk to your doctor . warnings and precautions talk to the doctor or nurse before using nuCALa . allergic reactions are very common ( may affect more than 1 in every 10 people
keep out of the sight and reach of children . do not use nucala after the expiry date which is stated on the label and carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 to 8 ). do not freeze . keep the nucale pre - filled pen in the outer carton in order to protect from light . after first opening or if carried as a spare you can carry your nucal
what nucala contains - the active substance is mepolizumab . 1 ml contains 100 mg of mepolizamab in 1ml . - other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate . polysorbate 80 , edta disodium dihydrate ; water for injections . what nuCALa looks like and contents of the pack nucale is presented as a clear and colourless solution for injection . it is supplied as : - 1 g solution for infusion - a pack containing 1 x 1 v , or as - as  a multipack containing 3 x1 mL solution for administration . not all pack sizes may be marketed .
what ninlaro is nINlaron is a cancer medicine that contains the active substance ixazomib , called a ' proteasome inhibitor '. what ? nninlaaro was prescribed to treat adult patients with a type of cancer of the bone marrow called multiple myeloma . ixizomiber reduces cell survival by stopping proteasoms from working . in myelama cells , a lot of proteins called proteases play an important role in controlling cell function . what is ' ninelar'? - ninchlar is used to treat multiple myomomum if : - the active ingredient in ninklar is lenalidomide and dexamethasone , or other medicines used to manage multiple myé
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking nnlar . if any of these apply to you , tell your doctor immediately and stop taking . you should not take the medicine if during treatment with nINlara , bleeding , persistent nausea , vomiting , diarrhoea ; nerve problems such as tingling , numbness , swelling or a persistent rash ; liver or kidney problems . your doctor may decide to reduce your dose , stop treatment with the next dose . before you start taking a dose of ninklararo you will have blood tests to check that you have enough blood cells . children and adolescents n
ninlaro should be prescribed to you by a doctor with experience in treating multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . nnlaron is taken in combination with lenalidomide , a medicine that contains dexamethasone , an anti - inflammatory medicine . taking nlargo in combinationwith lenaldomide and dex amethamethason is the recommended treatment for patients on a 4 - week treatment . you will be given n inlara once daily on the same day of the week . it is usually taken on the first 3 weeks of the year and then again on the third day of each month . your doctor will tell you how long you should keep taking lenadomide in the first
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds easily bruise nausea vomiting diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet( peripheral oedema ) skin rash ( itchy ) all over the body . rare side effects these may affect up to 1 in 1 , 000 people : allergic reactions ( anaphylactic shock ) ninlaro may cause a combination of a variety of symptoms , which may include : tremor or hyperactivity ( see section 2 ) high blood sugar ( hypoglycaemia ) feeling sick ( nausea ) or vomiting ( di
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister or carton after exp . the expiration date refers to the last day of that month . store below 30 . keep the capsule in the outer carton in order to protect from light and moisture . this medicine does not require any special temperature storage conditions . does not use if you notice any damage or signs of tampering to medicine packaging .
what ninlaro contains each hard capsule contains 2 . 3 mg of ixazomib . each capsule contains 3 . 4 mg of the active substance , ixazamibe citrate . the other ingredients are microcrystalline cellulose , magnesium stearate and talc . capsule shell : gelatin , titanium dioxide ( e171 ), red iron oxide ( ileum ). printing ink : shellac , propylene glycol , potassium hydroxide , black iron oxide , yellow ( oblong ). nninlanaro 3 mg hard capsules : ixizomibbing 3 mg capsules: xazomimab citrate the other ingredient is : microcrystalline capsule content : macrocrystalline , microcrystalline collagen , and magnesium sterarate , all in the
do not use palforzia : - if you are allergic to peanuts , or to arachis hypogagaea . warnings and precautions talk to your doctor or pharmacist before using palforizia , - children and adolescents ( aged 4 months to 17 years ) who have responded to treatment with palforziea - this medicine contains peanut allergy . peanut ( desensitisation ) should be avoided during treatment with paleforziа . if allergic reactions occur , palforzaa must be stopped . food allergies should be handled under the supervision of a healthcare professional . you should follow the instructions for use of palfor zia carefully .
do not take palforzia - if you are allergic to peanut allergy . warnings and precautions talk to your doctor or pharmacist before taking palfor zia . - people with severe asthma if your asthma does not go away or if he / she has a problem swallowing . some people with long term problems with your digestive system such as a severe mast cell disorder or severe or life -threatening anaphylaxis will develop within 60 days of starting treatment . your doctor will decide if this applies to you . you will not be given palforzaa until the symptoms have disappeared . peanut allergy may occur when you are treated with palforizia , but it is not known if it causes an allergic reaction . during treatment with pal forzia some people developed peanut allergy and allergic reactions have continued after you have been given pal for zia as it is believed that peanut allergy
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this is because allergy or allergic reactions ( anaphylaxis ) can occur rarely . they can happen within 3 months of starting treatment with palforzia . you will be given initial dose escalation . these treatment phases are called the initial dose elevation and up - dosing phases . your doctor will decide when to restart palforzaa , and will explain how to prevent you from taking palfor zia : - try to avoid desensitisation , particularly on the day you are feeling unwell , or if your asthma is not stable after initial dose elevation . initial dose evolution can be continued during the first 4 to 5 hours after the first day . if this happens , you should contact your doctor immediately . it is very important that
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with palforzia : - severe allergic reactions tell your doctor or nurse straight away if you get any of the following symptoms after stopping palforza , and getting the reaction : trouble breathing - throat tightness - feeling of fulness - trouble swallowing - speaking - changes in voice - dizziness / fainting , severe stomach cramps or pain , vomiting , diarrhoea - extreme flushing or itching of the skin palforizia can cause problems with the stomach and digestive system . tell your physician straight away or go to the hospital if the symptoms get worse or get worse . not known : frequency cannot be estimated from the available data - low blood sugar . reporting of side effects you can help provide more information on
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiration date refers to the last day of that month . store below 25 . this medicine does not require any special temperature storage conditions . dispose of any hard lumps of powder after dilution . any unused solution should be thrown away .
what palforzia contains the active substance is : palaforzian 0 . 5 mg , 1 mg / 10 mg or 20 mg . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , magnesium stearate palforza 100 mg : powder for oral powder in capsules after opening microcrystalline microcrystalline cell , coloidal an hydroous siLICA , and magnesium STEarate paforzie 300 mg - powder for or oral powderin sachet microcrystalline silico , co - administration colloidal nhydrous silica , e572 , indigo carmine , iron oxide red ( e172 ) and magnesium strenuous . this medicine contains beige oral powder . initial dose escalation ( see section 3 ). pack sizes of 13 and over 50 single 
zerene belongs to a group of substances called benzodiazepine - related medicinal products , which also contain hypnotic actions and which help you to sleep . zere is used in adults , adolescents and children from one month of age . it is used when sleeping problems do not go away after a long period of treatment . the duration of treatment should usually vary from a few days to two weeks . do not stop taking zerenne unless your doctor tells you to .
do not take zerene if you suffer from hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zere . zerenede sleep apnoea syndrome , which occurs more often during the night , and for short periods afterwards . you have severe kidney or liver problems . your doctor may ask you to have myasthenia gravis very weak or tired muscles . this may result in severe breathing or chest problems , especially in women . children and adolescents ( aged 18 years and older ) zerent is not recommended for children and teenagers because it has not been studied in this age group . the safety and efficacy in children and young people have not been established . therefore , zerennee has not yet been studied and its undesirable effects have been observed with any medicine , including any medicines that may induce physical dependence .
always take zerene exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is 10 mg once a day , if your doctor advises you to take a higher dose , less than 10 mg twice a night . if there is no reason to believe that you are going to have difficulty falling asleep , call your doctor right away . do not take zene if the above applies to you : 65 - if : you have mild to moderate liver problems , take 65 mg once or 5 mg twice daily . for mild to medium liver problems take 5 mg once daily , until your doctor tells you otherwise . take the capsule once if this applies to your first dose . it may become cloudy , you may notice that you have an overdose , or you may become increasingly drow
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common (affecting 1 to 10 users in 100 ) uncommon ( affect 1 to10 users in 1 , 000 ) rare ( affect1 to 10 user in10 ,000 ) very rare (affecting less than 1 patient in 10 and more than 10 ,0000 ) not known ( frequency cannot be estimated from the available data ). as with all medicines the side effects can be increased if there are any other variations in your healthy habits . some patients have experienced the following side effects while taking zere : drowsiness , memory difficulties and sensations like tingling in the extremities 
what zerene contains the active substance is zaleplon 5 mg . the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ), titanium dioxide ( idr - 1521 ). the printing ink contains gelatin , titanium dioxide . printing in black ink ( containing red iron oxide ( ), yellow iron oxide , black iron oxide [ e172 ), sodium laauryl  sulfate ) and silicon dioxide ( ( s - 13050 ) printing inked in black on the body . inks contain shellac , lecithin , simethicone , yellow iron dioxide ( the ink may contain red in
